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Abstract 
Host-Guest chemistry based on mesoporous silica materials has attracted increasing attention 
in the past two decades. Potential applications for these functionalized materials are in the 
fields of controlled drug delivery, catalysis, separation or encapsulation of functional 
biomolecules.  
The present work is focused on the synthesis of nanosized, mesoporous drug delivery devices, 
which are able to release a preloaded drug as a result of a certain trigger action, e.g. during the 
endocytosis in a cancer cell. For this purpose, several different synthesis strategies had to be 
developed in order to incorporate the different required functional groups within one 
mesoporous silica nanoparticle.  
A spatial separation of two different functionalities was achieved by the development of a 
sequential co-condensation approach. With this approach, core-shell bifunctionalized 
colloidal mesoporous silica could be synthesized. The obtained particles are an important 
prerequisite for other systems presented in this work. 
The applicability of the copper-(I)-catalyzed Huisgen reaction (click reaction) as mild 
synthetic tool for the immobilization of biomolecules in the channels of mesoporous silica 
was investigated. In this joint project between our group and the research group of Prof. Ernst 
Wagner (LMU), it was shown that a sensitive enzyme can be immobilized with this strategy 
in the pores of SBA-15. It was demonstrated that the recoverability and long-term stability of 
the active enzyme benefits from the encapsulation in the host.  
The well-known strong biotin-avidin interaction was used for the construction of a protease-
responsive cap system for controlling the release from colloidal mesoporous silica. 
Fluorescein was released from the nanoparticles as a model compound for small drug 
molecules. In order to monitor the release, a custom-made two-compartment fluorescence 
cuvette was designed. Thermoresponsive opening through protein denaturation was 
demonstrated for temperatures higher than 90 °C. 
A programmable opening temperature for this concept became possible by using DNA-linkers 
between the silica surface and the avidin cap. It was demonstrated that the length of the 
double-stranded DNA controls the opening temperature of the avidin cap. This work was 
carried out as a join project between our group, the research group of Prof. Thomas Carell 
(LMU) and the baseclick GmbH.  
Redox-responsive drug delivery was investigated in living cells. In this context, the release of 
disulfide-linked, dye-labeled cystein from the core of colloidal mesoporous silica was 
monitored by confocal fluorescence microscopy at a single cell level, in collaboration with the 
research group of Prof. Christoph Bräuchle. It was shown by photoinduced endosomal rupture 
that the endosomal escape is a bottleneck in redox-based drug delivery. 
This concept was extended through the synthesis of photosensitizer-functionalized, 
PEGylated colloidal mesoporous silica. It was demonstrated that particle-loaded endosomes 
collapse under irradiation with 405 nm light and release the particles into the cytosol.  
In another joint project between the groups of Prof. Bein, Prof. Bräuchle, Prof. Rädler and 
Prof. Leonhardt together with Dr. Ulrich Rothbauer (all LMU), the novel photosensitizer-
functionalized porous nanoparticles were used as carriers for the delivery of small GFP-
binding antibodies from Camelidae sp. into GFP-tubulin expressing HuH7 cancer cells. 
Additionally, the particles were encapsulated by a supported lipid bilayer. The attached 
photosensitizer was shown to play a key role in the delivery mechanism. Light-irradiation was 
used to destroy both surrounding membranes (supported lipid bilayer and endosomal 
membrane). 
Finally, the pH-responsive release of the membrane-intercalating peptide mellitin from a 
mesoporous SBA-15 host was demonstrated.  This was possible through the use of pH-
sensitive acetal linkers. The release of the peptide was shown by the lysis of mouse 
erythrocytes. This work was carried out in collaboration with the group of Prof. Ernst 
Wagner. 
To summarize, mesoporous silica materials were functionalized with different biomolecules 
in order to generate novel materials for potential applications in drug delivery or other 
controlled release applications. The newly developed concepts provide a basis for future work 
on mesoporous silica as a powerful and versatile drug delivery platform.  
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1. Introduction 
1.1 Ordered porous materials and their evolution 
Before the early 1990’s, zeolites (crystalline alumosilicates exhibiting microporosity) were 
considered to be the prototype ordered porous materials. This materials class was copiously 
investigated for many applications like ion exchangers, molecular sieves and catalysts.1,2 
Apart from these traditional zeolite application fields, newer areas of research include medical 
applications,3-5 photovoltaics,6,7 heat storage,8 chemical sensors9-11 or hydrogen storage 
materials.12-14 Porous materials to be used as carriers for enzymes or for the controlled release 
of larger molecules require larger pores, thus the small pores of zeolites between 0.5 and 1 nm 
exclude this materials class as possible option for such applications. In 1992, the Mobil Oil 
corporation introduced a novel type of silica-based molecular sieve, the M41S familiy.15,16 
The main characteristics of this material include the long range order of mesopores, formed 
by amorphous silica walls, its high internal surface area of around 1000 cm2g-1, and pore 
diameters around 3-5 nm, respectively. This materials class was soon extended by the 
development of different synthesis strategies. Today, mesoporous silica materials with pore 
diameters in the range between about 2-50 nm are accessible. This flexibility allows the 
construction of tailor-made materials for diverse applications such as controlled release,17 
catalysis based on immobilized enzymes18,19 or the growth of nanowires in the confined 
environment of mesopores.20-22  
Another class of porous materials was introduced by Yaghi et al. in 1995, i.e., the so-called 
metalorganic frameworks (MOF).23 A MOF consists typically of di-, tri- or tetravalent metal 
centers, which are connected by organic linkers with corresponding complexing ligand 
moieties. MOFs with larger cages were published a few years later, featuring pore sizes of 
about 2 nm. These so-called MILs (Materiaux de Institute Lavoisier) were the first crystalline 
mesoporous solids.24,25 Another class of porous hybrid materials with covalent bonds was 
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developed by Yaghi et al. in 2005: covalent organic frameworks (COFs). This class of 
material can be obtained by the condensation of organoboronic acids with diol-moieties.26   
The widely discussed field of multifunctional mesoporous silica-based drug delivery devices 
emerged after the development of nanosized mesoporous silica particles.  
The following work will highlight the progress of the synthesis of such a drug delivery device 
based on mesoporous silica. Several aspects like biocompatible synthesis strategies and tuning 
the behavior of the particle in a cancer cell will be considered. The different prerequisites for 
the function of the nanodevice to be generated are studied in detail and a solution to each of 
the issues will be proposed.  
 
1.2 Synthesis of mesoporous silica 
The formation of mesoporous materials such as the M41S-familiy is driven by a cooperative 
self-assembly of organic surfactants and inorganic species. As structure-directing surfactants, 
micelles of quaternary ammonium salts (hexadecyltrimethylammonium bromide) that form 
liquid crystalline micelles are used. Silica precursors like tetraethyl orthosilicate can be 
hydrolyzed under hydrothermal conditions in basic media, resulting in silica materials with 
high internal surface area and highly ordered pore structures with pore diameters around 4 
nm, surrounded by amorphous pore walls. The obtained materials were classified based on the 
geometrical arrangement of the cylindrical pores. The MCM-41 material exhibits a 2D 
hexagonal arrangement of pores, while MCM-48 has a 3D cubic pore system. A 1D array of 
layered sheets is called MCM-50 (Figure 1.2.1).27   
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Figure 1.2.1. Structures of mesoporous M41S materials: (a) MCM-41, (b) MCM-48, and (c) 
MCM-50. Picture taken from reference 27. 
 
Other strategies to create mesoporous silica structures use neutral surfactants. In the materials 
introduced by Pinnavaia et al., non-ionic interactions between the organic template and the 
inorganic silica precursor are responsible for the formation of the porous materials.28,29 HMS 
(Hexagonal Mesoporous Silica) materials use primary amines as template to create 
mesoporous silica structures.30 Poly(ethylene oxides) are used as a template in the formation 
of MSU materials (Michigan State University).31 Accessible pore diameters using this 
strategy are in the range of 4 nm to 14 nm. The advantage of the neutral surfactants used in 
HMS and MSU materials is the easy recoverability of the template.28  
Another very prominent type of mesoporous silica materials was presented by Stucky et al. in 
1998, the SBA materials (Santa Barbara materials).32,33 Triblock copolymers of the Pluronic 
family were used as template. The structure of the template consists of poly(ethylene oxide)x-
poly(propylene oxide)y-poly(ethylene oxide)x units with variable chain lengths x and y. The 
synthesis environment for the SBA materials is strongly acidic. A main feature of the 
obtained mesoporous materials is the improved hydrothermal stability, due to the formation of 
thicker pore walls compared to MCM-materials.34 The obtainable pore diameters are up to 18 
nm and the pore walls do contain additional microporosity, due to the embedding of 
poly(ethylene oxide) side chains in the structure.32,35 
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1.3 Formation mechanism of mesoporous silica 
In general, four ingredients are necessary to form a mesoporous silica material: a surfactant, a 
silica source, an acid- or base catalyst and a solvent like ethanol or water. Based on this 
generalized recipe, many different synthesis procedures have been developed and were 
extensively reviewed in the recent years.27,36-38 For cationic surfactants, the formation 
mechanism of mesoporous silica is strongly influenced by ionic interactions between anionic 
oligosilicates and the cationic headgroup of the template (e. g. CTAB), and no initial liquid 
crystalline phase is necessary for the synthesis.39,40 In a first step, Coulomb forces lead to an 
assembly of silicate polyanions at the positively charged headgroups of the cationic 
surfactants. As a result, the charge density changes dramatically at this interface, which leads 
to the formation of micelles in a structure depending on the applied reaction conditions. The 
final mesostructure is formed by crosslinking and polymerization of the silicate species. The 
product is a result of the optimized interfacial energy of the organic surfactant and the 
inorganic silica.  
In contrast to this cooperative self-assembly process, another formation mechanism called 
“true” liquid crystal templating is known (TLCT). In the latter case, the liquid-crystalline 
phase is already present at the applied reaction conditions.41 The inorganic precursor is added 
and polymerized thereafter. A schematic overview showing the two possible general 
formation mechanisms is presented in figure 1.3.1. 
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Figure 1.3.1. Schematic overview about mesoporous silica formation mechanisms: (A) 
cooperative self-assembly and (B) true liquid crystal templating (Figure taken from reference 
36). 
 
A subsequent removal of the template can be achieved either by calcination at high 
temperatures or by extraction procedures. A typical extraction procedure used in the present 
work uses ethanolic ammonium nitrate solutions. The exchange of template with ammonium 
is highly efficient due to the high similarity of surfactant head group and extraction reagent.42 
Other extraction methods apply supercritical CO2, plasma or microwave irradiation.43-45   
 
1.4 Functionalization of mesoporous silica 
In order to manipulate and tune the silica surface to be used in specific applications, organic 
moieties that are covalently attached to the surface serve well. In general, there are two 
different approaches to achieve such functionalization: Post-synthetic grafting of the surface 
with chloro- or alkoxysilanes or direct co-condensation of the organic functionality during the 
synthesis.46,47 More recently, metalorganic reagents like Grignard – or organolithium 
compounds were introduced as alternative route to achieve organic functionality on 
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mesoporous silica surfaces, resulting in direct Si-C bond formation.48,49 This method allows, 
for example, the incorporation of multiply bonded residues in a one-step reaction. Post-
synthetic grafting is achieved by attaching organotrialkoxysilanes to the pore walls of pre-
synthesized, template-free mesoporous silica. Co-condensation includes copolymerization of 
an organosilane with the silica precursor in the presence of the templating surfactant. The 
metalorganic functionalization route is based on the substitution at silicon atoms with 
metalorganic compounds, resulting in the formation of direct Si-C bonds. 
 
1.5 Synthesis of mesoporous silica nanomaterials 
After the introduction of the M41S materials family in 1992 by Mobil Oil, a number of 
research groups have searched for strategies to obtain mesoporous silica materials with 
particle sizes in the nanometer range.15,16 In 1999, Brinker et al. developed a self-assembly 
approach to obtain mesoporous particles in an aerosol-based synthesis.50 The used reactor is 
shown in Figure 1.5.1. 
 
Figure 1.5.1. A diagram of the applied aerosol reactor. Figure was taken from reference 50. 
 
An atomizer creates silica precursor/surfactant droplets with a size distribution characterized 
by a geometric standard deviation of 2. Finally, the produced particles are collected on a 
Teflon filter or directly on a TEM grid. Depending on the applied template type, lamellar, 
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cubic or hexagonally ordered mesoporous silica particles were obtained. The synthesized 
particles showed a size distribution around 120 nm and tunable pore sizes between 3 and 40 
nm. Another approach uses neutralization of the synthesis solution after a short period of 
particle growth.51 CTAB-templated mesoporous silica particles featuring particle sizes 
between 10 and 100 nm were obtained, but the yield was relatively low. Hexagonal 
arrangement of the pores was only observed for particles featuring a diameter of 60 nm or 
larger.   
Imai et al. have developed a synthesis route using complementary, immiscible surfactant 
systems.52,53 While one of the applied surfactants acts as templating agent defining the 
mesostructure, the growing particles are surrounded by a second surfactant. This hinders the 
diffusion of growth species to the growing surface and leads to a slowed down particle 
growth. A schematic representation to illustrate the functions of the two surfactants is given in 
Figure 1.5.2. 
 
 
 
Figure 1.5.2. Schematic representation of the functions of two surfactants. Figure was taken 
from reference 52.  
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A typical surfactant mixture uses CTAB/Pluronic F127. An exceptionally great variety of 
pore structures and sizes can be achieved by applying mixtures of triblock-copolymers such 
as Pluronic P123 or F127 combined with fluorocarbon surfactants.54 Round-shaped MCM-41 
nanoparticles with particle sizes around 200 nm were obtained in a microwave heating 
approach including the addition of ethylene glycol as another dielectric medium in the 
synthesis.55 Other strategies to limit the particle growth include the use of complexation 
agents such as triethanolamine (TEA).56-59 The chelating capabilities of TEA leading to 
silatrane complexes in the synthesis solution60 prevents a fast condensation reaction of the 
silica.61,62 In the present work, the latter strategy for the synthesis of colloidal mesoporous 
silica was applied. The obtained high particle concentrations and narrow size distributions 
make this approach ideal for the introduction of subsequent functionalization steps.  
 
1.6 Targeted drug delivery with porous silicates 
Currently, functional nanomaterials are widely discussed as drug carriers in cancer therapy or 
other medical applications. The use of nanocarriers that are able to transport a drug directly to 
tumor tissue within a living system can help to reduce the drug dose and therefore reduce 
unwanted side effects. Liposomes have been used to transport cytostatics or therapeutics to 
cancer tissue with many different cargos such as doxorubicin or DNA plasmids. Some of the 
loaded liposomes have already been approved after clinical trials.63 Other groups use 
nanosized polymeric conjugates to deliver genes, peptides or toxins into cancer cells.64-67 
Zeolites were also investigated for their potential in drug delivery and controlled release 
applications.68,69 As an example, the potential use of commercially available zeolite Y was 
studied as carrier for anthelmintic drugs. It was shown that the loaded zeolite was able to 
improve the killing rates of adult worms in vivo.70 Mesoporous silica nanoparticles were 
widely investigated for potential applications in targeted drug delivery.71-75 Silica itself is non-
toxic and exhibits an excellent biocompatibility.76-78 Additionally, the incorporated mesopores 
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with tunable diameters between about 3 and 20 nm offer enough space for the loading with 
even spacious therapeutic molecules like nucleic acids, peptides or antibiotics.79-83 However, 
for a mesoporous silica nanoparticle to serve as a sophisticated drug delivery vehicle, it has to 
fulfill a couple of important prerequisites. In order to overcome the synthetic challenges, a 
number of multidisciplinary approaches are necessary.  
In Figure 1.6.1, the ultimate goal of the research of the present work is presented as a cartoon.  
 
 
Figure 1.6.1. Cartoon of an ideal mesoporous silica based drug delivery nanodevice. 
 
In the cartoon, a number of different functionalizations are visible. First, an inner core 
functionalization is necessary in order to tune the interaction of a loaded guest molecule with 
the pore walls. However, on the outer particles’ surface, a number of different additional 
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groups need to be attached selectively. A targeting ligand enables the particle to bind to 
specific receptors, which are overexpressed on the desired cancer cell surface. The function of 
the stimuli-responsive gatekeeper is to release the cargo only as a result of a certain trigger 
effect, e.g. after cell entrance. A fluorescent label on the surface of the particle allows 
monitoring the mechanisms of cellular uptake with fluorescence microscopy. If it is possible 
to access such multifunctional nanodevices, we anticipate that they will permit the reduction 
of the applied drug doses in cancer therapy, as the drugs are transported and released directly 
to the desired locus of activity. This will largely reduce unwanted side effects and enables the 
use of more powerful tools to kill cancer tissue within the organism.  
 
1.7 Site-selective functionalization of mesoporous silica structures 
The challenge of introducing molecular functionality at defined loci within one particle of 
mesoporous material is subject of the current research. Molecular functionality attached to the 
inorganic surfaces can change the properties of the obtained material dramatically. This is 
crucial not only in host-guest chemistry, but also in the fields of catalysis and sorption.84,85 
First attempts to control the locus of incorporated functionalization were published by Chen et 
al.86 The control was achieved by a partial cleavage of P123 surfactant in the mesopores of 
SBA-15, leaving the micropores unextracted. Subsequent functionalization with 
trimethylchlorosilane and further template removal allowed the deposition of metals 
selectively in the micropore volume of SBA-15. A selective functionalization of the outer 
surface was achieved by the addition of (3-mercaptopropyl)trimethoxysilane to radially 
growing mesoporous silica microspheres.87 The obtained material showed a 
hydrophilic/hydrophobic core/shell structure, characterized by the reductive deposition of 
aqueous platinum precursors to the inner core of the silica sphere. One approach to 
distinguish between a preferential post-synthetic functionalization on the outer surface and the 
inner pore walls is varying the ratio of added functionalized silanes, assuming the most 
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accessible silanols to be present on the outer surface.88 By adding only a fractional amount of 
grafting agent compared to the present silanols, a preferential functionalization on the outer 
surface takes place. Other research groups showed an outer surface functionalization by 
leaving the template unextracted during functionalizations steps, thus hindering the access to 
the interior pore surface.89-91 However, independently achieved results from different groups 
have shown that chloro- and trialkoxysilanes can efficiently replace surfactant molecules and 
can even produce completely extracted materials.92-95 We have recently shown that the 
functionalization of template-filled pores occurs already at room temperature conditions after 
4 hours.96 Therefore, we have developed a site-selective co-condensation approach for 
colloidal mesoporous silica nanoparticles, allowing us to introduce molecular functionality 
dispersed throughout the whole particle volume or concentrate it towards the outer shell 
(Figure 1.7.1.). 
 
 
Figure 1.7.1. The functional groups are dispersed within the particle volume depending on 
the addition time of the organosilane component. Figure was taken from reference 96.  
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In the present work, the existing approach was successfully extended to yield multifunctional, 
core-shell structured mesoporous silica nanoparticles via a sequential co-condensation 
process, allowing a differentiation between the outer and inner organic functional groups 
(joint project with Dr. Valentina Cauda).97 The synthesized core-shell particles are an 
important prerequisite for the manufacturing of our version of a mesoporous silica-based drug 
delivery device.  
 
1.8 Stimuli-responsive gatekeeper and molecular valves for mesoporous silica 
For an effective drug delivery device, it is important to release the medication only under 
defined conditions, e.g. upon entrance into a cancer cell. The synthesis of such valves has 
become an interesting and widely investigated field of research, attracting scientists from 
multiple disciplines around the world.  
In the literature, the reported molecular valve concepts are mainly based on the following 
triggers: 
1. Enzyme responsive 
2. Redox-responsive 
3. UV-light responsive 
4. pH-responsive  
 
Another elegant approach uses supported lipid bilayers as biocompatible shell carried by the 
surface of colloidal mesoporous silica.   
 
1.8.1 Enzyme-responsive valves 
Stoddart et al. presented an esterase-responsive “snap-top” release mechanism for 
mesoporous silica nanoparticles (MSN), based on a cyclodextrin (CD) cap (Figure 1.8.1).98 In 
this case, the surface of MSN was reacted with tri(ethylene glycol) linkers, onto which the CD 
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threads. A terminal azide group was subsequently reacted with an ester-linked adamantyl 
stopper, preventing the CD cap from leaving the MSN surface. The release of Rhodamin B 
was not detected before esterase addition.  
 
 
 
Figure 1.8.1. Synthesis of a snap-top cover for mesoporous silica nanoparticles. The figure 
was taken from reference 98.  
 
Others have shown the synthesis of lactose-capped mesoporous silica nanoparticles, which 
open upon β-galactosidase action.99 MCM-41 was loaded with [Ru(bipy)3]Cl2 in oder to 
monitor the release. As molecular cap, they used a lactose derivative consisting of β-D-
galactose and β-D-glucose linked trough a glycosidic bond. The cleavage of this bond by β-
galactosidase led to a removal of the steric barrier and the dye could be released. 
In the present work, I will report on biotin-functionalized colloidal mesoporous silica, which 
is capped by avidin proteins. A release of fluorescein molecules is triggered by the addition of 
the protease trypsin.100  
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1.8.2 Redox-responsive opening of molecular valves 
Molecular valve mechanisms that react on reductive environments offer a great potential in 
drug delivery. Disulfide-based mechanisms have already demonstrated their potential in this 
field, e.g. in polymer conjugates.101  
Disulfide-based controlled release mechanisms were also studied in mesoporous silica 
nanoparticles (MSN). The snap-top covered MSN system described under 1.8.1 (ref. 98) was 
extended to a redox-responsive valve very recently.102 The applied adamantyl-stoppers for the 
cyclodextrin-caps were linked with a disulfide-bridge instead of an esterase-sensitive ester-
bond. This leads to an opening of the valves upon creation of a reductive milieu.  
Lin et al. have attached disulfide-bridged cadmium sulfide (CdS) nanoparticles to the pore 
openings of MSN (Figure 1.8.2).103  
 
Figure 1.8.2. Concept for the redox-responive release of vancomycin from CdS-capped 
mesoporous silica nanoparticles. Figure taken from reference 103. 
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They were able to show a release of vancomycin and adenosine triphosphate at the presence 
of a reducing agent such as mercaptoethanol or dithiothreitol (DTT). In order to avoid the 
toxic CdS, the same group has applied a redox-sensitive bond to attach superparamagnetic 
iron oxide nanoparticles on MCM-41.104 The functionality was again demonstrated by the 
release of fluorescein upon addition of DTT. In another work of Lin et al., membrane-
impermeable cysteine was delivered into living cells.105 For this purpose, the cysteine was 
directly linked to the silica wall by a disulfide bridge. The advantage of this approach is that 
synthetically demanding caps are not necessary, as the delivered species themselves are 
reversibly attached to the pore walls. A closer look into the mechanism of this approach by 
live-cell imaging is provided in the present work, as a joint project with the research group of 
Prof. Bräuchle.106  
Cystamine crosslinks of poly(N-acryloxysuccinimide) shells for MSN´s were shown to 
release cargo on demand. The presence of DTT acts as a trigger.107 Another approach uses 
ferrocenedicarboxylic acid coupled to (3-aminopropyl)-modified MSN surfaces. After loading 
the particles with Rhodamin B, the pores were closed with a cyclodextrin (CD).108 
Electrochemical oxidation of the ferrocene units lowers the interaction between the CD and 
the functionalized particle surface and thus, the incorporated dye gets released.  
 
1.8.3 UV-light responsive molecular release mechanisms 
In the synthesis of UV-light responsive valves, photocleavable molecules that link the 
capping agent to the pore openings are used. As an example, cyclodextrin caps were linked to 
the silica surface by o-nitrobenzylesters. Irradiation of the functionalized particles resulted in 
a release of the cargo.109 Zink et al. have reported in several publications on the acceleration 
of release by the incorporation of light-driven “nanoimpellers”. This interesting functionality 
is given by light-induced cis-trans isomerization of azobenzenes, pushing out loaded 
molecules like rhodamine B or camptothecin from the inside of the pores (Figure 1.8.3).110-112  
1. Introduction 
 16 
 
 
Figure 1.8.3. Molecular structure of the incorporated, light driven nanoimpellers. Figure was 
taken from reference 110. 
 
The high affinity of β-cyclodextrines (β-CD) to the trans-form of azobenzenes was also used 
in the construction of a photoresponsive gatekeeper mechanism. Irradiation of the β-CD-
capped material leads to isomerization of the applied azobenzene-linker and thus detaching of 
the β-CD cap.113 Coumarin-derivatives can act as photo-responsive gatekeeper molecules for 
MCM-41.114 UV-light irradiation (λ > 310 nm) of the coumarin-functionalized silica surface 
causes a [2+2] photocycloaddition between two coumarin molecules, leading to an efficient 
closing of the pores. Reopening is achieved by irradiation at higher energy (λ = 250 nm). 
Another group has combined this mechanism with the azobenzene nanoimpellers to control 
the release kinetics of cholesterol from mesoporous silica.115  
Photoresponsive release of fluorescein in cells was introduced by Lin et al. with gold 
nanoparticle-capped MSN. The utilized gold nanoparticles were functionalized with 
thioundecyltetraethyleneglycoester-o-nitrobenzylethyldimethylammonium bromide (TUNA), 
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which functions as a photochemical linker. Being irradiated with UV-light, the TUNA linker 
is converted into a negatively charged carboxylate, leading to an electrostatically driven 
dissociation of the gold from the also negatively charged silica surface (Figure 1.8.4).116   
 
 
 
Figure 1.8.4. Construction and function of the UV-light driven controlled release from 
mesoporous silica. Figure was taken from reference 116. 
 
1.8.4 pH-responsive molecular valves 
One of the reported pH-responsive systems uses a crown-ether to encircle a naphthalene-
containing dialkylammonium center. The release of coumarin from this system was shown by 
the addition of base, leading to a proton abstraction from the used linker, thus weakening the 
interaction between the applied crown-ether and the surface.117 Kim et al. have introduced a 
pH-responsive pseudorotaxane-based cap system, which is composed of biocompatible 
materials only.118 The surface of the MSN was post-synthetically modified with 
polyethyleneimine (PEI), which was subsequently complexed by cyclodextrines. Lowering 
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the pH led to a positively charged PEI backbone, thus the cyclodextrine caps were detached 
from the surface (Figure 1.8.5).  
 
 
Figure 1.8.5. Schematic illustration of complexation from PEI with cyclodextrines. Figure 
taken from reference 118. 
 
Zink et al. have reported base-activated Cucurbit[6]uril (CB[6]) pseudorotaxane caps, 
attached to the silica surface by an azide-alkyne cycloaddtition. This reaction was self-
catalyzed by the CB[6] and resulted in a triazol-ring surrounded by the CB[6] moiety. Upon 
deprotonation at pH 10, the CB[6] was detached and was no longer able to hinder the release 
of Rhodamine B into the solution.119 This principle was successfully extended to the 
construction of an acid-activated cap system by the same group.120 The CB[6] unit is now 
sitting around a organic chain which contains three ammonium groups. Two of the contained 
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ammonium groups are tetramethylene ammoniums while the third and terminal group is an 
anilinium unit (Figure 1.8.6).   
 
Figure 1.8.6. Concept of an acid-activated, Cucurbit[6]uril capped mesoporous silica particle. 
Figure taken from reference 120. 
 
A lowering of pH to the point where the anilinium ion gets protonated leads to a release of the 
CB[6], followed by the release of the incorporated guest molecules. A combination of the 
light-driven nanoimpellers and the CB[6] based cap system in one particle gives AND-logic 
controllable release behaviors.121 For an effective release of the incorporated compound, two 
stimuli are required. Base addition leads to an opening of the CB[6]-caps as described for 
reference 118, but the encapsulated guest is not released until the photoinduced cis-trans 
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isomerization of the incorporated nanoimpellers described in reference 109, Figure 1.8.3 is 
activated.  
Cucurbit[7]uril was used as capping agent by ferrocene-functionalized MSNs at low pH 
values. The stability of the complex is weakened at pH > 4 and therefore, an incorporated 
guest molecule can be released.108 
Our group has recently shown a pH-dependent release of Ibuprofen from core-shell 
functionalized colloidal mesoporous silica CMS.122 CMS with an outer-surface aminopropyl- 
functionality was further reacted with 4-sulfophenyl isothiocyanate. The ionic interaction 
between the attached sulfonic acid groups and the remaining protonated aminogroups of the 
surface led to a closure of the pores, preventing Ibuprofen from leaching out of the particle. 
An opening was achieved by proton abstraction from the surface (addition of base), leading to 
an electrostatic repulsion of the sulfonic acid gatekeeper. Another group has applied a layer of 
polyamines to the surface of mesoporous silica.123 Protonation of the linear amine-chains 
created a rigid layer structure, blocking the access to the pores.  
A polyelectrolyte multilayer was shown to seal effectively the pores of hollow mesoporous 
silica spheres at high pH values.124 In the present work, we have investigated the applicability 
of acetal linkers for a pH-responsive release of mellitin peptides from SBA-15, in a joint 
project with the group of Prof. Wagner from the pharmaceutical department of the University 
of Munich (LMU).125  
 
1.8.5 Supported lipid bilayers on mesoporous silica nanoparticles 
Another interesting possibility to control the delivery of drugs with mesoporous silica 
nanoparticles is to combine the easy functionalization capabilities of the silica surface with 
the exceptional biocompatibility of phospholipid bilayers. Brinker et al. have introduced such 
supported bilayers made from a mixture of 1,2-dioleolyl-sn-glycero-3-[phospho-L-serine] 
(DOPS) and 1,2-dioleolyl-3-trimethylammoniumpropane (DOTAP) prepared by an 
1. Introduction 
 21 
electrostatically driven lipid exchange mechanism.126 It was demonstrated that these so-called 
protocells are able deliver doxorubicin and other compounds into cells. Our group in 
cooperation with the groups of Prof. Bräuchle and Prof. Rädler (both LMU Munich) has 
recently shown that particles coated with a lipid bilayer can deliver the plant toxin colchicine 
into living cells. 
 
Figure 1.8.7. Synthesis scheme of a lipid bilayer coated, colchicine-loaded colloidal 
mesoporous silica particle. Figure was taken from reference 80. 
 
 
 The successful delivery was evaluated by live-cell imaging. Specifically, the 
depolymerization of GFP-labeled microtubules was observed.80 
 
1.9 Targeting of cancer cells with nanoparticles 
The specific entry of nanoparticles into cancer cells can be enhanced by attaching ligands to 
the surface that interact with cell receptors being overexpressed in cancer cells. Prominent 
examples for such receptors are the epidermal growth factor receptor (EGFR),127 the folate 
receptor128 or the integrin ανβ3-receptor.129,130  
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Linden et al. have studied the folate receptor as target for drug delivery with mesoporous 
silica nanoparticles.131 They constructed polyethyleneimine (PEI)-coated MSN´s that were 
further reacted with folic acid to yield the targeting system. They showed an efficient uptake 
of folic acid-modified nanoparticles compared to the unfunctionalized case. They further 
investigated the delivery of membrane-staining dyes with these targeting systems. As a result, 
they could show that HeLa-cells with a highly expressed folate receptor do preferentially take 
up the particles, made visible by a high fluorescence intensity of the membrane.132 Another 
group has initially investigated the efficiency of targeting the ανβ3-receptor using arginine-
glycine-aspartate tripeptide (RGD) functionalized mesoporous silica nanoparticles with a 
positive result.133 They observed a more effective endocytosis by using targeting particles. A 
similar result was achieved by functionalizing gold nanoparticles or polymers with the RGD 
peptide.134,135 The specific targeting of the epidermal growth factor receptor with the EGF 
peptide is another way to directly target cellular surfaces. One group has synthesized 
conjugates of 2-methacryloyloxyethyl phosphorylcholine with EGF, loaded with paclitaxel, 
showing a preferential uptake in tumor cells in vitro and in vivo.136 Wagner et al. have shown 
the synthesis of DNA-polyplexes conjugated with the EGF peptide, including investigations 
of the uptake and gene transfection efficiency in cells.137  
 
1.10 Polyethylene glycol in drug delivery applications 
In the field of systemic drug delivery, it has been known for decades that polyethylene glycol 
(PEG)-carrying conjugates show a prolonged blood circulation time in vivo. The inert 
polymer represents a steric barrier to the surface of the nanocarrier and can minimize protein 
binding.138 This effect, often referred to as stealth effect, reduces the effectivity of the 
reticuloendothelial system to recognize the circulating nanomaterials and thus improves the 
pharmacokinetics.  So far, PEGylation has been applied on various potential drug carriers like 
liposomes,139 polymeric drug and DNA conjugates,140,141 or even viral capsids.142 In the 
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context of mesoporous silica, the effect of PEGylation of the silica surface was studied 
recently.143 The post-synthetically modified mesoporous silica nanoparticles (MSN) were 
investigated in terms of protein adsorption. It was shown that PEGylated MSNs adsorb far 
less human serum protein on their surface than the unfunctionalized reference material. 
Hemolysis was additionally studied, showing a very low hemolysis percentage of 0.9 %, 
compared to more than 14 % of the unfunctionalized reference material.  
In our group we have initially shown that CMS nanoparticles with an outer co-condensed 
PEG-shell are stabilized against degradation by biologically relevant anions such as 
phosphate. The results indicate that the PEG shell conserves the mesoporous structure up to a 
week of immersion in Simulated Body Fluid144 (SBF) at 37°C whereas unfunctionalized 
particles degrade within a couple of hours.145 In further studies, it was demonstrated that the 
density and the chain length of a co-condensed PEG-chain (see Figure 1.10.1) has an 
influence on the degradation behavior of the CMS nanoparticles.146  
 
 
Figure 1.10.1 Colloidal mesoporous silica nanoparticles with an outer shell of different PEG 
chain lengths. 
 
By varying these parameters, it is even possible to tune the degradation behaviour to the 
desired application. This is of great interest for future injectable blood-persistent biomedical 
systems and site-specific drug delivery devices.  
In the present work, we use functional PEG-linkers attached to the silica surface for further 
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functionalization with organic molecules on the outer surface of the particle.  
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 2. Characterization 
2.1 X-ray Diffraction 
Electromagnetic radiation with wavelengths between 10 and 0.01 nm is defined as X-rays. To 
generate X-rays, a cooled metal anode is bombarded with a highly energetic and focused 
electron beam. When the electrons hit the target, their loss of energy is partly emitted as a 
continiuous background spectrum called “Bremsstrahlung”. Additionally, narrow lines that 
are characteristic for the applied target appear in the spectrum, resulting from a X-ray 
fluorescence process. The impact of primary electrons can create holes in energetically low 
shells of the target atoms. Electrons from higher shells are then falling into these holes. The 
energy is released as X-ray photons. Monochromatic X-ray radiation can be created by 
blocking filters, isolating a single emission from these processes.  
X-rays are used to determine structural properties of crystalline solid materials.1 As the 
wavelengths of the X-ray photons lie in the Ångstrøm range, the wavelength lies in the same 
order of magnitude as the distances of atoms in solid matter. Thus, structural information of 
the ordered lattice of crystals can be gained by interpreting the constructive and destructive 
interferences of X-rays scattered by the lattice planes (Figure 2.1.1). 
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Figure 2.1.1 Illustration of the Bragg relation. A constructive interference occurs when the 
path difference is a multiple integer of the X-ray wavelength.  
 
Bragg´s law defines the conditions at which constructive interference of scattered X-rays is 
observed (equation 2.1.1). 
 
nλ = 2 d sin θ (eq. 2.1.1) 
n: order of interference 
λ: X-ray wavelength 
d: lattice spacing 
θ: angle of incidence 
 
In the present work, ordered mesopores in amorphous silica frameworks are characterized by 
X-ray diffraction. In this case, the walls of the ordered mesopores define the lattice planes of 
the material. 
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2.2 Infrared (IR) and Raman spectroscopy 
Infrared (IR)2 and Raman3 vibrational spectroscopy are methods to characterize the chemical 
bonding of the elements contained in a sample. The characteristic vibrational modes of 
functional groups can be used to gain this information. Radiation of the infrared region of the 
electromagnetic spectrum is used to excite these modes. Usually, electromagnetic radiation 
between 200- 4000 cm-1 is used. The absorbed light from the sample is characteristic for the 
contained functionalities. To be visible in IR spectroscopy, a vibrational mode of a molecule 
needs to change the dipole moment of the compound during the vibration. Thereby, the 
molecule itself does not need to have a permanent dipole.  
However, in Raman spectroscopy, inelastic scattering of monochromatic light is detected. The 
scattering of the light occurs upon interaction with the electron clouds around chemical bonds. 
Since this relies on a different physical process than IR spectroscopy, the general selection 
rules of observable vibrational states are different. For a vibrational mode visible in Raman 
spectroscopy, the polarizability of the bond is changed during the vibration. The amount of 
deformation of the electron cloud determines the signal intensity.  
Photons are able to excite a given vibrational state into a virtual energy state. Photons can be 
re-radiated in all directions after relaxation of the electrons (Figure 2.2.1). 
 
Figure 2.2.1 Rayleigh-, Stokes-, and anti-Stokes scattering. 
2. Characterization 
 38 
Most of the incident light is scattered and released without changing the frequency, i.e. as 
Rayleigh scattering. Photons with lower energy are scattered if the excited system was in an 
energetically low state and relaxes back into higher vibrational states. This “Stokes 
scattering” results in weak bands at lower frequencies. On the other hand, “anti-Stokes 
scattering” result from relaxation into vibrational states of lower energy than the original. 
Although both Stokes and anti-Stokes scattering can be used to measure molecular vibrations, 
Stokes scattering is mainly used. This is due to the required excited vibrational states for anti-
Stokes scattering, which typically results in lower intensities.  
 
2.3 Thermogravimetric analysis and Differential Scanning Calorimetry 
Thermogravimetric analysis investigates the mass loss of a sample related to the temperature 
of a heating ramp. Thereby, the temperature is raised with a constant heating rate. During this 
process, evaporation and pyrolysis reactions can occur among other possible processes. 
Oxidation reactions can be either excluded or included, controlled through the use of an inert 
gas atmosphere such as argon or nitrogen or a synthetic air mixture, respectively. In the 
present work, oxidation reactions were included, as we investigate the combustion of organic 
groups on the inorganic silica framework. The used gas mixture passes the sample with an 
approximately laminar flow, leading to a removal of desorbed components. The obtained 
thermograms include information about the temperature stability of the samples and 
quantitative information about the amount of organic groups included in the sample.  
Additionally, Differential Scanning Calorimetry (DSC) can be peformed during the TGA 
measurement. With this technique, the difference of heat needed to heat the sample and an 
inert reference is determined. From this, information about endothermic or exothermic 
processes during sample heating is gained. For example, it is possible to distinguish between 
combustion (exothermic) and evaporation (endothermic) steps. Thermogravimetric analyses 
of the samples were performed on a Netzsch STA 440 C TG/DSC. 
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2.4 Nitrogen Sorption 
Sorption of nitrogen molecules on surfaces is commonly used for the determination of pore 
characteristics and surface areas of porous solids.4,5 From the measured amount of adsorbed 
nitrogen at different pressures and constant temperature, adsorption and desorption isotherms 
can be generated. As defined by IUPAC, there are six major types of isotherms (Figure 2.4.1). 
 
 
Figure 2.4.1 The six types of gas sorption (IUPAC) isotherms. 
 
Every type displayed in Figure 2.4.1 is characteristic for a certain type of solid material 
(Table 2.4.1).  
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Table 2.4.1 Classification of adsorption isotherms 
Isotherm Type Corresponding Material 
I Microporous material, remains static after complete pore filling 
II Nonporous or macroporous material, high adsorption energy 
III Nonporous or macroporous material, low adsorption energy, weak 
interaction between adsorbate and adsorbens 
IV Mesoporous material 
V Mesoporous material with very weak interaction between adsorbate and 
adsorbens  
VI Stepwise multilayer adsorption on nonporous, uniform material 
 
During a nitrogen sorption experiment, the gas is added at 77 K. In the case of mesoporous 
silica materials, the applied adsorbate is bound to the surface (adsorptive) by van-der-Waals 
forces, leading to physisorbed nitrogen molecules. The adsorbed amount of gas is plotted 
against the relative pressure in order to obtain an isotherm. The obtained isotherm can then be 
interpreted to gain information on the porous features of the investigated sample. Three 
different models are most commonly applied in the literature to describe isotherms. They are 
named after its developers, Langmuir, Freundlich or Brunauer-Emmett-Teller, respectively.  
The simplest method for the characterization of isotherms is the Langmuir interpretation. It is 
based on a few simple approximations: 
1. Adsorption leads only to a monolayer of adsorbed molecules 
2. The surface is uniform, every binding site is equal 
3. The ability of a molecule to bind specific surface sites is independent from the 
occupancy of neighboring binding sites.  
 
These simple approximations are expressed in Langmuir´s equation (eq. 2.4.1) 
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 eq. 2.4.1) 
n: amount of absorbate, nm: capacity of one monolayer, p: pressure, B: constant  
 
While the Freundlich interpretation is generally based on the same approximations, Brunauer-
Emmett-Teller´s model (BET) also incorporates multilayer adsorption.6 Therefore, the initial 
monolayer serves as a substrate for further adsorption processes. As a result from these 
approximations, the BET-equation can be expressed (eq. 2.4.2). 
  (eq. 2.4.2) 
n: amount of adsorbate, nm: capacity of one monolayer, C: BET constant, p: equilibrium pressure, p0: saturation 
vapor pressure of adsorbate. 
Based on Kelvin´s equation, a model for calculating the pore diameters was developed by 
Barrett, Joyner and Halenda (BJH - diameter).4,5 However, for small mesopores in the range 
of 4 nm, the pore diameters calculated from BJH are typically 1 nm smaller than the real 
diameters. This can be attributed to the existence of an adsorption potential within the pores 
leading to an enhanced stability of incumbent fluid phases against capillary driving forces.7 
For the applicability of microscopic methods such as grand canonical Monte-Carlo 
simulations and density functional theory, specific knowledge about the structure and surface 
atoms of the investigated material is essential.  
DFT techniques include site-wise attraction between surface atoms and the adsorbate 
molecules and adsorbate-adsorbate attractions, among numerous other factors. The obtained 
system´s free energy is then minimized by primarily changing the number density as a 
function of distance from the surface. A differentiation has to be made between local and non-
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local density functional theory (NLDFT). While local density functional theory assumes a 
fluid to be structureless when calculating long-range interactions between adsorbate particles, 
NLDFT is used for strongly interacting boundaries. As the solid walls of mesoporous silica 
have an influence on the number density, NLDFT is used for calculating the pore size 
distribution in this work. Nitrogen sorption measurements were performed on a 
Quantachrome Intstruments Nova 4000e at -196°C.  
 
2.5 Dynamic Light Scattering 
Hydrodynamic radii of particles in colloidal solutions can be determined by Dynamic Light 
Scattering (DLS).8,9 Thereby, the Brownian motion of the particles is measured and then 
mathematically correlated to the particle size. In the experiment, the particle solutions are 
illuminated with a laser. The resulting intensity fluctuations in the scattered light are 
analyzed. Laser light that was scattered from small particles results in a speckle pattern on the 
detector, resulting from constructive and destructive interference. As the particles in 
suspension are constantly moved by Brownian motion, the speckle pattern is also permanently 
changing on the detector. With the help of a digital correlator in the instrument, changes of 
the speckle pattern are measured with time. A second-order autocorrelation curve is derived 
from the measured intensity trace (eq. 2.5.1). 
      (eq. 2.5.1) 
q: wave detector 
τ: delay time 
I: intensity 
Siegert´s equation is used to relate the normalized scattered electric field autocorrelation 
function to the second order correlation curve. (eq. 2.5.2) 
 
2. Characterization 
 43 
 (eq. 2.5.2) 
q: wave detector 
τ: delay time 
β: correction factor 
 
The obtained first order autocorrelation curve is then fitted by a number of algorithms to give 
a number of single exponential decays related to the translational diffusion coefficients of 
different particle size populations in polydisperse samples. Thus, a monodisperse sample 
gives a single exponential function. (eq. 2.5.3, eq. 2.5.4) 
 
  (eq. 2.5.3) 
 
  (eq. 2.5.4) 
D: diffusion coefficient 
n0: refractive index of the solution 
λ: wavelength of laser 
θ: angle of scattering experiment 
As the above experimental conditions are defined, the diffusion coefficient D of the 
investigated sample can be calculated. Furthermore, the hydrodynamic diameter of the 
colloidal sphere is calculated by using Stoke-Einstein´s equation (eq. 2.5.5). 
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  (eq. 2.5.5) 
D: diffusion coefficient 
k: Boltzmann constant 
T: temperature 
η: solvent viscosity 
d: hydrodynamic diameter 
Most samples display a broad distribution of particle sizes. While the scattering from larger 
particles needs to be described by Mie theory, the scattering intensity of small particles in a 
beam of unpolarized light can be described by Rayleigh scattering (eq. 2.5.6). 
 
 (eq. 2.5.6) 
I: Intensity of the scattered light 
I0: Intensity of the incoming light 
θ: Scattering angle 
R: Distance to the particle 
λ: Wavelength of the incoming light 
n: Refractive index of the particle 
d: Particle diameter 
 
The obtained distribution curves are often dominated by a small amount of larger aggregates 
or particles, as the scattering intensity is proportional to d6. In order to gain better information 
of the synthesized nanoparticle suspensions, it is more likely to give the volume-weighted or 
number-weighted distributions. They are proportional to d3 or d, respectively.  
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The DLS meaurments in this work were performed on a Malvern Zetasizer Nano equipped 
with a 4 mW He-Ne laser (633nm) and an avalanche photodiode detector. 
 
2.6 Zeta Potential 
The zeta potential of a particle is the potential that exists on the boundary called 
hydrodynamic shear or slipping plane. This potential denotes the electrostatic potential at the 
interfacial layer of a colloid as compared to that of the bulk fluid.10 When colloids are 
dispersed in ion containing solutions, the charged surface affects the distribution in the areas 
near the interface. This leads to the formation of an electric double layer. The inner region of 
the double layer consists of strongly bound ions and is calles Stern layer. The outer region 
contains diffuse ions, which are less firmly bound to the surface (Figure 2.6.1). 
 
 
Figure 2.6.1. Scheme of electric double layer around a negatively charged colloid 
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The zeta potential is determined indirectly by measuring the electrophoretic mobility. Henry´s 
equation describes the releation between the electrophoretic mobility and the zeta potential 
(eq. 2.6.1). 
€ 
UE =
2εzf (Ka)
3η   (eq. 2.6.1) 
UE: Electrophoretic mobility 
ε: Dielectric constant 
z: Zeta potential 
f(Ka): Henry´s function 
η: Viscosity 
 
To obtain the electrophoretic mobility, the particles´ velocity is determined by Laser Doppler 
Velocimetry (LDV).10 The LDV applies an electrical field of known strength across the 
sample, through which a laser is then passed. The electrophoretic mobility determines the 
velocity with which the particle moves. This will then induce a frequency shift in the incident 
laser beam. Henry´s function is commonly set to f(Ka)=1.5, according to Smoluchowski´s 
approximation. This approximation applies, when the electric double layer is very thin 
compared to the particles diameter. Hückel´s approximation uses f(Ka) = 1.0 and is used by 
thick double layers compared to the particles diameter or dispersions in organic media.  
 
2.7 Fluorescence Spectroscopy 
Fluorescence spectroscopy is a type of electromagnetic spectroscopy that analyzes the 
fluorescence of the investigated sample. Fluorescence itself is the process of light emitting 
deactivation of electronically excited states (Fig. 2.7.1).11  
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Figure 2.7.1 Mechanism of the fluorescence process 
 
Absorption of incoming light results in a vertical electronic excitation according to Franck-
Condon´s rule. The excited molecule loses energy upon collisions with its environment until it 
reaches the vibrational ground state of the excited electronic state. The released energy upon 
the transition into the electronic ground state results in a photon emission. The energy of the 
emitted photon is of lower energy compared to the absorbed photon due to the occurred non-
radiative deactivation.  
In this work, this method is used for the spectroscopic characterization of fluorescence-
labeled particles or guest molecules. Most important for very limited amounts of sample, the 
functionalization can be more easily detected while the sample remains intact. 
 
2.8 Transmission Electron Microscopy (TEM)12 
Conventional light microscopes are limited to magnifications of 1000 and resolutions down to 
about 0.2 µm. Max Knoll and Ernst Ruska built the first electron microscope in 1931. A 
transmission electron microscope (Figure 2.8.1) uses the same basic principles as the light 
microscope but uses an electron beam instead of light.  
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Figure 2.8.1 Scheme of a Transmission Electron Microscope 
 
The used electron beam, generated by a tungsten filament or a field emission gun, is 
accelerated by a potential difference between about 40 and 1000 keV and then focused by 
electrostatic and/or electromagnetic lenses. When hitting the specimen, the diameter of the 
electron beam has typically reached a few nm. Microscopes using a high acceleration voltage 
offer a higher resolution and a better translumination of the samples. The electron beam that 
has transmitted the specimen carries information about the inner structure of the sample. The 
spatial variation of this information is magnified by a series of electrostatic/electromagnetic 
lenses and then recorded by a phosphor screen or a CCD camera. The resolution of TEM is 
usually limited by spherical aberration. However, the new generation of aberration correctors 
allows resolutions down to the atomic level.  
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3.1 Introduction 
Although many different approaches for the synthesis of mesoporous silica featuring particle 
sizes in the nanometer range were proposed,1-5 the spatially defined incorporation of 
functionality is still a critical issue. By controlling the location of two or more different 
molecular functionalities on the inner and outer surface of the spherical mesoporous particles, 
it is possible to control many key properties like host-guest interactions and interactions with 
the environment in a differentiated and defined way. The external surface of such a particle 
can be, for example, equipped with anchor groups for tumor cell targeting or gatekeepers.6-8 
Moreover, the functionalization of the inner pore walls can be used to control the diffusional 
behavior of bioactive cargo molecules along with providing stability to sensitive guest 
species.9-11 Recent examples of site-selective functionalization of silica structures are the 
generation of Janus particles or sequential grafting procedures before and after template 
extraction.12,13 It was shown that a preferential distribution of functional groups towards the 
pore openings occurs even in calcined pores.14 In our group, we have recently found a way to 
selectively add functionality on the outer surface of the particle. A delayed co-condensation 
approach allows the control of the distribution of the functionality on the inner or outer 
surface of radially growing colloidal mesoporous silica (CMS) with a worm-like pore 
structure.15 Not only the distribution of functional groups within one particle, but also the 
density of functional groups can be controlled. The present work includes the synthesis of 
3. Multiple Core-Shell Functionalized Colloidal Mesoporous Silica Nanoparticles 
 51 
CMS exhibiting two different functional groups on the inner and external surface of each 
particle. A novel sequential co-condensation protocol controlling the incorporation of the 
silica precursors at different stages of the particle growth was developed. Additionally, we 
investigated another approach, which uses post-synthetic grafting of previously outer-surface 
functionalized particles. The different approaches are highlighted in Figure 3.1.1. 
 
 
 
 
 
3. Multiple Core-Shell Functionalized Colloidal Mesoporous Silica Nanoparticles 
 52 
 
Figure 3.1.1 Synthesis scheme of the two applied approaches. (a) Delayed co-condensation 
approach, followed by template extraction and grafting of a second functional group. (b) 
Sequential co-condensation approach with two different and separated functionalizations. (c) 
Sequential co-condensation approach with two different functionalizations both incorporated 
in the core of the particle.  
  
The project was a joint project with the group member Dr. Valentina Cauda. The 
experimental protocols and analytical ideas are the result of the collaboration.  
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3.2 Experimental Section 
3.2.1 Applied Chemicals 
Tetraethylorthosilicate (TEOS, Fluka, >98%), triethanolamine (TEA, Aldrich, 98%), 
cetyltrimethylammonium chloride (CTAC, Fluka, 25 wt% in H2O), bidistilled water from a 
Millipore system (H2O from Milli-Q Academic A10), (3-chloropropyl)trimethoxysilane 
(ClPTES, Fluka, 98%), (3-aminopropyl)trimethoxysilane (APTES, ABCR, 96%), 
phenyltriethoxysilane (PTES, Aldrich, 98%), fluorescein isothiocyanate (FITC, Fluka, 
>90%), tetraoctylammonium bromide (Aldrich, 98%), toluene (Aldrich, 99.8 %), hydrogen 
tetrachloroaureate (HAuCl4•3 H2O, Sigma, 99.99%), dodecanethiol (Fluka, >97%), sodium 
borohydride (Aldrich, >98%). All chemicals were used as received without further 
purification. 
 
3.2.2 Synthesis of unfunctionalized CMS (Un-CMS) 
Mesoporous silica nanoparticles were prepared according to a previously published 
procedure.5 A mixture of TEOS (1.92 g, 9.22 mmol) and TEA (14.3 g, 95.6 mmol) was 
heated for 20 minutes at 90°C under static conditions in a 100 mL polypropylene reactor. A 
solution of CTAC (25 wt% in water, 2.41 mL, 1.83 mmol) and water (21.7 g, 1.21 mol) 
preheated to 60 °C was added, and the resulting mixture was stirred at room temperature for 
12 hours. The resulting molar composition of the mixture was 1 TEOS : 0.20 CTAC : 10.4 
TEA : 130.2 H2O.  After addition of 50 mL of ethanol, the mesoporous silica nanoparticles 
were separated by centrifugation (43.146 rcf, 20 min) and redispersed in ethanol. 
 
3.2.3 Synthesis of CMS by co-condensation and post-grafting (Approach A, samples 
CMS(A)-ClOUT and CMS(A)-NHOUT)  
A mixture of TEA (14.3 g, 95.6 mmol) and TEOS (1.92 g, 9.22 mmol) was heated for exactly 
20 min at 90°C without stirring in a 100 mL polypropylene reactor (solution 1).  After 20 
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minutes, a mixture of CTAC (2.41 mL, 7.29 mmol) and H2O (21.7 g, 1.21 mol), preheated to 
60°C was added to solution 1 and stirred for 30 min at 500 rpm. The resulting molar 
composition of the mixture was 1 TEOS: 0.20 CTAC: 10.4 TEA: 130.2 H2O. After 30 
minutes, a 1:1 mixture of TEOS and functionalized trialkoxysilane (RTES) was added 
(0.0922 mmol TEOS and 0.0922 mmol RTES). The RTES reagents used here were ClPTES 
and APTES for samples CMS(A)-ClOUT and CMS(A)-NHOUT, respectively. After addition of 
50 mL ethanol, CMS nanoparticles were separated by centrifugation (43.146 rcf, 20 min), 
redispersed in ethanol, and extracted according to the procedure described below.  
 
3.2.4 Synthesis of bifunctional CMS by sequential co-condensation (core-shell 
functionality, Approach B1, sample CMS(B)-PhIN-NHOUT) 
A mixture of TEA (14.3 g, 95.6 mmol), TEOS (1.56 g, 7.48 mmol) and PTES (111 mg, 0.46 
mmol) was heated for exactly 20 min at 90°C without stirring in a 100 mL polypropylene 
reactor (solution 1). After 20 minutes, a mixture of CTAC (2.41 mL, 7.29 mmol) and H2O 
(21.7 g, 1.21 mol), preheated to 60°C was added to solution 1 and stirred for 20 min at 500 
rpm. Then, TEOS (183 mg, 0.922 mmol) was quickly poured into the mixture. The reaction 
was stirred for another 40 minutes. After that time, a 1:1 mixture of TEOS (19.2 mg, 92.2 
µmol) and APTES (20.4 mg, 92.2 µmol) was added. After addition of 50 mL of ethanol, the 
mesoporous silica nanoparticles were separated by centrifugation (43.146 rcf, 20 min) and 
redispersed in ethanol. 
 
3.2.5 Synthesis of core-bifunctional CMS by sequential co-condensation (Approach B2, 
sample CMS(B)-Ph/NHIN) 
A mixture of TEA (14.3 g, 95.6 mmol), TEOS (1.47 g, 7.37 mmol), PTES (111 mg, 0.46 
mmol), and APTES (82.7 mg, 0.46 mmol) was heated for exactly 20 min at 90 °C without 
stirring in a 100 mL polypropylene reactor (solution 1). After 20 minutes, a mixture of CTAC 
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(2.41 mL, 7.29 mmol) and H2O (21.7 g, 1.21 mol), preheated to 60 °C was added to solution 1 
and stirred for 20 min at 500 rpm. Next, TEOS (183 mg, 0.0922 mmol) was added to the 
mixture, divided into 4 equal aliquots (46 mg each), which were added every 3 minutes. The 
resulting reaction mixture was stirred overnight at room temperature. After addition of 50 mL 
of ethanol, the mesoporous silica nanoparticles were separated by centrifugation (43.146 rcf, 
20 min) and redispersed in ethanol. 
 
3.2.6 Extraction of the template 
The extraction of the template from the obtained CMS materials was performed by heating 
the samples (1 g) under reflux at 90 °C for 45 minutes in a solution containing 2 g ammonium 
nitrate in 100 mL ethanol, followed by 45 minutes under reflux at 90 °C in a solution of 4 g 
concentrated hydrochloric acid in 100 mL ethanol. The extracted CMS nanoparticles were 
collected by centrifugation and washed with 100 mL ethanol after each extraction step. The 
samples were obtained as clear ethanolic suspensions.   
 
3.2.7 Post-grafting of the samples CMS(A)-ClOUT and CMS(A)-NHOUT  
In order to achieve inner pore wall functionalization, the samples CMS(A)-ClOUT and 
CMS(A)-NHOUT were post-grafted with organotrialkoxysilanes. To the extracted samples 
CMS(A)-ClOUT and CMS(A)-NHOUT  (50 mg in 5 mL of ethanolic suspension), the amount of 
0.5 mmol of the respective organotrialkoxysilane (APTES for sample CMS(A)-ClOUT, ClTES 
for sample CMS(A)-NHOUT) was added. The resulting mixture was stirred for 4 hours under 
reflux conditions. The functionalized CMS were collected by centrifugation, washed with 10 
mL of ethanol and redispersed in 5 mL of ethanol. 
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3.2.8 Fluorescein isothiocyanate labeling 
FITC-labeling was performed on the samples synthesized in 3.2.4 and 3.2.5, following a 
literature procedure.16  
The amount of 85 mg of CMS dispersed in 10 mL of ethanol was added to a 10 mL solution 
of FITC in ethanol. The resulting suspension was stirred in the dark for 24 hours at room 
temperature. The labeled CMS were collected by centrifugation, washed two times with each 
20 mL of ethanol and redispersed in 10 mL of ethanol.    
 
3.2.9 Synthesis of dodecanthiolate gold nanoparticles  
The gold nanoparticles were synthesized by following a literature procedure.17,18 
Tetraoctylammonium bromide (0.75 g, 1.25 eq.)  was vigorously stirred at room temperature 
in 40 mL of toluene. Hydrogen tetrachloroaureate (0.15 g, 0.5 eq.) was dissolved in 12.5 mL 
water and added to the tetraoctylammonium bromide solution and stirred for 30 minutes. The 
organic phase was separated from the water, and dodecanethiol (0.56 g, 2.79 mmol) was 
added to the organic phase (AuCl4- -solution). The reaction temperature was adjusted to -78 
°C using a dry ice/acetone bath. Sodium borohydride (0.38 g, 10 eq.) was suspended in 25 mL 
of absolute ethanol and slowly added over a period of 15 minutes to the stirred AuCl4--
solution. Stirring was continued for 1 hour at -78 °C followed by 3 hours of room 
temperature. The solvent was removed in vacuo and the black product was redispersed in 30 
mL of ethanol and sonicated in order to remove byproducts. Finally, the dodecanthiolate gold 
nanoparticles were washed on a glass frit with 80 mL of ethanol and 150 mL of acetone and 
were then redispersed in 40 mL of toluene.  
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3.3 Results and discussion 
As a first approach to gain bifunctionalized core-shell structured mesoporous silica 
nanoparticles, our previously published delayed co-condensation approach was used to yield 
starting materials with molecular functionality exclusively on the outer surface (Approach 
A).15 Tetraethylorthosilicate (TEOS) was hydrolyzed in a reaction mixture containing 
cetyltrimethylammoniumchloride (CTAC) and triethanolamine (TEA). 30 minutes after seed 
generation, a second set of reactants consisting of a 1:1 mixture of TEOS and ClTES/APTES, 
respectively, was added to the reaction mixture. As a result, colloidal mesoporous silica 
particles with either chloropropyl- or aminopropyl moieties placed on the outer surface of the 
particles were obtained after template extraction (samples CMS(A)-ClOUT, CMS(A)-NHOUT). 
In order to introduce a second functional group on the inner surface (pore walls), a post-
grafting approach was applied. As the outer surface is already carrying organic functionality, 
a preferential grafting of the inner pore walls is anticipated. The sample CMS(A)-ClOUT was 
grafted with APTES, the sample CMS(A)-NHOUT with ClTES. The two obtained samples can 
therefore be considered as complementary (samples CMS(A)-ClOUT-NHIN, CMS(A)-NHOUT-
ClIN). Nitrogen sorption isotherms were recorded to determine surface area and porosity of the 
synthesized samples. The isotherms can be found in the Appendix (Figures A-1.1, A-1.2), the 
BET surface areas and NLDFT pore characteristics are displayed in Table 3.3.1.  
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Table 3.3.1 Calculations from the nitrogen sorption measurements from samples in Approach 
A 
 
Sample 
 
NLDFT pore size 
[nm] 
NLDFT pore volume 
[cm3g-1] 
 
BET surface area 
[m2g-1] 
Un-CMS 3.77 0.86 1134 
CMS(A)-ClOUT 3.77 0.80 1184 
CMS(A)-ClOUT-NHIN 3.77 0.80 1077 
CMS(A)-NHOUT 3.77 0.75 1050 
CMS(A)-NHOUT-ClIN 3.77 0.55 439 
 
 
For characterization of the location of the groups, zeta potential measurements were 
performed. If the post-grafting of functional groups affected only the inner pore walls of the 
particles, this process should not affect the zeta potential curves. However, a different result 
was obtained (Figure 3.3.1).  
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Figure 3.3.1 Zeta potential measurements of the samples produced in approach A in 
comparison to the unfunctionalized sample Un-CMS. (a) shows a comparison of CMS(A)-
NHOUT, CMS(A)-NHOUT-ClIN, and Un-CMS, (b) shows a comparison of CMS(A)-ClOUT, 
CMS(A)-Cl OUT-NHIN, and Un-CMS 
 
In Figure 3.3.1a (triangles), the sample CMS(A)-NHOUT carries a positive surface charge at 
low pH values, due to the protonation of the amino groups. On the contrary, since the 
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chloropropyl groups are uncharged at high or low pH values, the zeta potential curve of the 
sample CMS(A)-ClOUT (Figure 3.3.1b, triangles), is similar to that of the unfunctionalized 
CMS. This shows that different functional groups can affect the physical properties of the 
external surface of the particle. However, post-grafting of the sample CMS(A)-ClOUT  with (3-
aminopropyl)triethoxysilane increased the zeta potential, meaning that the outer surface of the 
particle is still accessible for further functionalization (Figure 3.3.1 b). Additionally, grafting 
of the sample CMS(A)-NHOUT with ClTES leads to a decrease of the zeta potential, 
confirming the findings described above. The performed zeta potential measurements imply 
that a complete spatial separation of two functional groups within one particle is not possible 
by following Approach A. The experiments in this direction were abandoned after these 
results. 
Therefore, another approach was developed, following a sequential co-condensation protocol 
based on our previously reported findings (Approach B, Figure 3.1.1 b, c).15 In particular, the 
two functional groups phenyl- and (3-aminopropyl-) were introduced during the synthesis. In 
approach B1 (Figure 3.1.1. b) the phenyl-groups were condensed in the core of the particle, 
spatially separated from the (3-aminopropyl-) functions attached on the outer surface (sample 
CMS(B)-PhIN-NHOUT). On the contrary, approach B2 creates mesoporous silica nanoparticles 
with both functions (Phenyl/3-aminopropyl) in the core, surrounded by a shell of pure 
mesoporous silica (sample CMS(B)-)Ph/NH)IN).  
In the synthesis protocol for approach B1, the synthesis was started with a co-condensed core 
made from two different precursors, TEOS and phenyltriethoxysilane (PTES). 20 minutes 
after the start of the hydrolysis, a small amount of pure TEOS was added to the reaction, 
yielding a shell of pure silica around the functionalized core. Another 40 min later, the shell 
functionality was introduced by adding a 1:1 mixture of APTES and TEOS to the solution. 
After template extraction, the sample CMS(B)-PhIN-NHOUT was isolated by centrifugation. 
The overall molar amount of Si in the synthesis was the same than in our conventional 
unfunctionalized CMS synthesis.5  
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Approach B2 starts with a co-condensation of three compounds, TEOS, APTES and PTES. 20 
minutes after the seed generation, a shell made from hydrolyzed TEOS was grown by adding 
4 small aliquots of TEOS to the synthesis in 3-minute steps. After the synthesis, the template 
was also extracted, giving sample CMS(B)-(Ph/NH)IN.  
The morphology of the obtained materials was investigated by transmission electron 
microscopy. Representative TEM images can be found in Figure 3.3.2. 
 
 
Figure 3.3.2 TEM images of the samples (a) Un-CMS, (b) CMS(B)-PhIN-NHOUT, and (c) 
CMS(B)-(Ph/NH)IN 
 
It can be seen that all synthesized materials are composed of nanosized particles (around 80 
nm) and that they exhibit mesostructured surfaces with worm-like pores.  
 The mesoporous structure of all samples was investigated by nitrogen sorption. The structural 
parameters calculated from the obtained isotherms can be found in Table 3.3.2. The 
corresponding isotherms and NLDFT pore size distributions can be found in the Appendix 
(Figure A-1.3). 
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Table 3.3.2. Data derived from nitrogen sorption for the samples from approach B  
 
Sample 
 
NLDFT pore size 
[nm] 
NLDFT pore volume 
[cm3g-1] 
 
BET surface area 
[m2g-1] 
Un-CMS 3.77 0.86 1314 
CMS(B)-PhIN-NHOUT 3.65 0.77 1302 
CMS(B)-(Ph/NH)IN 3.54 0.60 1059 
 
As can be seen, the synthesized samples show the typical pore sizes and high surface areas. A 
slight reduction of pore volume with increasing core functionality is observed. This can be 
taken as a first hint for a spatial control over the incorporated functionalization. In order to 
investigate the surface charge, zeta potential measurements were performed. It is expected 
that the locus of the amino groups has a strong influence on the zeta potential. An overview 
over the derived data can be found in Figure 3.3.3.  
 
Figure 3.3.3 Zeta potential of the samples derived from approach B: () CMS(B)-PhIN-
NHOUT, () CMS(B)-(Ph/NH)IN, () Un-CMS.  
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The highest zeta potential is measured for the sample CMS(B)-PhIN-NHOUT, indicating that 
the amino groups are incorporated on the outer shell of the particles and thus are contributing 
to the high value.  
The two very similar curves for the unfunctionalized CMS and the sample CMS(B)-
(Ph/NH)IN show that the amino groups are not present on the outer surface of the particles. 
The material interacts with the external environment like an unfunctionalized particle.  
Raman spectroscopy serves to confirm the presence of phenyl groups in the sample. The 
Raman spectra of the samples CMS(B)-PhIN-NHOUT and CMS(B)-(Ph/NH)IN can be found in 
Figure 3.3.4. 
 
 
Figure 3.3.4 Raman spectra of the samples (a) CMS(B)-PhIN-NHOUT and (b) CMS(B)-
(Ph/NH)IN. 
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The strong signal at 1000 cm-1 in both spectra corresponds to the C-H in-plane deformation 
vibration from the aromatic ring. This result is underlined by the signal at 3080 cm-1, also 
present in both samples, which is caused by the aromatic =C-H stretching vibration.  
 
The following characterization of the synthesized materials with fluorescent methods 
was performed and analyzed in cooperation by Dr. Valentina Cauda from our group. 
  
Although the above-mentioned zeta potential and nitrogen sorption measurements provide 
many hints about the loci of the different functional groups, we have developed a procedure 
based on fluorescence quenching. For this purpose, the amino-groups of the particles were 
labeled with FITC, forming a thiourea linkage between the dye and the functionalized particle 
(see Figure 3.3.5). 
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Figure 3.3.5 (a) Reaction scheme between the aminopropyl groups of the CMS nanoparticle 
and fluorescein isothiocyanate. (b) Expected spatial distribution of the attached fluorescent 
dyes within the two samples.  
 As indicated by our synthesis procedures from approach B1 and B2, the sample CMS(B)-
PhIN-NHOUT carries the fluorescent dye on the outer surface whereas the sample CMS(B)-
(Ph/NH)IN has the fluorescence dye attached at the inner pore walls.  
Gold nanoparticles (AuNP) where synthesized according to a literature procedure, yielding 
nanoparticles with about 4 nm in diameter.18 A representative TEM image of the synthesized 
gold nanoparticles can be found in Figure 3.3.6. 
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Figure 3.3.6 Transmission electron micrograph of colloidal dodecane thiolate gold 
nanoparticles used for the fluorescence quenching experiments. 
 
 As reported in the literature, gold nanoparticles can be used as efficient quencher of 
fluorescence, due to an energy transfer between the dye and the AuNP.19 We have prepared 
three solutions containing different concentrations of AuNP (SOL1: 5.56 nM; SOL2: 5.56 
µM; SOL3: 5.56 mM) in order to gradually quench the fluorescence emission of the FITC-
labeled samples. Figure 3.3.7 shows the changing fluorescence emission intensities related to 
an increasing AuNP concentration in solution. It should be noted that the emission spectrum 
of the sample CMS(B)-PhIN-NHOUT shows an emission band at 550 nm in addition to the 
expected fluorescein emission at 519 nm. The red-shifted additional emission can be 
attributed to the formation of so-called J-aggregates. The J-band occurs due a delocalized 
coherent excitonic state caused by a head-to-tail alignment of transition dipoles of the dye.20 
This can be associated with the high local concentration of FITC on the outer surface of the 
particles in the sample CMS(B)-PhIN-NHOUT. This arrangement of dyes cannot take place in 
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the pores due to the confined environment. A gradual reduction of fluorescence intensity upon 
addition of AuNP to the sample CMS(B)-PhIN-NHOUT is observed (Figure 3.3.7a).  
 
 
Figure 3.3.7 Fluorescence emission spectra (excitation at 450 nm) for FITC-labeled CMS 
quenched by gold nanoparticles. The intensities decrease with increasing amount of gold 
nanoparticles added to the solution. The different lines represent curves obtained from the 
experiments with the different gold nanoparticle solutions. SOL1: dotted line, SOL2: dashed 
line, SOL3: empty circles. Sample CMS(B)-PhIN-NHOUT is shown in (a), sample CMS(B)-
(Ph/NH)IN is shown in (b).  
 
The energy of the dye is successfully transferred to the metal surface, where emissionless 
surface-plasmon excitations and electron hole pair excitations take place. This mechanism is 
not effective over distances greater than 8 nm.21 However, in the sample CMS(B)-(Ph/NH)IN, 
no influence of the presence of AuNP ist observed (Figure 3.3.6b). Due to their size, the 
AuNP cannot enter the pore system. Therefore, the required short distance between the dye 
and the AuNP for an effective energy transfer is not given, as the dye molecules are attached 
in the core of the particle. This experiment clearly shows that we are able to control the spatial 
distribution of functional groups within one mesoporous silica nanoparticle.  
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3.4 Conclusion 
We have investigated two different approaches toward spatially controlled functionalization 
of colloidal mesoporous silica. In one case, a delayed co-condensation approach to 
functionalize the external surface exclusively was followed by a post-grafting of the internal 
surface. It was demonstrated by zeta potential measurements that a precise separation of two 
functions in core- and shell regions of a particle was not efficiently achieved. The second 
method uses a sequential co-condensation approach. An initial co-condensation was mantled 
with a shell of pure silica. Finally, a shell carrying a different functionality was grown. We 
have demonstrated by several methods like zeta potential, nitrogen sorption and fluorescence 
quenching with gold nanoparticles that this approach is a highly effective way to incorporate 
core-shell functionality into our colloidal mesoporous silica. As will be highlighted in this 
work, this strategy opens the gate for the design of numerous, multifunctional nanodevices 
based on our mesoporous silica nanoparticles.  
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 4. Click-Chemistry for High-Density Biofunctionalization of Mesoporous 
Silica 
 
The following work is based on the publication indicated below. 
Axel Schlossbauer, David Schaffert, Johann Kecht, Ernst Wagner, and Thomas Bein; Journal 
of the American Chemical Society 2008, 130, 12558-12559  
 
4.1 Introduction 
In order to design effective, multifunctional silica nanoparticles, the investigation of mild, 
biocompatible and high-yield reactions for the purpose of surface functionalization are of 
essential interest.1-4 In this context, surface-based click chemistry is attracting increasing 
attention.5-7 The mild reaction conditions of the copper-(I)-catalyzed azide-alkyne 
cycloaddition and its very high yield make this reaction suitable for the functionalization of 
surfaces with sensitive biomolecules.3,7 Recent publications have used the click approach to 
immobilize peptides,7 DNA8 or carbohydrates9 for various applications. One possibility to 
demonstrate the potential of the click approach as biocompatible reaction on mesoporous 
silica surfaces is the immobilization of sensitive enzymes in the pores of mesopororus silica 
by using this reaction. Supported enzymes on mesoporous solids have many possible 
applications in biotechnology, including synthesis and purification of fine chemicals, catalysis 
for green chemistry or sensing.10,11 It has been shown that the stability and recoverability of 
enzymes benefit from encapsulation in mesoporous hosts.12 In earlier work, lysozyme was 
adsorbed into the pores of SBA-15.13 However, the non-covalent interactions between 
mesoporous silica materials and proteins are too weak to prevent the absorbed biomolecules 
from leaching out of the pore system during further washing and reaction steps, thus leading 
to relatively low loading levels.14,15 Organic modification of the pore walls of a mesoporous 
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host or glutaraldehyde-based cross-linking can sometimes prevent the absorbed enzymes from 
leaching out of the pore system.12,16 However, these methods are typically limited to certain 
proteins and carry the risk of deactivating the enzyme.   
First attempts at covalent enzyme immobilization in mesoporous silica have claimed the 
binding of penicillin-G-acylase onto glycidopropyl-functionalized mesoporous silica, 
although no proof of covalent attachment was provided.17 Another approach encapsulates 
enzymes by a layer-by-layer assembly of oppositely charged species around mesoporous 
silica spheres loaded with enzymes. It was shown that the activity can be conserved during 
various recovery cycles, but the loading level was poor and leaching tests were not 
performed.18 In the present work, the stable covalent immobilization of the protease trypsin in 
the channel system of a large-pore SBA-15 host by a click-chemistry approach is presented 
(Figure 4.1.1). 
 
 
Figure 4.1.1 Illustration of immobilized trypsin in a pore of SBA-15 mesoporous silica 
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 This versatile and mild method for the covalent immobilization of functional biomolecules 
on mesoporous supports allows for unprecedented functionalization densities while retaining 
enzyme activity and preventing protein leaching from the mesoporous support. This work was 
carried out in cooperation with David Schaffert from the research group of Prof. Ernst 
Wagner, Department of Pharmacy at the University of Munich (LMU).    
 
4.2 Experimental Section 
4.2.1 Applied Chemicals  
Tetraethyl orthosilicate (TEOS, Fluka, >98%), cetyltrimethylammonium bromide (CTAB, 
Aldrich, 95%), (3-chloropropyl)trimethoxysilane (CTMS, Fluka, 95 %), Mesitylene (Aldrich, 
98%), sodium azide (Fluka, 99 %), 4-pentynoic acid (Fluka, 97%), N-(3-
dimethylaminopropyl)-N-ethylcarbodiimide (EDC, Fluka, 97%), trypsin from bovine 
pancreas (Sigma, lyophilized, essentially salt-free, TPCK treated), Nα-p-tosyl-L-arginine 
methyl ester hydrochloride (Sigma), phosphate buffer solution (Sigma), tris(hydroxymethyl) 
aminomethane (TRIS, Sigma, 99.8 %), 2-(N-morpholino)ethanesulfonic acid (MES, Sigma, 
99.5 %). All chemicals were used as received without any further purification.   
 
4.2.2 Preparation of large pore SBA-15 spherical particles  
Large pore SBA-15 was synthesized according to literature.19 Pluronic 123 (3 g) was 
dissolved in 1.5 M HCl (60 mL). CTAB (0.6 g) and mesitylene (1.5 g) were first mixed with 
25 mL of destilled water separately, before the two solutions were combined and stirred 
thoroughly as Ethanol (20 mL absolute) was added. The resulting solution is referred to as the 
surfactant solution. To the surfactant solution, the amount of 10 mL TEOS was added 
dropwise. The resulting mixture was vigorously stirred (500 rpm) at 35°C for 45 min before 
being transferred to a Parr autoclave and being heated to 75°C for 12 hours at static 
conditions. Subsequently, the mixture is aged at 125°C for another 12 h. The resulting white 
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powder was filtered off, was washed with 100 mL of water and 100 mL of ethanol and dried 
at 60°C overnight. Removal of the template was obtained through calcination at 550°C for 5 
hours (heating rate 1°C/min). 
 
4.2.3 Preparation of 3-chloropropyl-functionalized large pore SBA-15 (SBA-Cl)  
Freshly calcined SBA-15 (200 mg) was dried at 110°C under vacuum conditions for 90 
minutes. Afterwards, dry toluene was added under nitrogen atmosphere. After addition of 3-
chloropropyltrimethoxysilane (1.5 mmol, 276 µl), the reaction mixture was allowed to stir for 
4 hours under reflux conditions. The now functionalized SBA-15 (SBA-Cl) was filtered off 
and washed with each 50 mL of toluene, methanol and water before being dried at 60°C 
overnight. 
 
4.2.4 Preparation of azide-functionalized SBA-15 (SBA-N3) 
The amount of 100 mg SBA-Cl was added to 5 mL of a saturated solution of sodium azide in 
DMF. The resulting mixture was stirred at 90°C for 3 hours. The material was then filtered 
off and was stirred in PBS buffer solution (for preparation, see 3.2.10) for another 3 hours to 
remove remaining DMF from the pore walls. After being filtered off again, the material was 
washed with 50 mL of water and 50 mL of ethanol before being dried at 60°C overnight. 
 
4.2.5 Acetylene functionalization of trypsin  
The amount of 10 mL of a solution containing trypsin (1mg/ml) in MES buffer (for 
preparation, see 3.2.12) was prepared. Subsequently, the amount of 500 µl of an aqueous 
stock solution containing 4-pentynoic acid (0.1 M) was added to the solution. The resulting 
mixture was vortexed for 2 minutes and then stored at 4°C for 15 minutes. The amount of 5 
mg EDC powder was added subsequently. The resulting mixture was vortexed for 2 minutes.  
The reaction mixture was stored at 4°C for 4 hours, after which the sample was dialyzed in a 
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cold room at 6°C against sodium phosphate buffer (10 mM, pH 7.2) for a period of 24 hours. 
The resulting acetylene-functionalized trypsin was used for the click reaction without further 
purification.  
 
4.2.6 Preparation of trypsin-functionalized large pore SBA-15 (SBA-trypsin)  
To a solution containing 7 mg of acetylene-functionalized trypsin, the amount of 50 mg SBA-
N3 was added. To a freshly prepared aqueous solution of CuSO4·5 H2O (1 mM, 5 mL), 1 mg 
of ascorbic acid was added and stirred at room temperature for 10 minutes. Then, 10 µl of the 
solution is added to the reaction mixture. The resulting mixture was allowed to stir at 4°C for 
14 hours. Subsequently, the suspension was centrifuged and washed two times with PBS 
buffer solution (50 mM, pH 7.1). 
 
4.2.7 Preparation of 3-chloropropyl-functionalized Cab-o-Sil aerogel (Cab-o-Sil-Cl) 
500 mg of Cab-o-Sil (Grade EH-2) were dried at 100°C under vacuum conditions for 4 hours. 
Afterwards, the amount of 15 mL toluene was added. After addition of 3-
chloropropyltrimethoxysilane (1.9 mmol, 345 µl), the reaction mixture was allowed to stir for 
4 hours under reflux conditions. The functionalized Cab-o-Sil (Cab-o-Sil-Cl) was washed 
with 50 mL of toluene, methanol and water by multiple centrifugation and redispersion cycles 
before being dried at 60°C for 12 hours.  
 
4.2.8 Prepapration of azide-functionalized Cab-o-Sil aerogel (Cab-o-Sil-N3) 
The amount of 100 mg Cab-o-Sil -Cl was added to 5 mL of a saturated solution of sodium 
azide in DMF. The resulting mixture was stirred at 90°C for 3 hours. The material was 
filtered off and stirred in PBS buffer solution for 3 hours in order to remove remaining DMF 
from the mesopores. The material was washed with 50 mL of each water and ethanol by 
centrifugation before being dried at 60°C for 12 hours. 
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4.2.9 Preparation of trypsin-functionalized Cab-o-Sil aerogel (Cab-o-Sil-trypsin)  
To a solution containing 7 mg of acetylene-functionalized trypsin (7 mL) in PBS buffer (pH 
7.4), the amount of 50 mg Cab-o-Sil-N3 was added. The amount of 1 mg ascorbic acid was 
added to a freshly prepared aqueous solution of CuSO4·5 H2O (1 mM, 5 mL) and the resulting 
mixture stirred at room temperature for 10 minutes. Subsequently, 12.5 µl of the copper-
containing solution were added to the reaction mixture. The resulting mixture was allowed to 
stir at 4°C for 24 hours. The trypsin-functionalized Cab-o-Sil was recovered by centrifugation 
and washed five times with 20 mL PBS buffer solution (50 mM, pH 7.1).  
 
4.2.10 Preparation of the applied PBS buffer 
The amounts of 8 g sodium chloride (NaCl), 0.2 g potassium chloride (KCl), 1.44 g 
disodiumhydrogen phosphate (Na2HPO4), and 0.24 g potassiumdihydrogen phosphate 
(KH2PO4) were dissolved in 800 mL water. The pH was adjusted to 7.4 mL using 1 M 
hydrochloric acid (HCl). Then, water was added to 1 L of volume.  
 
4.2.11 Preparation of the applied TRIS buffer 
The amount of 5.57 g Tris(hydroxymethyl)-aminomethane (TRIS, C4H11NO3)and 0.169 g 
calcium chloride-dihydrate (CaCl2 · 2 H2O) was dissolved in 60 mL of water. The pH was 
adjusted to 8.1 using 1 M hydrochloric acid (HCl). Water was added to 100 mL of volume.  
 
4.2.12 Preparation of the applied MES buffer 
The amount of 1.95 g 2-(N-morpholino)ethanesulfonic acid (MES, C6H13NO4S) was 
dissolved in 500 mL water. The pH was adjusted to 5.5 using 1 M hydrochloric acid (HCl). 
Then, water was added to 1 L of volume.  
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4.2.13 BCA Assay for protein quantification 
For the quantification of trypsin in solution, a Pierce BCA (bicinchoninic acid) Protein Assay 
was used. A trypsin stock solution was prepared containing 2 mg/mL trypsin in PBS buffer 
solution. For a calibration curve, the following samples featuring different trypsin 
concentrations were prepared according to Table 4.2.1. 
Table 4.2.1 Prepared solutions for a trypsin calibration curve 
concentration [µg/mL] 0 5 10 15 20 25 
µL PBS 100 97.5 95 92.5 90 87.5 
µL trypsin stock  0 2.5 5 7.5 10 12.5 
 
5 µl of the investigated sample were diluted in 95 µL PBS buffer (2 < cmax < 0.1 mg/mL).  
BCA-Kit solution B and A were mixed 1:50. 500 µL of the resulting BCA assay mixture was 
added to every sample. The samples were incubated at 60°C for 30 minutes in a thermocycler. 
150 µL of every sample were transferred into a well plate, absorption was measured at 590 
nm using a TECAN well plate reader. 
By using the linear equation of the calibration curve, the concentration of each investigated 
sample can be determined. The obtained calibration curve can be found in Figure 4.2.1.  
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Figure 4.2.1. Trypsin calibration curve for protein quantification. 
 
4.2.14 Trypsin activity determination 
The activity of trypsin, acetylene-modified trypsin (sp-trypsin), and silica supported trypsin 
(SBA-trypsin) was quantified by the release of Nα-p-tosyl-L-arginine from the substrate Nα-p-
tosyl-L-arginine methyl ester hydrochloride (TAME) according to a procedure developed by 
Hummel.20 The reaction is monitored photometrically by measuring the increase of extinction 
at 247 nm. 
In the following, one unit is defined as the amount of enzyme releasing 1 µmol Nα-p-tosyl-L-
arginine per minute under the denoted conditions. 
A TAME stock solution is prepared containing 189 mg TAME in 50 mL water. The enzyme 
is dissolved in 0.001 n HCl with an enzyme concentration of  5.5 µg/mL. 
For the activity determination, a 1.5 mL cuvette with 75 µL TAME solution, 200µl enzyme 
solution (1.1 µg enzyme), and 1225 µl Tris buffer was prepared. For the sample SBA-trypsin, 
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the amount of 55 µg sample containing 6.6 µg of enzyme (data from TGA and BCA assay) 
was dispersed in a mixture of 75 µl TAME solution, 100 µl 0.001 n HCl, and 1325 µl Tris 
buffer. 
For the sample Cab-o-Sil-trypsin, 14 µg solid sample containing 2 µg of enzyme (data from 
TGA and BCA assay) was dispersed in the mixture described for SBA-trypsin. The extinction 
at 247 nm was acquired at intervals of one minute. Between each acquisition, the SBA-
containing suspension was homogenized by shaking. The enzyme activity was determined 
from the slope of the obtained linear curve (eq. 4.2.1).  
 
€ 
E247
0.54⋅ Ew
⋅ 1.5    eq. 4.2.1  
E247: Increase in extinction at 247 nm 
0.54: Extinction of 1 µmol Nα-p-tosyl-L-arginine 
Ew: Initial weight of enzyme in mg per 0.1 mL solution 
1.5: Total volume of sample in mL 
 
The curve measured for trypsin can be found in Figure 4.2.2. The resulting slope of the linear 
regression is 0.0091 min-1. 
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Figure 4.2.2 Activity determination curve for native trypsin.  
 
By using equation 1, an activity of 346.3 units was found for native trypsin. The curve 
measured for sp-trypsin is shown in Figure 4.2.3. The resulting slope of the linear regression 
is 0.0088 min-1. This corresponds to 334.9 units for sp-trypsin.  
 
Figure 4.2.3. Acitivity determination curve for sp-trypsin. 
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The curve measured for SBA-trypsin is shown in Figure 4.2.4. 
 
 
Figure 4.2.4. Activity determination curve of SBA-trypsin. 
 
The slope of 0.0104 in Figure 4.2.4 and a loading of 123 mg enzyme per 1 g SBA-15 (TGA 
and BCA quantification) correspond to an enzyme activity of 65.6 units per mg enzyme.  
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Figure 4.2.5. Activity determination curve of Cab-o-Sil-trypsin. 
 
 
With the slope of 0.00902 in Figure 4.2.5 and the determined enzyme loading of 141 mg 
enzyme per 1 g of Cab-o-Sil, the remaining enzymatic activity can be calculated to 84 u/mg.  
 
4.2.15 Procedure for the applied leaching test 
The sample SBA-trypsin was re-suspended in Tris-buffer solution for 4 hours. The 
supernatant and the powder were then separated by centrifugation. Then, the absorption at 
279 nm of the protein in the supernatant was measured. A previously acquired calibration 
curve (Figure 4.2.6) was used to quantify the amount of enzyme leached out of the pores.   
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Figure 4.2.6. Calibration curve for the determination of trypsin concentrations in the 
performed leaching experiment. 
 
 
4.3 Results and Discussion 
Large-pore SBA-15 was synthesized according to previously published procedures.19 
Tetraethyl orthosilicate (TEOS) was hydrolyzed in a reaction mixture containing Pluronic 123 
as template, cetyltrimethylammonium bromide (CTAB) as co-template, mesitylene as 
swelling agent, potassium chloride, and hydrochloric acid. Removal of the template was 
achieved by calcination at 550 °C for 5 hours (heating rate 1 °C/min). Mesoporous silica 
spheres featuring diameters of 6 µm with a surface area of 700 m2g-1 and pore sizes of around 
9 nm were obtained. A choice of SEM images of the synthesized material can be found in 
Figure 4.3.1. 
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Figure 4.3.1. SEM-Pictures of the obtained SBA-15 microspheres. 
 
The silica surface was functionalized with (3-chloropropyl)-trimethoxysilane (sample SBA-
Cl) using a post-synthetic grafting approach. The mesostructure of the resulting materials was 
demonstrated by small-angle X-ray diffraction (Figure 4.3.2) 
 
 
Figure 4.3.2 XRD-patterns of the sample (a) SBA-15 and (b) SBA-Cl. 
 
By a substitution reaction with sodium azide (NaN3) in N,N-dimethylformamide (DMF), an 
azide-functionalized mesoporous silica surface was created (SBA-N3). Acetylene-modified 
trypsin (sp-trypsin) was synthesized according to previously reported procedures, using 4-
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pentynoic acid as reagent and N-(3-dimethylaminopropyl)-N-ethylcarbodiimide (EDC) as 
activating agent.21 
 Subsequently, SBA-N3 was reacted with sp-trypsin in a copper-(I)-catalyzed Huisgen 
reaction (Click reaction) at 4 °C in aqueous medium followed by vigorous washing steps, 
resulting in trypsin-functionalized mesoporous silica (SBA-trypsin, Figure 4.3.3). 
 
 
Figure 4.3.3 Covalent attachment of trypsin into the mesoporous system of large-pore SBA-
15 achieved by Click chemistry (schematic). 
 
The result of the click reaction and the presence of trypsin in the sample were monitored by 
IR spectroscopy (Figure 4.3.4).  The almost complete loss of intensity of the azide stretch 
signal (2105 cm-1, Figure 4.3.4 a, b) indicates the covalent attachment of trypsin to the 
surface. The emerging strong absorption bands located at 1667 cm-1 and 1531 cm-1 are 
assigned to the amide bonds of the attached protein (Figure 4.3.4 b, c). 
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Figure 4.3.4. IR spectra of the samples (a) SBA-N3, (b) SBA-trypsin, and (c) trypsin. 
 
Nitrogen sorption measurements of samples SBA-15, SBA-Cl and SBA-trypsin confirm the 
presence of the large trypsin molecules attached to the pore walls (Figure 4.3.5, Table 4.3.1).  
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Figure 4.3.5 Nitrogen sorption isotherms of the sample (black) SBA-15, (red) SBA-Cl, and 
(green) SBA-trypsin. 
 
Table 4.3.1 Nitrogen sorption data of the synthesized samples 
sample name BET surface 
[m2g-1] 
pore size 
[nm] 
pore volume 
[cm3g-1] 
SBA-15 701 8.91 1.89 
SBA-Cl 651 8.40 1.69 
SBA-trypsin 430 6.95 0.73 
 
The considerable decrease in surface area, NLDFT pore volume, and pore diameter in sample 
SBA-trypsin clearly indicates functionalization with the enzyme on the inner surface. The 
functionalization density was determined by thermogravimetric analysis (TGA, Figure 4.3.6) 
and confirmed by a bicinchoninic acid assay (BCA-assay).  
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Figure 4.3.6 TGA curves for the samples (a) SBA-15, (b) SBA-Cl, and (c) SBA-trypsin. 
 
While the unfunctionalized SBA-15 only shows a minor mass loss of less than 1 % (Figure 
4.3.6 a), the mass loss of 5.0 % in sample SBA-Cl corresponds to 0.68 mmolg-1 of 
chloropropyl residues bound to the silica surface (Figure 4.3.6 b). Based on the mass loss of 
15% in the sample SBA-trypsin (Figure 4.3.6 c), the amount of bound enzyme can be 
calculated to be 12 wt%. Detailed calculations of the obtained values from TGA can be found 
in the Appendix (A-2).  
The results from TGA were confirmed by BCA-assay quantification of the remaining protein 
in the supernatant of the synthesis solution (see section 4.2.13 for experimental procedure, 
appendix A-3 for detailed calculation of the results).  
Based on these results, the protein activity of the surface-bound enzyme in SBA-trypsin was 
determined. In order to prove the retention of the enzymatic activity, the assay developed by 
Hummel was applied.20 The performance of trypsin, acteylene-modified trypsin (sp-trypsin), 
and silica-supported trypsin (SBA-trypsin) was photometrically quantified by the release of 
Nα-p-tosyl-L-arginine methyl ester hydrochloride (TAME). In the following, one unit is 
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defined as the amount of enzymatic activity releasing 1 µmol of Nα-p-tosyl-L-arginine per 
minute. The curves obtained from the assay can be found in the experimental section (4.3.14). 
Both sp-trypsin and SBA-trypsin remain biologically active. The activity found for trypsin 
was 346 units/mg, while sp-trypsin showed an activity of 334 units/mg. The high activity of 
SBA-supported trypsin was calculated to be 7.9 units/mg (host+enzyme), corresponding to 
65.6 units/mg (enzyme), or retention of 20% of enzyme activity relative to aqueous solution. 
As a reference, nonporous silica aerogel was functionalized the same way, resulting in an 
enzymatic activity of 80 units/mg (enzyme) or 10.8 units/mg (host+enzyme). In comparison, 
the reported activity of chymotrypsin is reduced to 1.7 % upon cross-linking with 
glutaraldehyde in SBA-15.16,22 The results show that porous SBA-15 causes no substantial 
diffusion limitations compared to nonporous silica. The remaining pore diameter of 7 nm still 
allows efficient substrate transport to the reactive site of the enzyme molecules. The 
stabilizing role of SBA-15 is demonstrated by the exceptional conservation of activity during 
multiple recovery cycles (Figure 4.3.7). 
Both enzyme-carrying materials SBA-trypsin and Cab-o-Sil-trypsin were compared in terms 
of reusability. After one catalytic cycle, both materials were centrifuged off (43500 rcf) and 
stored at 4 °C for 2 h. Then, the hosts were resuspended and the enzyme activity experiments 
were repeated. As can be seen in Figure 4.3.7, SBA-trypsin recovers 72 % of its initial 
catalytic activity after 4 recovering cycles. In contrast, Cab-o-Sil-trypsin recovers only 6 
percent of its initial activity. This can be explained by the possibility of autodegradation in the 
case of Cab-o-Sil-trypsin, as the enzymes attached to the surface of non-porous silica 
nanoparticles are still able to degrade each other. 
This experiment clearly demonstrates the benefitial role of SBA-15 in our approach.  
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Figure 4.3.7 Reusability of the samples (■) SBA-trypsin and (▲) Cab-o-Sil-trypsin. 
 
Leaching experiments were performed in order to show the stability of the covalent enzyme 
attachment. The amount of 1.1 mg SBA-trypsin was allowed to stir in 2 mL Tris buffer 
solution for 4 h. Then, the solid support was separated from the solution by centrifugation 
(5000 rpm for 10 min). Subsequently, the absorption of the supernatant solution was 
determined by UV-vis spectroscopy at 279 nm. The absorption value of 0.00673 implies that 
trypsin leaching has not occurred. This result was confirmed by BCA assay using 150 µl of 
the supernatant of the leaching experiment described above. As a complementary approach, 
the catalytic activity of the supernatant was determined as described in 4.3.13. The obtained 
curve is shown in Figure 4.3.8. The resulting slope of zero implies that the measured solution 
does not contain any measureable amount of trypsin.  
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Figure 4.3.8 Obtained catalytic curve of the supernantant of the performed leaching 
experiment. 
 
These data clearly prove that leaching does not occur under the experimental conditions.  
 
4.4 Conclusion 
In summary, we present a novel approach for the covalent modification of mesoporous silica 
with intact enzymes. The high covalent functionalization density under simultaneous retention 
of enzyme activity and the absence of leaching demonstrates the promising potential of this 
approach. This approach was chosen to demonstrate the applicability of the click reaction on 
mesoporous silica. Especially, the mild reaction conditions allow the immobilization of 
sensitive biomolecules. The findings are important not only in the field of applied 
biocatalysis, but also for the design for silica-based nanodevices for bio-related applications 
like drug delivery or biomolecule-based molecular machines.   
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 5. Biotin-Avidin as Protease-Responsive Cap-System for Controlled Guest 
Release from Colloidal Mesoporous Silica 
 
The following work is based on the publication indicated below: 
Axel Schlossbauer, Johann Kecht, and Thomas Bein; Angewandte Chemie, International 
Edition 2009, 48, 3092-3095  
 
5.1 Introduction 
Recently, cap systems for colloidal mesoporous silica (CMS) acting as stimuli-responsive 
release mechanisms have been developed.1,2 Among other possible applications, the 
controlled release of molecules such as peptides or antibacterial agents has attracted growing 
attention in the design of smart detergents.3,4 CdS nanoparticles, polymers or large molecules, 
i.e., cyclodextrins and rotaxanes have been used as cap-systems to keep compounds from 
leaching out of porous hosts and to permit their controlled release.5,6 Opening stimuli include 
changes in pH value or temperature, as well as light-irradiation,,esterase activity and redox 
reactions, depending on the system.5,7 However, many of the existing cap-systems still present 
challenges in terms of their biocompatibility or the toxicity of the capping agents used. One 
possible solution could be the direct use of native biomolecules, such as proteins, to block the 
pores of CMS reversibly. It is anticipated that such species would enable high 
biocompatibility and tailored interactions between the CMS and the locus of activity. Opening 
of the pore system is possible by removal of the capping system; that is, by the direct cleavage 
of a link or, as demonstrated in this study, through a decrease of protein-bonding interactions 
by proteolytic hydrolysis. Until now, the biotin-avidin system has mainly been used in 
biorecognition,8 biosensing,9 or biomedical applications.10,11 Here we describe the use of the 
well-studied biotin-avidin complex for a biomolecule-based, enzyme-responsive cap-system 
for CMS nanoparticles, and demonstrate the operability of this system by controlled release of 
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fluorescein molecules. Thus, it is possible to design a sophisticated biocompatible cap-system 
with protease-responsive properties by direct application of an existing biological system. The 
presence of proteases in modern detergents offers the possibility of a protease-responsive 
opening mechanism in order to release sensitive substances that benefit from protective 
encapsulation.12 
 Recently, we developed a strategy for integrating molecular functionality exclusively into the 
outer surface shell of CMS in precisely controlled amounts while leaving the inner pore 
system unfunctionalized.13 Here we use this method to design mesoporous nanospheres with 
protein coupling sites located exclusively on the outer particle surface. This approach enables 
the attachment of large proteins without uncontrolled pore clogging inside the mesoporous 
hosts, and the whole pore volume is available for cargo molecules. For reference experiments, 
unfunctionalized CMS was synthesized according to our previously published procedures.14 
 
5.2 Experimental Section 
5.2.1 Applied chemicals  
Tetraethylorthosilicate (TEOS, Fluka, >99%), (3-mercaptopropyl)-triethoxysilane (MPTS, 
Gelest, 95%), cetyltrimethylammonium bromide (CTAC, Fluka, 25% in H2O), 
triethanolamine (TEA, Aldrich, 98%), avidin from egg white (Sigma, lyophilized powder), 
trypsin from bovine pancreas (Sigma, lyophilized powder), fluorescein sodium salt (Fluka, 
standart for fluorescence), Saline-sodium citrate buffer, pH=7.0 (SSC-buffer, Sigma). All 
chemicals were used as received without further purification. Doubly distilled water from a 
Millipore system (Milli-Q Academic A10) was used for all synthesis and purification steps.  
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5.2.2 Preparation of colloidal mesoporous silica nanoparticles (CMS)  
Mesoporous silica nanoparticles were prepared according to literature from reaction mixtures 
with a molar composition of 1 TEOS: 0.20 CTAC: 10.37 TEA: 130.15 H2O.14 The combined 
TEOS (1.92 g, 9.22 mmol) and TEA (14.3 g, 95.6 mmol) were heated for 20 minutes at 90 °C 
without stirring in a 100 mL polypropylene reactor. A solution of CTAC (25 % in water, 2.41 
mL, 1.83 mmol) and water (21.7 g, 1.21 mol) preheated to 60 °C was added, and the resulting 
mixture was stirred at room temperature for 12 hours. After addition of 100 mL ethanol, the 
mesoporous silica nanoparticles were separated by centrifugation, redispersed in ethanol and 
extracted according to the procedure described below.  
 
5.2.3 General procedure for the selective functionalization of CMS with 3-
mercaptopropyl moieties by co-condensation (CMS-SH)  
The reactants were mixed following the previously published synthesis procedure for CMS.13 
However, a second set of reactants was added at 30 minutes after combination of the initial 
TEOS/TEA and CTAC solutions. The reactants were added to the stirred reaction mixture 
with an Eppendorf micropipette and consist of TEOS and (3-mercaptopropyl)-triethoxysilane 
(MPTES) in the molar ratio 1 : 1. The combined amount of both silanes was 185 µmol, i.e. 2 
% of the total amount of “Si” in the initial CMS synthesis. The resulting mixture was stirred 
at room temperature for 12 hours followed by purification and extraction as described for 
CMS.  
 
5.2.4 Extraction of CMS  
Extraction of the organic template from the CMS materials was performed by heating the 
colloidal suspensions containing 250 mg of CMS for 45 minutes under reflux at 90 °C in a 
solution containing 2 g ammonium nitrate in 100 mL ethanol, followed by 45 minutes under 
reflux in a solution of 4 g concentrated hydrochloric acid in 100 mL ethanol. The CMS 
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materials were separated by centrifugation and washed with ethanol after each extraction step. 
CMS materials were obtained as clear ethanolic suspensions.  
 
5.2.5 Biotin-functionalized colloidal mesoporous silica nanoparticles (CMS-BIO)  
20 mg CMS-SH was transferred into a 50 mL flask and redispersed in 20 mL SSC-buffer (pH 
= 7, 0.15 M sodium chloride, 15 mM trisodium citrate)). Subsequently, 1.1 mg (2.4 µmol) of 
avidin from egg white was added to the reaction mixture. The resulting suspension was stirred 
for 12 hours at room temperature. The resulting colloidal suspension was washed by 
centrifugation and then redispersed in 20 mL of SSC-buffer.  
 
5.2.6 Fluorescein-loaded CMS and CMS-BIO  
The amount of 10 mg CMS-BIO or CMS was transferred to 20 mL of a 1 M fluorescein 
disodium salt solution in a saline-sodium citrate-buffer (pH = 7, 0.15 M sodium chloride, 15 
mM trisodium citrate). The resulting mixtures were stirred for 1 hour. After centrifugation, 
CMS and CMS-BIO were both washed with 20 mL SSC-buffer. CMS was then directly 
subjected to the described release experiment after being redispersed in 200 µL SSC-buffer. 
CMS-BIO was redispersed in 5 mL SSC-buffer solution and subsequently capped with avidin 
(see 5.2.7).  
 
5.2.7 Avidin-capped, fluorescein loaded CMS (CMS-AVI)  
To the amount of 10 mg fluorescein-loaded CMS-BIO redisersed in 5 mL SSC-buffer (pH=7, 
0.15 M sodium chloride, 15 mM trisodium citrate), 7 mg avidin from egg white was added. 
The resulting mixture was stirred at room temperature for 12 hours. The suspension was 
centrifuged and washed three times with each 5 mL of SSC buffer. The product was then 
redispersed in 200 µL SSC buffer solution. CMS-AVI was then subjected to the described 
release experiment (5.2.8).  
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5.2.8 Fluorescence spectroscopy setup 
Fluorescence experiments were performed in order to show the time-dependent release of 
fluorescein from the mesopores of colloidal mesoporous silica spheres. Fluorescein sodium 
salt was excited with 490 nm and showed a maximum of emission at 511 nm (excitation slit 
1.0 mm, emission slit 1.0 mm, integration 0.5 sec). For the release experiment, a ROTH 
Visking Typ 8/32 dyalisis membrane with a molecular cut-off of 14.000 g/mol was used. A 
picture of our custom made Teflon container can be seen in Figure 5.5. The suspension is 
filled into the container, which is subsequently closed by a dialysis membrane. The closed 
container is then put onto a fluorescence cuvette, which is completely filled with water. The 
released dye is able to pass through the applied membrane while the relatively large particles 
are held back.  
 
5.3 Results and Discussion 
Colloidal mesoporous silica spheres with mercaptopropyl-functionalities exclusively on the 
outer particle surface were synthesized by applying our recently developed delayed co-
condensation approach.13 Briefly, tetraethylorthosilicate (TEOS) was hydrolyzed in a reaction 
mixture containing cetyltrimethylammonium chloride (CTAC) and triethanolamine (TEA). A 
mixture of TEOS and (3-mercaptopropyl)-triethoxysilane equivalent to 2 % of the total silane 
content was added 30 minutes after the generation of the seeds, resulting in mesoporous silica 
nanoparticles bearing mercaptopropyl moieties exclusively on the outer particle surface 
(CMS-SH). As a reference sample, pure unfunctionalized CMS were synthesized as well 
(sample CMS). After 12 hours, the template-filled pores of both samples CMS and CMS-SH 
were extracted, resulting in clear suspensions featuring particle sizes around 80 nm, BET 
surfaces of approximately 1100 m2/g and NLDFT pore sizes of about 3.8 nm. A 
representative TEM picture of the CMS is shown in Figure 5.3.1.  
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Figure 5.3.1 TEM picture  of the sample CMS-SH. 
 
The subsequent treatment of CMS-SH in aqueous solution at room temperature with biotin-
maleimide (in 2-fold excess with respect to the thiol groups incorporated in the CMS) resulted 
in biotinylation of the outer surface of CMS-SH (to give CMS-BIO, Figure 5.3.2).  
 
 
 
Figure 5.3.2 Attachment of biotin-maleimide to the thiol-functionalized CMS surface.  
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CMS-BIO was then loaded with fluorescein by stirring CMS-BIO (10 mg) in 25 ml of a 1 M 
solution of fluorescein disodium salt for 1 hour. After centrifugation and redispersion in a 
citrate buffer solution (pH = 7), avidin (5 mg) was added to cap the filled pores (CMS-AVI, 
Figure 5.3.3). 
 
 
  
Figure 5.3.3 Attachment of avidin caps on the biotinylated CMS surface. The four subunits of 
avidin can each bind to one biotin moiety attached to the surface. 
 
The closure reaction was performed by stirring at room temperature for 12 hours. The 
resulting material was washed three times to remove all dye molecules located outside the 
closed pores. Unfunctionalized CMS was loaded with dye as described for CMS-BIO, but 
only one washing step was performed. The results of the different reaction steps were 
monitored by IR spectroscopy (Figure 5.3.4). 
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Figure 5.3.4 IR-spectra of the samples (a) CMS-SH, (b) CMS-BIO and (c) CMS-AVI. The 
absorbance is expressed in Kubelka-Munk (KM) units. 
 
 The emerging broad absorption band around 1680 cm-1 in sample CMS-BIO can be assigned 
to various vibrations of the hydrazide and cyclic urea structures contained within the attached 
biotin-maleimide molecules (Figure 5.3.4b). The typical amide vibrations in sample CMS-
AVI are located at 1530 cm-1 and also around 1650 cm-1 (Figure 5.3.4c). Signals below 1500 
cm-1 can be mainly attributed to the silica framework. Changes in pore volume and diameter 
were investigated by nitrogen sorption experiments (Figure 5.3.5).  
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Figure 5.3.5 Nitrogen sorption isotherms of the samples CMS-SH (), CMS-BIO (), and 
CMS-AVI (). 
 
For BET and NLDFT calculations, only cumulative pore volumes are specified for pores 
smaller than 8 nm owing to the considerable textural porosity of the CMS samples. No 
decrease in pore diameter is observed in samples CMS, CMS-SH and CMS-BIO. This result 
indicates that the internal surface of the mesoporous particles remains unfunctionalized (Table 
5.3.1). The corresponding pore size distribution graphs can be found in the Appendix (A-4). 
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Table 5.3.1 NLDFT pore diameters and pore volumes from the synthesized CMS samples. 
 
 CMS CMS-SH CMS-BIO CMS-AVI 
Pore diameter (nm) 3.9 3.8 3.8 ---- 
Pore volume (cm3 g-1) 0.8 0.8 0.6 0.19 
 
 
The decrease in surface area and pore volume by approximately 30 % in the sample CMS-
BIO is attributed to partial pore blocking due to the large organic moieties on the outer shell 
of the CMS. In the case of CMS-AVI, a striking almost complete elimination of nitrogen-
accessible mesopore volume was observed as a result of pore blocking of the mesopores by 
the large proteins. We take this observation as evidence of a very effective pore closure by the 
attached avidin.  
Measurements of the zeta potential were made to show the effect of the different 
functionalization steps on the surface charge. As can be seen in Figure 5.3.6, the synthesized 
materials show characteristic surface potentials corresponding to the molecules covering the 
outer silica surface.  
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Figure 5.3.6 Zeta potential curves of the samples CMS-SH (filled squares), CMS-BIO (empty 
triangles), and CMS-AVI (empty circles). 
 
The thiol-carrying surface of the sample CMS-SH is slightly protonated at pH = 2. At higher 
pH values, the acidic character of the thiol group leads to a deprotonation of SH and therefore 
leading to a more negative surface potential.  The biotinylated surface of CMS-BIO shows a 
different behaviour (Figure 5.3.6, empty triangles). The structure of the biotin-maleimide 
molecule does not include possible protonation sites. Corresponding to the structure, the zeta 
potential of CMS-BIO at low pH is much lower than the values obtained for CMS-SH. 
However, the surface of CMS-AVI can be protonated at the aminogroups included in the 
structure of the attached protein thus leading to a higher zeta potential. 
In order to show that we maintain the colloidal state of the samples after all synthesis steps, 
dynamic light scattering experiments were performed. The results show that we obtain 
colloidal samples after each functionalization reaction (Figure 5.3.7). 
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Figure 5.3.7 DLS measurements of the samples CMS-SH (black), CMS-BIO (red), and CMS-
AVI (blue). 
 
The enzyme-responsive release properties were investigated with fluorescence spectroscopy. 
An aqueous suspension containing either 2 mg of CMS-AVI or of loaded unfunctionalized 
CMS was transferred into a specially designed container, which could be closed by a holey lid 
lined with a dialysis membrane. This custom-made system fits on the opening of a 
fluorescence cuvette (see Figure 5.3.8). 
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Figure 5.3.8 Custom made release experiment setup featuring  a 200 µl Teflon tube (a) 
which is closed by a dialysis membrane (b). This setup is put onto a fluorescence cuvette 
filled with water (c).   
   
Whereas the colloidal particles are too large to diffuse through the dialysis membrane, 
fluorescein can enter the free cuvette volume readily and be observed by fluorescence 
spectroscopy at a temperature of 37 °C.  In a reference experiment, it was shown that the 
dialysis membrane used (with a molecular weight cut-off of 16000 g/mol) does not act as a 
diffusion barrier for fluorescein (see Appendix A-5). Fluorescein was excited at 490 nm, 
which led to a fluorescence emission maximum at 511 nm. In another reference experiment, 
the unfunctionalized CMS host released the entire loaded amount of dye within minutes 
(Figure 5.3.9, ). The concentration of fluorescein inside the cuvette remained stable after 30 
minutes. This concentration was attributed to a relative release ratio of 100%. The attached 
avidin in sample CMS-AVI prevented the loaded fluorescein from escaping the pore system. 
After 60 minutes, no significant release of fluorescein was observed, which indicates that the 
new closure mechanism is highly efficient (Figure 5.3.9, ).  
A very different result was obtained after the addition of the protease trypsin (1 mg) to the 
colloidal suspension. In an earlier study, trypsin had been used to hydrolyze avidin to obtain 
information about its amino acid sequence.15 In our case, the proteolytic digestion of avidin 
allows the loaded dye to escape from its host. The concentration of released fluorescein 
increased shortly after the addition of trypsin (Figure 5.3.9, ). 
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Figure 5.3.9 Protease-responsive release curve of the sample CMS-AVI () and release from 
unfunctionalized CMS (). 
 
After 4 hours, no further increase in the concentration of released fluorescein was observed, a 
result that indicated the complete release of the loaded dye.  
Interestingly, the enzyme-responsive release curve features a fairly slow release for the first 
hour after the addition of trypsin. This result can be explained by the tryptic hydrolysis 
process, in which an increasing number of caps are cleaved. After one hour, the capping 
proteins are effectively digested, which leads to a faster release of the guest molecules. After 
140 minutes following the addition of the protease, the observed amount of fluorescein 
remained stable (100%). The absolute amounts of released dye were determined by UV-vis 
spectroscopy. All investigated samples released comparable amounts of fluorescence dye  
(around 0.03 mg per mg sample, see Appendix A-6 for calculations). These data clearly 
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demonstrate that we are able to close the pore system of CMS with the avidin-biotin system, 
and to subsequently release the loaded molecules by enzymatic hydrolysis of the caps.  
We carried out a complementary thermoresponsive release experiment to compare the 
efficiency of the different cap-opening methods. In this case, the attached protein caps were 
opened by denaturation. Therefore, they were opened immediately and simultaneously. An 
increase in the temperature to 90 °C weakened the affinity of avidin for the biotinylated 
surface and led to the fast and fairly linear release of the loaded fluorescein molecules (Figure 
5.3.10). In contrast to the enzyme-responsive opening mechanism, the thermoresponsive 
release occurs directly after the stimulation (temperature increase).  
 
 
Figure 5.3.10 Thermoresponsive release of fluorescein from the sample CMS-AVI. 
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5.4 Conclusion 
In summary, we have presented a biomolecule-based enzyme-responsive cap system for 
mesoporous silica. We show that the attachment of avidin to the outer surface of CMS can 
prevent the uncontrolled leaching of incorporated guest molecules. The tight closure of the 
pores can be explained by the structure of the avidin-biotin complex. The four subunits of 
avidin (molecule size 4.5 x 5.5 x 6 nm3)16 can each bind to one biotin molecule; thus, a strong 
interaction between the avidin and the biotin-covered CMS surface results. We have 
demonstrated an opening mechanism based on the controlled enzymatic hydrolysis of the 
attached protein avidin. The advantage of this system lies in the use of native biomolecules. 
Thus, the creation of toxic or carcinogenic species can be avoided. This approach offers new 
possibilities for applications of mesoporous hosts in the fields of detergent design and drug 
delivery.  
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 6. A Programmable DNA-Based Molecular Valve for Colloidal Mesoporous 
Silica 
 
The following work is based on the publication indicated below: 
Axel Schlossbauer, Simon Warncke, Philipp M. E. Gramlich, Johann Kecht, Antonio 
Manetto, Thomas Carell, and Thomas Bein, Angew. Chem., Int. Ed. 2010, 49, 4734-4737 
 
6.1 Introduction 
Recently, stimuli-responsive gatekeepers or valves for the controlled release of guest 
molecules from mesoporous silica hosts have been developed.1-4 Controlled release 
mechanisms are of great interest in many different fields such as drug delivery, detergent 
design, or additives in polymers. For example, inorganic nanoparticles, large molecules and 
also polymers have been applied to prevent guest molecules from leaving the pore system.5-7 
The release mechanisms include those based on changes in the reduction potential, pH, UV 
irradiation, or temperature.8-10 For instance, gold nanoparticles were functionalized with 
photocleavable linkers and subsequently adsorbed onto the surface of MCM-41. Other 
systems utilize the external presence of enzymes for the controlled release of incorporated 
guests.11,12 One approach uses α -cyclodextrins fixed with ester-bound adamantyl-stoppers. 
Opening was achieved by the addition of porcine liver esterase, leading to a removal of the 
stoppers.12 Our research has recently centered on systems using biomolecules as components 
for the design of the molecular valves. For example, we have demonstrated the applicability 
of the biotin-avidin complex as biomolecule-based valve on novel core-shell functionalized 
colloidal mesoporous silica, which opens by enzyme action or at high temperature (see 
chapter 5).3 The molecular valves reported so far are commonly based on one specific 
opening mechanism, which is determined by the chemical nature of the system. Here we 
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demonstrate that a molecular valve system can be made programmable by encoding the 
desired behavior in a DNA sequence that is part of the responsive system. We demonstrate 
this concept with the programmable opening temperature of a molecular valve on the pore 
mouths of novel core-shell colloidal mesoporous silica (CMS, Figure 6.1.1). 
 
 
Figure 6.1.1 Concept of the programmable molecular valve system. Melting the DNA linkers 
at specifically encoded temperatures opens the avidin caps. 
 
 As discussed in Chapter 3, we have developed the controlled molecular core-shell 
functionalization of colloidal mesoporous silica, which is a prerequisite for the complex 
assembly of the different functionalities at different locations of the nanoscale porous 
particles.13,14  
As described below, we have selectively attached biotin-labeled DNA double strands to the 
pore mouths of the core–shell mesoporous nanoparticles. This procedure allows a subsequent 
closing of the pores by the protein avidin whilst leaving open the internal pore volume of the 
mesoporous nanoparticle. The opening of the valve is achieved by DNA strand melting at the 
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specific melting temperature of the oligonucleotide.   
The work was carried out in cooperation with the research group of Prof. Thomas Carell, 
University of Munich, in particular with Philipp M. E. Gramlich and Simon Warncke and the 
Baseclick GmbH.    
 
6.2 Experimental Section 
6.2.1 Applied Chemicals 
Tetraethylorthosilicate (TEOS, Fluka, >99%), (3-chloropropyl)-trimethoxysilane (ClTMS, 
Fluka, 95%), cetyltrimethylammonium bromide (CTAC, Fluka, 25% in H2O), triethanolamine 
(TEA, Aldrich, 98%), sodium azide (NaN3, Fluka, 99%), avidin from egg white (Sigma, 
lyophilized powder), fluorescein sodium salt (Fluka, standard for fluorescence), N,N-
dimethylformamide (DMF, Sigma, > 99.8 %). All chemicals were used as received without 
further purification. Doubly distilled water from a Millipore system (Milli-Q Academic A10) 
was used for all synthesis and purification steps. DNA oligomers and 
tris(benzyltriazolylmethylamine) ligand were received as a gift from Baseclick GmbH.  
 
6.2.2 Preparation of colloidal mesoporous silica nanoparticles (CMS)  
Mesoporous silica nanoparticles were prepared according to literature procedures.13 The 
combined TEOS (1.92 g, 9.22 mmol) and TEA (14.3 g, 95.6 mmol) were heated for 20 
minutes at 90 °C without stirring in a 100 mL polypropylene reactor. A solution of CTAC (25 
% in water, 2.41 mL, 1.83 mmol) and water (21.7 g, 1.21 mol) preheated to 60 °C was added, 
and the resulting mixture was stirred at room temperature for 30 minutes. A second set of 
reactants was added at 30 minutes after combination of the initial TEOS/TEA and CTAC 
solutions. The reactants were added to the stirred reaction mixture with an Eppendorf 
micropipette and consist of TEOS and (3-chloropropyl)-trimethoxysilane (ClTMS) at the 
molar ratio 1 : 1. The combined amount of both silanes was 185 µmol, i.e., 2 % of the total 
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amount of “Si” in the initial CMS synthesis. The resulting mixture was stirred at room 
temperature for 12 hours. After addition of 100 mL ethanol, the mesoporous silica 
nanoparticles were separated by centrifugation, redispersed in ethanol and extracted according 
to the procedure described in 6.2.3.  
 
6.2.3 Extraction of CMS  
Extraction of the organic template from the CMS materials was performed by heating the 
colloidal suspensions containing 250 mg of CMS for 45 minutes under reflux at 90 °C in a 
solution containing 2 g ammonium nitrate in 100 mL ethanol, followed by 45 minutes under 
reflux in a solution of 4 g concentrated hydrochloric acid in 100 mL ethanol. The CMS 
materials were separated by centrifugation and washed with ethanol after each extraction step. 
CMS materials were obtained as clear ethanolic suspensions.  
 
6.2.4 Synthesis of azide-functionalized CMS (CMS-N3) 
100 mg of the extracted sample CMS-Cl were washed with anhydrous DMF for three times 
by centrifugation. Finally, the particles were redispersed in 20 mL of anhydrous DMF and 
transferred into a 100 mL Schlenk flask equipped with a soxhlet extractor under nitrogen 
atmosphere. The Soxhlet extractor was filled with dried molecular sieve with a 4 Å pore size. 
The drying process was carried out for three hours at 90 °C. The resulting dried suspension 
was then saturated with 100 mg NaN3. The reaction mixture was stirred at 80 °C for 5 hours. 
The amount of 50 mL water was then added. The particles were subsequently washed three 
times with 50 mL water followed by centrifugation and then redispersed in 20 mL of water, 
yielding sample CMS-N3.  
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6.2.5 Attachment of alkyne-modified oligonucleotides to CMS-N3 (CMS-DNA15, CMS-
DNA25)  
Alkyne-modified double-stranded DNA (0.70 mM, 71 µL, 50.0 nmol in water) was added to 1 
mg CMS-N3. In a separate vial, 1 µL CuBr solution (0.1 M in DMSO/ tBuOH 3:1) and 2 µL 
of the tris(benzyltriazolylmethylamine) ligand (0.1 M in DMSO/ tBuOH 3:1) were mixed and 
added freshly to the DNA-particle mixture, which was then stirred overnight at room 
temperature. DNA-functionalized CMS was washed three times with 1 mL of MilliQ doubly 
distilled water followed by centrifugation. Subsequently, the particles were redispersed in 1 
mL of water.  
 
6.2.6 Fluorescein loading and avidin capping of CMS-DNAx(CMS-DNA15-AVI, CMS-
DNA25-AVI)  
The amount of 2 mg fluorescein disodium salt was added to the respective suspensions of the 
samples CMS-DNA15 and CMS-DNA25 described in 6.2.5, and the resulting mixture was 
stirred at room temperature for two hours. Subsequently, the amount of 1 mg avidin from egg 
white was added to each of the suspensions. This capping process was carried out for two 
hours of stirring at room temperature. The samples were then washed five times with 1 mL of 
water by centrifugation, before each sample was redispersed in 200 µL of water.  
 
6.3 Results and Discussion 
Colloidal mesoporous silica (CMS) with chloropropyl functionality exclusively on the outer 
shell of the nanoparticles was synthesized by using our recently developed delayed co-
condensation method for the controlled synthesis of functionalized core–shell mesoporous 
nanoparticles.13 This approach avoids uncontrolled pore clogging of the nanoparticles upon 
the attachment of large organic moieties to the surface. Herein, the inner pore walls remain 
unfunctionalized, leaving the whole pore volume available for loading with guest molecules, 
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such as drugs or other organic molecules. A reaction mixture containing tetraethyl 
orthosilicate (TEOS), cetyltrimethylammonium bromide (CTAB), and triethanolamine (TEA) 
results in the spontaneous generation of seeds that grow further radially. After 30 min, a 1:1 
mixture of 3-chloropropyltrimethoxysilane and TEOS was added to the reaction to yield 
organic functionality exclusively at the outer shell of the nanoparticles. CMS with particle 
sizes of about 50 nm were thus obtained as determined by transmission electron microscopy 
(TEM). A TEM image of the sample CMS-Cl can be found in Figure 6.3.1. 
 
Figure 6.3.1 TEM-picture of the sample CMS-Cl 
 
The functionalized mesoporous particles feature pore sizes of 3.8 nm and a pore volume of 
0.99 cm3g-1, as determined from nitrogen sorption isotherms with non-local density functional 
theory (NLDFT). The corresponding isotherm is shown in Figure 6.3.2. 
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Figure 6.3.2 Nitrogen sorption isotherm of the sample CMS-Cl. 
 
The colloids were then transferred into dry N,N-dimethylformamide. The remaining water 
from the pore system was removed under mild conditions according to our previously 
published vapor extraction procedure for 3 hours at 90 °C using molecular sieves.15 This 
approach protects the particles from temperature-induced agglomeration. The resulting water-
free suspension was then saturated with sodium azide and heated to 85 °C for 5 hours to give 
an azide-carrying surface (sample CMS-N3).  
The azide- modified surface was used to attach biotin- and alkyne-functionalized DNA double 
strands by a click chemistry approach. The double strands act as a linker between the particle 
surface and the avidin protein caps. The applied DNA oligomers bear an alkyne functionality 
at their 5’ end. Specifically, a C8-alkyne-desoxyuridine-phosphordiamidite that features a C8-
alkyne linker at the 5-position of the base was incorporated at the 5’ end of the DNA strands. 
This method was recently introduced by some of us.16,17 The functionalized DNA oligomers 
were then pre-hybridized with complementary strands carrying a biotin functionality at their 
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3’ end by briefly heating a 1:1 mixture of the strands to 95 °C and slow cooling to room 
temperature in a 500 mM sodium chloride solution. For our experiments, two different	  double 
strands were synthesized, a 25 mer and a 15 mer. Along with the described alkyne and biotin 
functionality, the 15 mer is modified with two dyes (Cy3, Cy5), one on each end of the 
respective complementary oligomers. This allows for a fluorescence resonance energy 
transfer (FRET) between the two strands to further characterize the hybridization state of the 
DNA at different temperatures.18 Furthermore, the synthesized DNA strands were 
characterized by MALDI-TOF mass spectrometry. An overview of the DNA oligomers that 
were applied is given in Table 6.3.1. 
Table 6.3.1 Sequences and MALDI-TOF analysis of the applied DNA strands. 
 
Applied DNA double strands 
5`- XCA CGT CGC ATC TTG GCC TAC GCC C -3` 
Mcalc. = 7616.4  Mfound = 7617.1 
3`-Bio-AGT GCA GCG TAG AAC CGG ATG CGG G – 5` 
Mcalc. = 8230.9  Mfound = 8231.4 
5`- XCA CGT CGC ATC TTT Cy3 - 3` 
Mcalc. = 5404.8  Mfound = 5405.6 
3`- Bio-AGT GCA GCG TAG AAA Cy5 – 5` 
Mcalc. = 5902.3  Mfound = 5902.8 
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Figure 6.3.3 Infrared spectra of the samples (a) CMS-Cl, (b) CMS-N3, and (c) CMS-DNA15-
AVI  (Inset shows a magnification of the azide stretch area). 
The DNA oligomers were then attached to the particles using a click chemistry approach.  We 
have elaborated in chapter 4 on the applicability of click chemistry on mesoporous silica 
surfaces.19 Samples were synthesized that carry the two different dsDNA introduced in Table 
6.3.1 (CMS-DNA15 and CMS-DNA25). The sequence of building up the molecular DNA 
valve was followed by IR spectroscopy (Figure 6.3.3). Whereas the sample CMS-Cl (Figure 
6.3.3a) only shows the silica framework vibrations, an azide band occurs in sample CMS-N3 
at 2105 cm-1 (Figure 6.3.3b). This band is strongly reduced in intensity upon DNA attachment 
during the click reaction. We take this result as evidence for the covalent DNA binding to the 
CMS sample. As can be seen in Figure 6.3.3, the sample CMS-DNA15-AVI shows the typical 
amide vibrations at 1551 cm-1 and 1650 cm-1 of the attached protein, along with the silica 
vibrations. The weak signals between 1500 cm-1 and 1300 cm-1 in sample CMS-DNA15-AVI 
6. A Programmable DNA-Based Molecular Valve for Colloidal Mesoporous Silica 
 120
can be attributed to the carbonyl vibrations of the desoxyribose backbone and the amino 
groups of the incorporated DNA.  
As described above, the attached strands have a biotin functionality that is now positioned 
closely to the surface of the nanoparticle pore mouth. The intact hybridization of the strands 
after the click reaction is indicated by a successful measurement of the FRET signal in the 
sample CMS-DNA15- AVI (Figure 6.3.4).  
 
Figure 6.3.4 FRET measurements of the sample CMS-DNA15-AVI in the closed state (line) 
and in the open state (dots). 
  
A corresponding reference FRET experiment using the pure as- received 15mer DNA can be 
found in the Appendix (A-7). In analogy, it is assumed that the longer and more stable DNA-
25mer is also in a hybridized state after the click reaction. 
The samples CMS-DNA15 and CMS-DNA25 were then loaded with fluorescein as a model 
compound for guest molecules. To achieve the loading, 1 mg of each sample was stirred in 1 
mL of a solution containing 2 mg fluorescein in water at room temperature for 2 hours. 
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Subsequently, 1 mg avidin from egg white was added and stirring was continued for another 
two hours. This leads to a coordination of the biotinylated DNA with the avidin protein and 
thus should close the pores of the colloidal particles. The subsequent release of fluorescein 
can be easily detected and quantified by fluorescence spectroscopy, as we have demonstrated 
in Chapter 5.3 After incorporation of the dye, the particles were centrifuged in a 1.5 mL vial 
and redispersed in water (pH 7). Thereafter three washing cycles were applied to remove free 
dye from the suspension, yielding the samples CMS-DNA15-AVI and CMS-DNA25-AVI. The 
samples were then transferred into a two-compartment fluorescence cuvette, which can be 
closed by a dialysis membrane and features a sample volume of 200 µL.3 With the two-
compartment temperature-controlled fluorescence cuvette, the release of small fluorescent 
molecules can be detected by fluorescence spectroscopy. The silica nanoparticles are too large 
to diffuse through the dialysis membrane (featuring a molecular weight cut-off of 16.000 
gmol-1) The opening mechanism of the molecular valve was examined with FRET 
measurements. As described above, the sample CMS-DNA15-AVI is equipped with the FRET 
pair Cy3-Cy5 on the complementary DNA strands (see Table 6.3.1). Cy3 has an absorption 
maximum around 550 nm and an emission at 570 nm that tails into the red. Cy5 is excited at 
650 nm and emits at 670 nm. With the attached double strand in a hybridized state, an 
emission at 670 nm can be achieved upon excitation at 550 nm, owing to the energy transfer 
occurring between the two dyes in close contact (less than 10 nm; see Figure 6.3.4).18,20 After 
the thermoresponsive release experiment (see below), the sample was centrifuged and then 
redispersed in 2 mL of water. As can be seen in Figure 6.3.4 (dots), the FRET emission at 670 
nm decreases substantially in intensity after the thermoresponsive release, indicating the 
opening of the molecular valve by separation of the DNA strands. Finally, the programmed 
thermoresponsive opening of the molecular DNA-avidin-biotin valves was demonstrated by 
quantification of the released fluorescein molecules with fluorescence spectroscopy in the 
two-compartment cuvette described above (Figure 6.3.5).  
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Figure 6.3.5 Release curves (normalized fluorescence intensity of fluorescein) of the samples 
CMS-DNA15-AVI (triangles) and CMS-DNA25-AVI (squares). 
 
All intensity values are normalized to the highest obtained fluorescent count of the respective 
sample. Therefore, the highest released amount of fluorescein is set to 100% relative release.  
The raw data of the obtained release measurement before normalization can be found in the 
Appendix (A-8). The temperature-dependent release curves show the striking effect of the 
DNA-linker on the valve-opening behavior. Whilst the 15mer opens at 45 °C, the longer 
25mer is still in a tightly sealed state at this temperature and thus keeps the avidin firmly 
bound to the CMS pore mouth. The sample CMS-DNA25-AVI does not convert into the open 
state until further heating to 65°C. Quantification of the released amount of fluorescein by 
UV/Vis spectroscopy gives comparable amounts of dye released in both samples. 
Specifically, the sample CMS-DNA15-AVI released 0.033 mg dye/mg CMS, whilst the 
sample CMS-DNA25-AVI released 0.040 mg dye/mg CMS.  
A calibration curve for the amount of released fluorescein and detailed calculations can be 
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found in the Appendix (Figure A-6.1, A-9)  
 
6.4 Conclusion 
In summary, we have shown how the incorporation of double-stranded DNA into a novel 
molecular valve can impart programmable, thermoresponsive release behavior at moderate 
temperatures. The successful assembly of this multifunctional nanodevice builds on the novel 
multifunctional core–shell colloidal mesoporous silica host with free available pore volume 
inside the host, selective functionalization of the pore mouths with dsDNA linker bearing two 
dyes for FRET monitoring, and biotin–avidin coupling for valve closure. These nanodevices 
allow the release temperature of incorporated guest molecules to be adjusted precisely for a 
desired application. The general concept of programmed release will be of significant 
importance in fields such as detergents or encapsulation of polymer hardeners.21 A further 
potential application is targeted drug release, although toxicological aspects have to be 
considered here as well. 
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 7. Role of Endosomal Escape for Disulfide-Based Drug Delivery from 
Colloidal Mesoporous Silica Evaluated by Live-Cell Imaging 
 
The following work is based on the publication indicated below: 
Anna M. Sauer, Axel Schlossbauer, Nadia Ruthardt, Valentina Cauda, Thomas Bein, and 
Christoph Bräuchle, Nano Letters 2010, 10 (9), 3684-3691 
 
7.1 Introduction 
Controlled	   release of drugs from functionalized mesoporous materials has attracted great 
interest in recent years.1-6 Triggers used to affect the controlled release include enzymatic 
digestion of gatekeepers,7-10 temperature,7 competitive binding,11 light-irradiaton,12-19 changes 
in the pH value,20-23 or changes in the redox potential.24-28 In Chapter 5 we have discussed an 
enzymatically triggered system, using tightly bound avidin proteins to seal the pores. An 
opening of these protein caps was shown by the release of fluorescein upon proteolytic 
digestion of the attached avidin. Most of the reported systems use valves or caps at the pore 
openings of the porous silica surface.7-9,11,13,20,24 Furthermore, redox-sensitive, disulfide-based 
mechanisms were applied in the field of drug delivery.29 In the context of mesoporous silica, 
for example, poly(N-acryloxysuccinimide) was grafted on mesoporous silica nanoparticles 
and cross-linked by cystamine, resulting in a closure of the pores. Reopening was achieved by 
the addition of a reducing agent.18 As many therapeutic peptides carry thiol functions, and 
nucleic acid oligomers can be functionalized with such groups, redox-driven intracellular 
disulfide cleavage offers a high potential in drug delivery. This approach can also be 
transferred to the pore system of mesoporous hosts. Binding and releasing drug molecules 
from the inner volume of mesoporous silica nanoparticles allows one to avoid synthetically 
demanding molecular valve concepts while retaining the benefits of protecting sensitive or 
immunoresponsive drugs in porous host materials. Mortera et al. have initially studied the 
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concept of disulfide bound agents attached to the pore system of mesoporous silica.25 They 
showed that membrane-impermeable cysteine can be successfully delivered into cells. 
Cysteine delivery into cells promotes the synthesis of glutathione (GSH), which plays a 
central role in cell biology. A number of diseases including cancer as well as 
neurodegenerative and cardiovascular diseases are associated with GSH depletion and 
existing treatment strategies aim at promoting GSH synthesis by cysteine delivery.18 While 
Mortera et al.25 have demonstrated that cell-induced release can be based on disulfide bridges 
in mesoporous silica, the cellular uptake mechanism and the specific locus as well as the time 
point of reduction inside the cell remains unknown. For a further development and 
optimization of this promising approach, it is of particular interest to focus on the details of 
nanoparticle entry and subsequent events after entry into the cell. Such processes can be 
followed effectively with highly sensitive live-cell imaging techniques, as they are available 
in the group of Prof. C. Bräuchle at the LMU. These techniques can monitor the uptake of a 
single particle and its trafficking inside the cell.30-32 A well-known bottleneck for drug 
delivery into the cytosol of cells is the endosomal escape of macromolecular substances or 
drug conjugates.33 Because of the low reductive or even oxidative milieu in endosomes, 
contact to the cytosol is essential for release of disulfide-bound agents.34 The use of 
photoactive compounds to open the endosome is one possibility to overcome this 
challenge.35,36 Recently, our collaborators in this project from the laboratory of Prof. C. 
Bräuchle (LMU München) have used the disulphonated porphyrin derivative meso-
tetraphenylporphine (TPPS2a) for the study of photoinduced endosomal release dynamics of 
DNA-containing polyplexes and dextranes in living cells.33 It was demonstrated that 
endosomal compartments could be damaged by activation of the membrane-bound 
photosensitizer to release the endosomal cargo. In the present work, photochemical release 
was used to study endosomal escape of colloidal mesoporous silica (CMS) nanoparticles in 
living HuH7 cells. HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell 
7. Role of Endosomal Escape for Disulfide-Based Drug Delivery from Colloidal Mesoporous 
Silica Evaluated by Live-Cell Imaging 
 
 128
line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982.37 
Core-shell functionalized CMS nanoparticles were obtained using the recently developed 
strategy described in Chapter 3. It allows integration of molecular functionalities at distinct 
locations within one mesoporous silica nanoparticle.38,39 We have synthesized CMS carrying 
a 3-mercaptopropyl-functionality at the inner pore walls of the core and 3-aminopropyl 
functionality on the outer particle surface. The outer surface was then labeled with N-
hydroxysuccinimidyl-ATTO488 (ATTO488-NHS) fluorescent dye, while the inner core was 
functionalized with ATTO633-labeled cysteine by disulfide formation, leading to dual-color 
particles. The long-term intracellular integrity of the dual-color CMS nanoparticles measured 
by spinning disk confocal microscopy confirmed that endosomal escape is a bottleneck for 
drug delivery into cells. Endosomal release of the CMS nanoparticles was achieved by 
application of the photosensitizer meso-tetraphenylporphine (TPPS2a) and monitored by 
highly sensitive widefield fluorescence microscopy in living cells in collaboration with the 
group of Prof. Bräuchle. The endosomal collapse was verified by the release of the fluid 
phase marker Alexa Fluor 488 Dextran (AFD). After endosomal collapse, release of 
nanoparticles, cleavage of the disulfide-bond and release of fluorescently labeled cysteine into 
the cytosol of living cells was observed. The obtained results demonstrate that endosomal 
escape is a limiting factor for the redox-triggered intracellular release of disulfide-bound 
cysteine from core-shell functionalized colloidal mesoporous silica (CMS). The developed 
synthesis of the dye-labeled core-shell structured CMS was adapted to fulfill the special 
requirements of the highly sensitive live-cell imaging techniques used here.  
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7.2 Experimental Section 
7.2.1 Applied Chemicals  
Tetraethylorthosilicate (TEOS, Fluka, >99%), (3-mercaptopropyl)-triethoxysilane (MPTES, 
Gelest, 95%), (3-aminopropyl)-triethoxysilane (APTES, Fluka, >97%), 
cetyltrimethylammonium bromide (CTAC, Fluka, 25% in H2O), triethanolamine (TEA, 
Aldrich, 98%), L-cysteine (97%, Sigma), ATTO488-NHS ester, ATTO633-NHS ester (both 
Atto-Tec), 2,2´-dithiopyridine (DTP, Fluka, >97%), N,N-dimethylformamide (DMF, Sigma, 
99.8%), L-glutathione reduced (GSH, Sigma-Aldrich), Alexa Fluor 488 Dextran (AFD, MW 
10 kDa, Invitrogen), cell culture media and fetal calf serum (Invitrogen), meso-
tetraphenylporphine (TPPS2a, LumiTrans®, PCI Biotech).  
All chemicals were used as received without further purification. Doubly distilled water from 
a Millipore system (Milli-Q Academic A10) was used for all synthesis and purification steps.  
 
7.2.2 Synthesis of CMS-SHcore-NH2shell by sequential co-condensation 
The colloidal mesoporous silica particles were synthesized by using our sequential co-
condensation approach discussed in Chapter 3.38,39 A mixture of TEOS (1.63 g, 7.82 mmol), 
MPTES (111.5 mg, 0.47 mmol), and TEA (14.3 g, 95.6 mmol) in a polypropylene reactor 
were heated for 20 minutes at 90 °C under static conditions. Then, a solution of CTAC (25 % 
in water, 2.41 mL, 1.83 mmol) and water (21.7 g, 1.21 mol) preheated to 60 °C was added 
and the mixture was allowed to cool to room temperature. The resulting mixture was stirred at 
room temperature for 20 minutes. The total amount of 138.2 mg TEOS (0.922 mmol) was 
added in four equal increments every three minutes, followed by another 30 minutes of 
stirring at room temperature. Next, a 1:1 mixture of TEOS (20.5 µL, 92.5 µmol) and APTES 
(21.6 µL, 92.5 µmol) was added to the reaction mixture (total volume 42.1 µL). The reaction 
was then allowed to stir for another 12 hours. After the addition of 100 mL ethanol, the CMS 
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were separated by centrifugation, redispersed in ethanol and subjected to the template 
extraction procedure described below.  
 
7.2.3 Template extraction from CMS 
The extraction of the organic template from the porous silica framework was achieved by 
heating 1 g of silica twice in 100 mL of an ethanolic solution of ammonium nitrate (2 g 
NH4NO3 in 100 mL ethanol), followed by 30 minutes under reflux in a solution of 4 g 
concentrated hydrochloric acid in 100 mL ethanol. After each step, the material was washed 
with 100 mL ethanol. After the extraction, the particles were collected by centrifugation and 
redispersed in 100 mL of absolute ethanol.  
 
7.2.4 Fluorescence labeling procedure for CMS-SHcore-NH2shell  
The amount of 1 mg of CMS material was redispersed in 200 µL of absolute ethanol in a 1.5 
mL Eppendorf tube. Then, 15 µl of a solution of ATTO488-NHS (1 mg dye in 500 µL dry 
DMF) was added and the resulting mixture was stirred for 2 hours at room temperature. 
Finally, the particles were washed 6 times with 1 mL ethanol each to remove remaining free 
dye, resulting in the sample CMS-SHcore-ATTO488shell. 
 
7.2.5 Fluorescence labeling procedure for the amino group of cysteine  
Cysteine (1 mg, 8.25 µmol) was dissolved in 200 µL of 0.1 M sodium bicarbonate buffer (pH 
8.3). Then, 62 µL of a solution of ATTO633-NHS (1 mg in 500 µL dry DMF) was added. The 
50-fold excess of cysteine is intended to minimize the amount of remaining free dye, since no 
purification of the product was performed. The resulting mixture was stirred for 2 hours.  
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7.2.6 Attachment of ATTO633-labeled cysteine to CMS-SHcore-ATTO488shell via 
disulfide bridge (CMS-CysATTO633core-ATTO488shell) 
The amount of 1 mg of CMS-SHcore-ATTO488shell was redispersed in 200 µL absolute 
ethanol. 2,2´-Dithiopyridine (1 mg, 4.5 µmol) was added and the mixture was stirred for 30 
minutes at room temperature. The colloids were collected by centrifugation. The successful 
activation of the bound thiol groups is indicated by the yellow color of the supernatant after 
centrifugation. After redispersion in 200 µL absolute ethanol, 130 µL of the prepared 
ATTO633-cysteine solution was added to the suspension. The resulting mixture was stirred 
for 2 hours at room temperature. The sample was washed six times by centrifugation and 
redispersion in water and was finally redispersed in 500 µL of water. In order to remove 
larger aggregates from the suspension, the sample was filtered through a Rotband® filter 
before incubation with cells.  
 
7.2.7 Attachment of ATTO633 to CMS-SHcore-ATTO488shell (CMS-ATTO633core-
ATTO488shell)  
The amount of 1 mg of CMS-SHcore-ATTO488shell was redispersed in 200 µL absolute 
ethanol. Then, 50 µL of ATTO633-maleimide was added to the suspension and the resulting 
mixture was stirred for 2 hours at room temperature. The sample was washed six times by 
centrifugation and redispersion in water. In order to remove larger aggregates from the 
suspension, the sample was filtered through a Rotband® filter before incubation with cells, 
resulting in the sample (CMS-ATTO633core-ATTO488shell). 
 
7.2.8 Cell culture 
HuH7 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM):F12 (1:1) with 
Glutamax I medium supplemented with 10% fetal calf serum at 37 °C in 5% CO2 humidified 
atmosphere. To reduce autofluorescence of the cells, the medium was changed to DMEM:F12 
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supplemented with 10% B-27 two days before seeding. The cells were seeded on collagen A-
coated LabTek chambered cover glass (Nunc). 
 
7.2.9 Spinning disk confocal microscope 
Confocal microscopy for live-cell imaging was performed on a setup based on the Nikon 
TE2000E and a spinning disk confocal microscope (Andor) utilizing a Yokogawa spinning 
disk unit CSU10. The system was equipped with a 1.49 NA 100x Plan Apo oil immersion 
objective from Nikon. For two color detection of ATTO488 and ATTO633, dichroic mirrors 
and band-pass filters HQ 525/50 and 730/140 were used (AHF Analysentechnik AG). Image 
sequences were captured with an electron multiplier charge coupled device (EMCCD) camera 
(iXon DV884; Andor). 
 
7.2.10 Long-term incubation and imaging of CMS nanoparticles in living cells 
 
In case of the long term (24 and 48 hours) incubations of HuH7 cells with dual-color CMS-
CysATTO633core-ATTO488shell nanoparticles, the following procedure was applied. HuH7 
cells were seeded in densities of 2·104 and 1·104 cells/cm2 and exposed to nanoparticles after 
9-12 hours. Measurements were perfomed on a spinning disk confocal microscope 24 and 48 
hours after particle addition. Prior to imaging, the medium was replaced by CO2-independent 
medium (Invitrogen) and the cells were kept on a heated microscope stage at 37°C. 
Samples were illuminated in an alternating fashion with 488 nm and 635 nm lasers exciting 
ATTO488 and ATTO633, respectively. The movies were recorded in 3 z-planes (distance 0.5 
µm) and are presented as z-projections. The exposure time per image was 300 ms, resulting in 
an actual frame rate of 0.5 frames per second for the movie showing the overlaid z-
projections. 
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7.2.11 Wide-field fluorescence microscope 
Wide-field fluorescence microscopy was performed on a custom-built setup based on the 
Nikon Ti microscope equipped with a 1.49 N.A. 60x Apo TIRF oil immersion objective 
(Nikon). The photosensitizer was excited by a 405 nm laser 1 min prior to imaging. Alexa 
Fluor 488 Dextran (AFD) and ATTO633 were excited by 488 and 642 nm laser light in 
alternating fashion. Fluorescence was collected in epifluorescence mode, split 
6into two emission channels by a dichroic mirror (565 DCXR, Chroma) and passed through 
filter sets (525/50 and 725/150, Semrock). The green and red emission channels were 
projected onto two EMCCD cameras (DU-897 iXon+, Andor). 
 
7.2.12 Dye release at single-particle level on glass 
Redox-cleavable CMS-CysATTO633core and the non-cleavable control CMS- ATTO633core 
nanoparticles were measured on glass on a wide-field fluorescence microscope first in water, 
then in 10 mM GSH solution. Movies of the ATTO633 and background fluorescence were 
recorded before (t < 0 min) and after (t > 0 min) addition of the GSH solution. The exposure 
time per frame was 200 ms, resulting in an actual frame rate of 1.7 frames per second due to 
alternating illumination. 
 
7.2.13 Photochemical release of CMS nanoparticles in HuH7 cells 
The photochemical release experiments were preformed on the basis of the experiments by de 
Bruin et al..36 In brief, the cells were seeded at a density of 0.6-0.75·104 cells/cm2, 3 to 4 days 
before imaging. 12-24 hours before imaging, the medium was replaced by a medium 
containing 0.025 µg/ml TPPS2a. AFD in a concentration of 0.24 mg/ml and the nanoparticles 
were added to the cells. Cells were incubated overnight, washed three times with CO2-
independent medium (Invitrogen) and subsequently transferred to a 37 °C heated microscope 
stage. The photosensitizer was activated by illumination with 405 nm laser light for 1 min. 
7. Role of Endosomal Escape for Disulfide-Based Drug Delivery from Colloidal Mesoporous 
Silica Evaluated by Live-Cell Imaging 
 
 134
After the activation of the photosensitizer, the measurement was performed with alternating 
excitation by 488 and 642 nm laser light with 200 ms exposure time resulting in a frame rate 
of 1.7 frames per second. 
 
7.2.14 Evaluation of the fluorescence intensity of CMS nanoparticles in vitro and in 
cells 
The fluorescence intensity of nanoparticles was obtained by calculating the mean 
fluorescence intensity of regions of interest (ROI) containing a single endosome or 
nanoparticle for all frames of a movie. To account for different laser excitation intensities and 
differing fluorescence intensities of individual movies, the mean fluorescence intensity was 
normalized to the initial background intensity defined by a ROI in a region without particles 
and plotted over time. 
 
7.3 Results and Discussion 
Axel Schlossbauer in the laboratory of Prof. Thomas Bein planned and performed all 
synthesis steps and non-microscopic characterization of the applied materials.  
 
Core-shell functionalized CMS nanoparticles were synthesized according to the sequential co-
condensation method described in Chapter 3 (Figure 7.3.1).39 A mixture of TEOS and 
MPTES was hydrolyzed in an aqueous reaction mixture containing triethanolamine and 
cetyltrimethylammonium chloride. 30 minutes after seed generation, a shell of pure silica was 
grown by adding four small amounts of TEOS (each 2.5 mol % of total Si content) in three-
minute steps. The mixture was stirred for another 30 minutes. Finally, a 1:1 mixture of TEOS: 
APTES (2% of total silica) was added to the reaction. The resulting mixture was stirred for 
another 12 hours at room temperature. After template extraction, colloidal mesoporous silica 
spheres featuring particle diameters of 80 nm (derived from transmission electron 
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microscopy) were obtained (sample CMS-SHcore-NH2shell). 
 
 
Figure 7.3.1 Synthesis scheme of core-shell functionalized colloidal mesoporous silica 
 
To characterize the porous properties of the sample, nitrogen sorption measurements were 
performed, showing a Brunauer-Emmett-Teller surface area of 1160 m2g-1 (The isotherm can 
be found in the Appendix A-9, Figure A-9.1). The pore size and volume was calculated to 3.8 
nm and 0.93 cm3g-1, respectively, according to nonlocal density functional theory. 
Subsequently, the amino-functionalized shell was labeled with ATTO488-NHS, yielding the 
sample CMS-SHcore-ATTO488shell. After vigorous washing steps, the thiol-functionalized core 
of the particles was activated with 2-2′-dithiopyridine (DTP) and further reacted with 
ATTO633-labeled cysteine, resulting in a disulfide-bridged labeled cysteine attached to the 
inner core of the porous nanoparticle (sample CMS-CysATTO633core-ATTO488shell, Figure 
7.3.2).  
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Figure 7.3.2 Attachment of ATTO633-labeled cysteine to the core of the colloidal 
mesoporous silica. 
 
 
Additionally, a number of reference samples were prepared to perform all experiments 
described in the following. An overview of all prepared fluorescent CMS-samples is given in 
Table 7.3.1.  
 
Table 7.3.1 Overview of all prepared fluorescent CMS samples 
CMS sample name Core functionality Shell functionality 
CysATTO633core-ATTO488shell N-ATTO633-labeled, 
disulfide-bridged cysteine 
ATTO488 
ATTO633core-ATTO488shell ATTO633 ATTO488 
CysATTO633core-NH2shell N-ATTO633-labeled, 
disulfide-bridged cysteine 
Aminopropyl- 
ATTO633core-NH2shell ATTO633 Aminopropyl- 
 
The progress of the increasing functionalization was monitored by Raman spectroscopy 
(Figure 7.3.3). The relevant peaks in the different spectra are marked with asterisks.  
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Figure 7.3.3 Raman spectra of the samples (a) CMS-SHcoreNH2shell, (b) DTP-activated CMS-
SHcore-ATTO488shell, (c) CMS-CysATTO633core-ATTO488shell, and (d) reduced CMS-SHcore-
ATTO488shell. 
After the initial particle synthesis, the sample CMS-SHcore-NH2shell (Figure 7.3.3 a) shows the 
characteristic thiol vibration at 2584 cm-1. The next synthesis step was the activation of the 
thiol-functionalities using DTP (Figure 7.3.3 b). The reaction is confirmed by Raman 
spectroscopy, by the emerging aromatic ring vibrations around 1000 cm-1 and the 
characteristic two bands for aromatic CN heterocycles at 1566 cm-1 and 1580 cm-1. 
Additionally, the thiol vibration disappears upon disulfide formation. Further reaction of the 
activated thiols with dye-labeled cysteine leads to the removal of the aromatic vibrations in 
the Raman spectrum (Figure 7.3.3 c), and there are still no free thiol functionalities visible in 
the spectrum. After the reduction of the newly formed disulfides with 10 mM GSH in a 
reference experiment, the Raman spectrum shows the signal of free thiols again (Figure 7.3.3 
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d). The presence and absence of cysteine in the samples before and after the reduction are also 
confirmed with IR spectroscopy. The corresponding spectra can be found in Figure 7.3.4. 
 
Figure 7.3.4 Infrared sprectroscopy of (a) CMS with disulfide linked cysteine before 
reductive cleavage and (b) after reductive cleavage. 
 
 To examine the applicability of the system for GSH-responsive delivery, reference 
experiments were performed. For this purpose, the sample was transferred into our recently 
developed two-compartment fluorescence cuvette. A dialysis membrane separates the two 
compartments. While the CMS particles are too big to diffuse through the membrane, 
released, labeled cysteine can easily pass through the barrier and can be observed by 
fluorescence spectroscopy, applying an excitation wavelength of 633 nm. For the experiment, 
1 mg of the sample in 200 µL of water was separated by the membrane from 3 mL of water in 
the other compartment. While no detectable amount of cysteine was released before the 
addition of GSH, the release starts immediately after creation of the reductive milieu (10 mM 
GSH in both compartments, Figure 7.3.5). One hour after the GSH addition, the concentration 
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of cysteine remains stable. This maximum release was normalized to 100%. 
 
 
Figure 7.3.5 Release of CysATTO633 from the sample CMS-CysATTO633core-ATTO488shell. 
 
The following analysis by microscopic methods was performed, analyzed and discussed 
in cooperation with Anna M. Sauer from the group of Prof. Christoph Bräuchle (LMU 
München).  
To follow the release of dye-labeled cysteine at a single-particle level by fluorescence 
microscopy, the functionalized CMS nanoparticles were sedimented on glass coverslips and 
incubated with 10 mM GSH solution. Movies of the nanoparticles were recorded before (t < 0 
min) and after (t > 0 min) addition of GSH solution. The mean fluorescence intensity of the 
ATTO633-labeled particles and the background was extracted and the intensity was plotted 
versus time as shown in Figure 7.3.6.  
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Figure 7.3.6 CysATTO633 release measured in vitro on a single-particle level. The mean 
fluorescence intensity of four single particles (black curves) on glass and background (gray 
curve) was extracted from a movie, normalized, and plotted versus time. The fluorescence 
intensity of ATTO633 was plotted for (a) redox cleavable CMS-CysATTO633core-
ATTO499shell and (b) noncleavable control CMS-ATTO633core-ATTO488shell nanoparticles. 
GSH was added at t = 0 min. The movies were recorded at 642 nm illuminaton with an 
exposure time of 200 ms and a frame rate of 3.4 s-1. 
 
In Figure 7.3.6 a, the relative CysATTO633 fluorescence intensity of CMS-CysATTO633core-
ATTO488shell nanoparticles (black) and background (gray) is displayed. After GSH addition 
the CysATTO633 fluorescence of the background (Figure 7.3.6 a, gray curve) increases up to 
a factor of 2.3 reaching a plateau after 8 min. The increase of CysATTO633 background 
fluorescence intensity indicates successful release of the dye from the functionalized CMS 
nanoparticles. Surprisingly, the CMS-CysATTO633core-ATTO488shell nanoparticles 
themselves (Figure 7.3.6 a, black curves) also showed an increase in Cys-ATTO633 
fluorescence intensity. This increase by a factor of 2 or more occurred within two minutes and 
on a faster time scale than the increase in background fluorescence and was unexpected. 
Instead, we expected a decrease in the particle´s CysATTO633 intensity after reductive dye 
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release. However, the increase of nanoparticle-associated CysATTO633 intensity is easily 
explained by a de-quenching effect of the pore-bound CysATTO633. The tight packing of the 
dye molecules inside the pores promotes a self-quenching of CysATTO633 similar to tightly 
packed octadecyl rhodamine B or calcein in liposomes.40 The release of dye lowers the dye 
concentration within the pores below the limit for self-quenching and the residual dye 
molecules start to fluoresce. The strong fluorescence of the nanoparticles also indicates that 
the disulfide-bound CysATTO633 is not completely released upon addition of GSH.  
The self-quenching effect of tightly packed ATTO633 in a constrained environment such as 
mesoporous silica has not been reported before. In the present study, this self-quenching 
effect of CysATTO633 permits a well-detectable readout for dye release with excellent 
signal-to-noise ratio. As a control, CMS-ATTO633core-ATTO488shell nanoparticles without 
cleavable disulfide linker were examined under similar conditions (Figure 7.3.6 b). The 
fluorescence intensities of both the background and the particles remained constant and a de-
quenching effect was not observed after addition of 10 mM GSH (at t = 0 min). This result 
confirms that only disulfide linker-bound dye is released by GSH and that the release is 
associated with a strong increase of nanoparticle fluorescence intensity. Another control 
experiment investigates the influence of TPPS2a on the redox-sensitive bond between the 
particle and the labeled cysteine. It is shown, at a single particle level, that the disulfide bridge 
remains stable and the simple presence of the photosensitizer doas not lead to a release of dye 
from the particle. The corresponding data of this experiment are plotted in the Appendix A-
10, Figure A-10.1).  
To summarize, we showed that release of disulfide bound CysATTO633 from CMS 
nanoparticles in 10 mM GSH can successfully be observed at a single-particle level. The 
release was accompanied by a de-quenching of the ATTO633 fluorescence and this effect 
permits a sensitive readout for the successful dye release.  
To investigate whether the reductive milieu inside living cells is sufficient to induce dye 
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release from CMS nanoparticles, we examined living cells exposed to CMS-
CysATTO633core-ATTO488shell nanoparticles for up to 2 days. After 24 and 48 hours of 
exposure, confocal z-stacks of HuH7 cells were acquired by spinning disk confocal 
microscopy and the colocalization of CysATTO633core with ATTO488shell was evaluated. 
Successful cell entry and intracellular localization of the CMS nanoparticles was detected by 
their characteristic intracellular motion such as transport by motor proteins30-32 (see movies 1 
and 2 in the Appendix-CD) and the location within the z-stack. Transmission light images of 
the cells showed no morphological signs of toxicity within our observation time. After 49 
hours, core-bound CysATTO633 and shell-bound ATTO488 signals of the intracellular 
particles were still colocalized. Additionally, fluorescence of free CysATTO633 in the 
cytoplasm was not detected. This indicates that within 49 hours, the disulfide-bound dye was 
not released. Two representative cells after 25 (Figure 7.3.7 a-c) and 49 hours (Figure 7.3.7 d-
f) of incubation are displayed.  
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Figure 7.3.7 Confocal microscopy of living HuH7 cells exposed to CMS-CysATTO633core-
ATTO488shell nanoparticles. Z-projections are shown consisting of the overlay of three 
planes inside an HuH7 cell exposed to CMS-CysATTO633core-ATTO488shell nanoparticles for 
25 hours (a-c) and 49 hours (d-f). The cell nucleus is indicated by a white circle and the outer 
white line represents the cell border. Fluorescence of the particles´ core (red a+d) and shell 
(green b+e) is highly colocalized as indicated by the yellow signal in the merged image 
(yellow c+f), which was superimposed on the transmitted light image of the cell. Scale bar: 10 
µm. (Images recorded and analyzed by Anna M. Sauer, Group of Prof. Bräuchle). 
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Fluorescence of the particle’s CysATTO633-core (red a + d) and ATTO488-shell (green b + 
e) was colocalized as indicated by the yellow signal in the merged image (yellow c + f), 
which was superimposed on the transmission light image of the cell. Our results indicate that 
CMS-CysATTO633core-ATTO488shell nanoparticles are taken up into HuH7 cells without 
detectable signs of toxicity. Reductive release of ATTO633-labeled cysteine from internalized 
particles was not detected within 49 h of incubation. Our data and previous studies show that 
CMS nanoparticles are taken up into and transported within endosomes.25 This implies that 
they are not accessible to the reductive milieu of the cytosol. Mortera et al. showed cytosolic 
fluorescence of reductively released cysteine.25 However, they did not show the release 
process itself. In our mechanistic study, we could not detect reductive release of ATTO633 
labeled cysteine. 
To overcome the endosomal membrane barrier that separates CMS nanoparticles from the 
cytosol and to follow the release at a single cell level in real time, we employed photoinduced 
endosomal release. In this method, the photosensitizer TPPS2a is incubated with the cells and 
incorporates into membranes via the endocytic pathway. TPPS2a is excited into its singlet 
state by irradiation with 405 nm laser light, followed by intersystem crossing to its triplet 
state. This excited state is then quenched by triplet oxygen producing singlet oxygen. Singlet 
oxygen is able to oxidize unsaturated fatty acids, cholesterol, and amino acids and leads to a 
collapse of the endosomal membrane followed by release of the endosomal content into the 
cytosol. To label endosomes and monitor endosomal release, the fluid phase marker Alexa 
Fluor 488 Dextran (AFD) was added to the cells along with CMS-CysATTO633core-NH2shell 
nanoparticles and the photosensitizer. AFD is internalized by fluid-phase endocytosis.41 After 
18-24 hours of incubation, the cells were examined by wide-field fluorescence microscopy. 
All CMS nanoparticles that exhibit typical intracellular motion were found to be colocalized 
with AFD. This indicates successful internalization of the CMS nanoparticles into endosomes. 
The fluorescence intensity of the endosomes varied depending on the amount of internalized 
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AFD. However, the CysATTO633 fluorescence was quite weak, probably due to the self-
quenching effect of the dye in the mesopores. Excitation of the photosensitizer was achieved 
by illumination of the sample with 405 nm laser for 1 minute (laser power density 0.2 W/cm2) 
this resulted in the termination of endosomal motion, as reported previously.33 Depending on 
the amount of photosensitizer incorporated in the endosomal membrane, the endosomes were 
ruptured within 1-4 minutes, leading to a spontaneous release of AFD into the cytoplasm as 
indicated by a sudden drop in endosomal AFD fluorescence and increase in cytosolic 
fluorescence. Concomitant with endosomal rupture and AFD release, the fluorescence 
intensity of the CMS-CysATTO633core-NH2shell nanoparticles increased due to the de-
quenching effect as described above and presented in Figure 7.3.8 a.  
Directly after photosensitizer activation the endosomes show still predominantly AFD 
fluorescence (Figure 7.3.8 b, depicted in green). Strikingly, only 4 minutes later the same 
endosomes show only CysATTO633 fluorescence (Figure 7.3.8 c, depicted in red). Please 
note that the diffuse red fluorescence within the nucleus area (big, white circle) is due to out 
of focus particle fluorescence.  
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Figure 7.3.8 Photoinduced endosomal release of CMS-CysATTO633core-NH2shell and fluid 
phase marker AFD inside living HuH7 cells monitored by wide-field fluorescence 
microscopy. The cells were exposed to CMS-CysATTO633core-NH2shell overnight. (a) 
Intensity plot of three exemplary tracked endosomes (highlighted by small circles in b and c) 
over time. The fluorescence intensity of CysATTO633 (upper three curves) showed a sudden 
increase concomitant to the decrease in AFD fluorescence intensity (corresponding lower 
three curves) due to endosomal rupture and AFD-dye release. (b) Fluorescence microscopy 
image overlays of the CysATTO633 (red) and fluid phase marker AFD (green) signal at 
activation of the photosensitizer and (c) 4 min later. The cell nucleus is indicated with the 
large white circle. Scale bar: 10 µm. (Data recorded and analyzed by Anna M. Sauer, Group 
of Prof. C. Bräuchle). 
 
With a size of 10 kDa, AFD can diffuse almost freely after endosomal release, and it is 
dispersed within the cytosol.42 In contrast, due to their large size and impaired motion in the 
crowded cell interior the nanoparticles remain at their location. The corresponding movie is 
available as movie 3 in the Appendix-CD. We also performed a control measurement showing 
that activated TPPS2a in solution has no influence on the fluorescence intensity of CMS-
CysATTO633core-NH2shell particles on glass (see Figure A-10.1 in the Appendix). As a control 
measurement, non-cleavable CMS-ATTO633core-NH2shell nanoparticles without cysteine 
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linker were incubated with AFD and the photosensitizer for 12-24 hours. The internalized 
CMS-ATTO633core-NH2shell nanoparticles showed colocalization with AFD until endosomal 
rupture. At endosomal rupture, the relative fluorescence intensity of AFD showed a sudden 
drop whereas the ATTO633 fluorescence remained largely constant with a slight intensity 
increase by a factor of 1.25 (Figure 7.3.9 a). This increase might be due to a small amount of 
unreacted dye inside the mesopores, which is released from the endosome after disruption of 
the endosomal membrane. The disruption of the endosomal membrane and release of AFD 
occurred within 4 min, and the CMS-ATTO633core-NH2shell nanoparticle fluorescence 
remained at the former endosomal regions (Figure 7.3.9 c). Figure 7.3.9 a displays the 
fluorescence intensity of AFD and CMSATTO633core-NH2shell nanoparticles of three 
representative endosomes (highlighted in Figure 7.3.9 b,c with small circles). The 
corresponding movie 4 is available in the Appendix-CD. The missing increase in ATTO633 
fluorescence intensity of non-cleavable dye indicates that ATTO633 is maintained in the 
pores and did not escape into the cytosol as observed for the disulfide-bound dye. 
 
 
 
 
 
 
7. Role of Endosomal Escape for Disulfide-Based Drug Delivery from Colloidal Mesoporous 
Silica Evaluated by Live-Cell Imaging 
 
 148
 
Figure 7.3.9 Photoinduced endosomal release of CMS-ATTO633core-NH2shell and fluid phase 
marker AFD inside living HuH7 cells monitored by wide-field fluorescence microscopy. The 
cells were exposed to CMS-ATTO633core-NH2shell overnight. (a) Intensity plot of three 
exemplary tracked endosomes (highlighted by small circles in b and c) over time. The 
fluorescence intensity of ATTO633 (upper three curves) showed no or only slight 
fluorescence increase concomitant to the decrease in AFD fluorescence intensity 
(corresponding lower three curves) due to endosomal rupture and AFD-dye release. (b) 
Fluorescence microscopy image overlays of the ATTO633 (red) and fluid phase marker AFD 
(green) signal at activation of the photosensitizer and (c) 4 min later. The cell nucleus is 
indicated with the large white circle. Scale bar: 10 µm. (Data recorded and analyzed by Anna 
M. Sauer, Group of Prof. Bräuchle). 
 
7.4 Conclusion 
To conclude, our results show that CMS-CysATTO633core nanoparticles were endocytosed by 
HuH7 cells without visible signs of toxicity. However, disulfide-bound dye in the pore system 
of internalized nanoparticles was not released within 49 hours of observation. Inefficient 
endosomal escape of the nanoparticles is generally a bottleneck for molecular delivery into 
the cytoplasm. After photochemical rupture of the endosomes by means of a photosensitizer, 
CMS-CysATTO633core nanoparticles successfully released disulfide-bound CysATTO633 
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into the cytoplasm showing that the reducing milieu of the cytoplasm is sufficient to cleave 
the cysteine linker. In case of non-cleavable CMSATTO633core nanoparticles without cysteine 
linker, release of ATTO633 was not observed. In addition, we show for the first time that 
linkage of ATTO633 at high concentration in the pores of silica nanoparticles results in 
quenching of the ATTO633 fluorescence. Release of dye from the pores promotes a strong 
de-quenching effect providing an intense fluorescence signal with excellent signal-to-noise 
ratio for single particle imaging. 
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 8. Photosensitizer-Functionalized PEGylated Colloidal Mesoporous Silica 
 
8.1 Introduction 
In recent years, mesoporous silica materials were investigated for new and advanced 
applications like targeted cancer therapy or other biomedical challenges.1-3 It was 
demonstrated that multifunctional constructions of silica nanocarriers are able to release cargo 
only under defined conditions. Once in the cell, the released cargo is able to induce metabolic 
processes within these cells. For example, the release of insulin and cyclic adenosine 
monophosphate was shown upon sugar-induced removal of endcaps from mesoporous silica 
nanoparticles.4 Another approach uses the reductive cleavage of disulfide-bridged compounds 
bound to the pore walls of mesoporous silica nanoparticles.5 As the intracellular milieu is 
referred to be reductive, a cleavage of these disulfide bridges occurs in the cells. However, we 
have recently shown that endosomal escape represents a bottleneck for this approach,6 since 
the intra-endosomal milieu does not have these reductive properties.7 Using photoactive 
compounds that induce the endosomal escape by creating singlet oxygen has been 
demonstrated to be a powerful tool to overcome this barrier.  
The concept of photodynamic therapy includes the use of photosensitizers (PS) to induce 
oxidative stress by light irradiation. The generation of singlet oxygen leads to the oxidation of 
membrane structures and thus induces the cell death.8-11 However, most of the approaches to 
incorporate PS into mesoporous silica lack control over the spatial distribution of the PS, as 
they are not covalently fixed to the particles. This leads to an uncontrolled leaching of the 
compounds, leading to immediate cell death by oxidation of the cellular membranes. For a 
more precise function of PS-equipped nanodevices that have the aim to solely giving access 
of the applied drug carrier to the cytosol, it is desirable to bind the PS directly to the surface 
of the mesoporous particles. This approach would concentrate photoactivity to the direct 
environment of the nanoparticles and thus would not impact endosomes not loaded with 
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particles. A first approach to covalently incorporate porphyrin-functionality in/on mesoporous 
silica structures was demonstrated very recently.12 For the synthesis, the authors of this study 
describe the creation of a hematoporphyrin-silane precursor, but no analytical evidence for the 
described product was given. A similar approach was published shortly thereafter by another 
group.13 The obtained material was used in photodynamic therapy. This publication centers on 
the synthesis of an anionic, sulfonated porphyrin derivative featuring one free amino group. 
This amino group was further reacted with isocyanatopropyltriethoxysilane, resulting in a 
water-soluble porphyrin sol-gel precursor. However, analytical data of the reaction product 
were not provided.   
In this Chapter, we present the synthesis of outer-surface porphyrin-functionalized, colloidal 
mesoporous silica particles (CMS). For this purpose, an amino-terminated derivative of 
protoporphyrin-IX was synthesized and characterized. Subsequently, it was covalently 
attached to a shell of poly(ethylene glycol) (PEG) attached to dye-labeled colloidal 
mesoporous silica nanoparticles. As indicated in the literature, PEG shells around 
nanomaterials enhance their colloidal and structural stability in biological environments.14,15 
Additionally, PEGylation was reported to protect against capture by the reticuloendothelial 
system in the blood stream (stealth effect).16  
The functionality of the obtained nanomaterial was investigated in HuH7 cancer cells by 
confocal fluorescence microscopy on a single cell level. An important prerequisite for the 
design of the particles is our recently developed delayed co-condensation approach in order to 
achieve functionality exclusively on the outer surface of the particle.17 This work was carried 
out as a joint project with Anna M. Sauer from the laboratory of Prof. Christoph Bräuchle 
(LMU München), who performed all microscopic investigations. 
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8.2 Experimental Section 
8.2.1 Applied chemicals 
Tetraethylorthosilicate (TEOS, Fluka, >99%), (3-mercaptopropyl)-triethoxysilane (MPTES, 
Gelest, 95%), (3-aminopropyl)-triethoxysilane (APTES, Fluka, >97%), 
cetyltrimethylammonium bromide (CTAC, Fluka, 25% in H2O), triethanolamine (TEA, 
Aldrich, 98%), Atto488-NHS ester and Atto633-NHS ester (both Atto-Tec), tetrahydrofuran 
(THF, Acros, 99.8%), protoporphyrin IX (Sigma, >95%), p-phenylenediamine (Sigma, 95%), 
triethylamine (Sigma, 99%), ethyl chloroformate (Fluka, >98%), ammonium nitrate (Sigma, 
99%), 1-maleinimido-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oic acid 
(mal-dPEG(8)-COOH, Iris Biotech), N-hydroxysuccinimide (NHS, Aldrich, 98%), N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide (EDC, Sigma, 97%), Alexa Fluor 488 Dextran 
(AFD, MW 10 kDa, Invitrogen), cell culture media and fetal calf serum (Invitrogen). All 
chemicals were used as received without further purification. Doubly distilled water from a 
Millipore system (Milli-Q Academic A10) was used for all synthesis and purification steps. 
 
8.2.2 Synthesis of CMS-NH2core-SHshell by sequential co-condensation  
The colloidal mesoporous silica particles were synthesized by using our recently developed 
sequential co-condensation approach, as described in Chapter 3.17,18 A mixture of TEOS (1.63 
g, 7.82 mmol), APTES (104 mg, 0.47 mmol), and TEA (14.3 g, 95.6 mmol) in a 
polypropylene reactor were heated for 20 minutes at 90 °C under static conditions. Then, a 
solution of CTAC (25 % in water, 2.41 mL, 1.83 mmol) and water (21.7 g, 1.21 mmol) 
preheated to 60 °C was added and the mixture was allowed to cool to room temperature. The 
resulting mixture was stirred at room temperature for 20 minutes. The total amount of 138.2 
mg TEOS (0.922 mmol) was added in four equal increments every three minutes, followed by 
another 30 minutes of stirring at room temperature. Next, a 1:1 mixture of TEOS and MPTES 
(each 92.5 µmol, 19.27 mg TEOS, 22.8 mg MPTES) was added to the reaction mixture. The 
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reaction was then allowed to stir for another 12 hours. After the addition of 100 mL ethanol, 
the CMS were separated by centrifugation, redispersed in ethanol and subjected to the 
template extraction procedure described below.  
 
8.2.3 Template extraction from CMS  
The extraction of the organic template from the porous silica framework was achieved by 
heating 1 g of silica twice in 100 mL of an ethanolic solution of ammonium nitrate (2 g 
NH4NO3 in 100 mL ethanol), followed by 30 minutes under reflux in a solution of 4 g 
concentrated hydrochloric acid in 100 mL ethanol. After each step, the material was washed 
with 100 mL ethanol. After the extraction, the particles were collected by centrifugation and 
redispersed in 100 mL of absolute ethanol.  
 
8.2.4 PEGylation of CMS-NH2core-SHshell with maleinimido-3-oxo-7,10,13,16,19,22,25,28-
octaoxa-4-azahentriacontan-31-oic acid (Mal-dPEG(8)-COOH, sample CMS-NH2core-
PEGshell)  
An ethanolic suspension containing 1 mg of CMS-NH2core-SHshell was centrifuged and 
redispersed in 500 µL of water. Subsequently, 100 µL of a solution of Mal-dPEG(8)-COOH 
(10 mg/mL, 1.69 µmol) in water was added. The reaction mixture was stirred for 14 hours at 
room temperature. In order to remove the excess of Mal-dPEG(8)-COOH, the particles were 
washed three times with each 1 mL of water, followed by centrifugation. Finally, the sample 
was redispersed in 500 µL of absolute ethanol, yielding the sample CMS-NH2core-PEGshell. 
  
8.2.5 Dye Labeling of CMS-NH2core-PEGshell (sample CMS-Atto488core-PEGshell; sample 
CMS-Atto633core-PEGshell) 
The amount of 15 µl of a solution of the respective Atto-NHS-ester (1 mg dye in 500 µL dry 
DMF) was added to the as-synthesized sample CMS-NH2core-PEGshell. The resulting mixture 
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was stirred for 4 hours at room temperature. Subsequently, the sample was washed by several 
cycles of centrifugation with 1 mL absolute ethanol each, until no free dye was visible in the 
supernatant. Finally, the sample was dispersed in 500 µL of THF for further functionalization. 
 
8.2.6 Synthesis of Protoporphyrin-IX-bis(phenyleneaminoamide) (PP-NH2)  
In a dry and darkened 100 mL three-neck flask, protoporphyrin-IX (100 mg, 0.178 mmol, 1 
eq.) was dissolved in 20 mL of water-free tetrahydrofurane and cooled to 0 °C under nitrogen 
atmosphere. Then, triethylamine (2.45 mL, 17.7 mmol, 100 eq.) was added to the solution. 
Ethyl chloroformate (1.7 mL, 17.9 mmol, 100 eq.) was added slowly (30 minutes) under 
stirring to the solution by using a dropping funnel. The resulting mixture 1 was stirred for 2 
hours at 0 °C.  
In a second dried and darkened 100 mL three-neck flask, finely powdered p-phenylene 
diamine (1.95 g, 17.9 mmol, 100 eq.) was dissolved in 10 mL THF under nitrogen 
atmosphere. To this solution, mixture 1 was added slowly with a syringe. The resulting 
mixture was stirred for 24 hours at room temperature in the dark. The solvent was removed in 
vacuo. The resulting precipitate was suspended in 15 mL of ice-cold water. The resulting 
suspension was filtered and washed three times with 15 mL each of ice-cold water. PP-NH2 
was obtained as a brown precipitate (85 mg, 0.114 mmol, 64%). 
Analytics: MS (ESI, acetonitrile/water): m/z = 743.38 [m+H]+, 765.36 [m+Na]+; exact 
formula mass: 742.37 g/mol; IR (emerging amide vibrations 1550 cm-1, 1634 cm-1)  
 
8.2.7 Attachment of PP-NH2 to CMS-Attocore-PEGshell  
The as-synthesized sample CMS-Attocore-PEGshell (based on 1 mg silica particles, 
approximately 0.17 µmol –COOH) was mixed with PP-NH2 (2 mg, 2.7 µmol). Subsequently, 
N-hydroxysuccinimide (2.3 mg, 20 µmol) and EDC (3.5 µl, 20 µmol) were added. The 
resulting mixture was stirred at room temperature in the dark for 14 hours. Subsequently, the 
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sample was washed 3 times with 1 mL THF each and 1 mL water. Finally, the sample was 
redispersed in 500 µL water and filtered through a Rotband® filter in order to remove large 
aggregates, yielding the samples CMS-Atto488core-PSshell or CMS-Atto633core-PSshell. 
 
8.2.8 Cell culture 
HuH7 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM):F12 (1:1) with 
Glutamax I medium supplemented with 10% fetal calf serum at 37 °C in 5% CO2 humidified 
atmosphere. To reduce autofluorescence of the cells, the medium was changed to DMEM:F12 
supplemented with 10% B-27 two days before seeding. The cells were seeded on collagen A-
coated LabTek chambered cover glass (Nunc). 
 
 
8.3 Results and Discussion 
Functionalized CMS with 3-mercaptopropyl functionality on the outer surface of the particles 
and 3-aminopropyl-groups in the core were synthesized according to our recently published 
procedure (see also Chapter 3; sample CMS-NH2core-SHshell).17 The particles feature diameters 
around 80 nm (derived from dynamic light scattering, DLS), NLDFT pores sizes around 4 nm 
and BET surface area of 1000 m2g-1. The corresponding isotherm and pore size distribution is 
displayed in the Appendix (Figure A-11.1, A-11.2). The obtained number-weighted particle 
size distribution, as derived from DLS, is plotted in Figure 8.3.1. 
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Figure 8.3.1 Number-weighted particle size distribution of the sample CMS-NH2core-SHshell.  
  
Subsequently, the particles were covered with a bifunctional polyethyleneglycol linker 
(maleimide-dPEG8-COOH) featuring eight ethylene glycol units. One end of the applied 
linker features a maleimide group, which attaches to the thiol-carrying surface of the CMS via 
Michael-addition, giving the sample CMS-NH2core-PEGshell. The opposite carboxylic acid 
terminus of the linker protrudes into the solvent. The next synthesis step includes the 
fluorescent labeling of the amino-functionalized core of CMS-NH2core-PEGshell with Atto488 
fluorescence dye (Sample CMS-Atto488core-PEGshell). The attached fluorescent dye allows 
further investigation of the synthesized materials by fluorescence microscopy. 
In order to react protoporphyrin IX as photosensitizer (PS) via an amide bond to the surface of 
CMS-Atto488core-PEGshell, an amino-modified protoporphyrin-IX (PP-NH2) is needed. The 
synthesis scheme of a modified literature procedure for the synthesis of PP-NH2 can be found 
in Figure 8.3.2.19  
 
8. Photosensitizer-Functionalized PEGylated Colloidal Mesoporous Silica 
 
 160
 
Figure 8.3.2 Synthesis scheme for PP-NH2. 
 
Protoporphyrin IX (PP-IX, 1) is reacted with ethyl chloroformate to give the mixed anhydride 
2. Further reaction of 2 with a large excess of p-phenylene diamine yields the amide 3 (PP-
NH2). The obtained compound PP-NH2 was characterized by IR spectroscopy and ESI mass 
spectrometry. The IR-spectrum shows a shift of the C=O stretching vibration from 1702 cm-1 
to 1648 cm-1 due to the amide formation (Figure 8.3.3 a,b). Correspondingly, the N-H 
bending signal (amide II-band) appears at 1515 cm-1 in the sample PP-NH2 (Figure 8.3.3b). 
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Figure 8.3.3 ATR-IR spectra of the samples  (a) PP-IX and (b) PP-NH2 (spectra are offset). 
 
The successful synthesis was also confirmed by electron spray ionization mass spectrometry 
(ESI-MS). The corresponding spectrum can be found in the appendix (A-12).  
CMS-Atto488core-PEGshell and PP-NH2 were subsequently reacted in a N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide (EDC) assisted amidation to yield the 
photosensitizer-functionalized sample CMS-Atto488core-PSshell (Figure 8.3.3). 
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Figure 8.3.3 Attachment of PP-NH2 to the PEGylated mesoporous silica nanoparticle. 
  
The PEGylation reaction step (CMS  CMS-PEG) was characterized by IR-Spectroscopy 
(Figure 8.3.4).  
 
Figure 8.3.4 IR-spectra of the samples (a) CMS and (b) CMS-NH2core-PEGshell. The bands 
discussed in the text are marked with asterisks 
 
The sample CMS shows the typical bands expected for organofunctionalized silica structures 
(Figure 8.3.4a). The band below 1300 cm-1 can be attributed to silica framework vibrations. 
The organic functionality (mercaptopropyl- and aminopropyl-) is observed between 2800 cm-1 
and 2900 cm-1, visible as CH2 stretching vibrations. Signals between 2900 cm-1 and 3000 cm-1 
occur due to ethoxy-groups on the surface attached mainly during the extraction procedure. 
The origin of these bands has been described earlier in the literature.20 However, the signals 
of the sample CMS-NH2core-PEGshell clearly show the increasing functionalization (Figure 
8.3.3b). The typical CH2 deformation- and wagging-vibrations of aliphatic ethers are visible 
as emerging bands at 1456 cm-1, 1411 cm-1 and 1362 cm-1. The strong amide bands at 1637 
cm-1 and 1550 cm-1 (amide I and amide II) are attributed to the maleimide-functions included 
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in the applied maleimide-dPEG8-COOH linker. The signal at 1710 cm-1 can be assigned to the 
C=O stretch of the terminal carboxylic acid.  
The successful covalent attachment of PP-NH2 to the particle (Figure 8.3.2, Sample CMS-
Atto488core-PSshell) was demonstrated by fluorescence spectroscopy after several washing 
steps in THF (Figure 8.3.5).  
 
 
Figure 8.3.5. Fluorescence emission spectra of the sample CMS-Atto488core-PSshell with an 
excitation wavelength of 488 nm (dotted line) and 405 nm (solid line).  
 
Excitation with 488 nm gives an emission maximum at 515 nm, corresponding to the 
particles’ fluorescence dye label. Excitation of the same sample 408 nm shows a sharp 
emission maximum at 632 nm, which is characteristic for the protoporphyrin IX emission.19 
As a reference, a suspension of CMS-Atto488core-PEGshell in THF was mixed with PP-NH2 in 
the absence of EDC. In contrast to the sample CMS-Atto488core-PSshell, PP-NH2 in the 
reference sample was simply removed by a few washing cycles in THF. This simple test 
additionally implies the covalent bonding of PP-NH2 to the PEGylated CMS-surface.   
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In order to demonstrate the functionality of the nanodevice in living cells with confocal 
fluorescence microscopy, another sample was prepared. The core of the particle intended as 
sample for live cell investigations was carrying an Atto633 dye instead of the Atto488 dye. 
The resulting sample CMS-Atto633core-PSshell was used in a confocal fluorescence microscopy 
investigation in combination with Alexa Fluor 488 Dextran (AFD). This water-soluble, 
fluorescently-labeled polysaccharide has a molecular weight of 10 kDa and can act as a fluid 
phase marker in live cell investigations. An uptake of the dextran via endocytosis leads to 
fluorescence-labeled intra-endosomal liquids. The endosomal release of the nanocarriers can 
be observed by using this approach. The collapse of the endosomal membrane leads to an 
abrupt loss of fluorescence intensity in the region of the formerly intact endosome in the 
observed fluorescence channel of AFD. We have recently applied this method to exactly 
determine the time point of endosomal release.6 Figure 8.3.6 shows a representative cell. The 
cell was exposed to the sample CMS-Atto633core-PSshell and AFD for 14 hours. The successful 
cell entry and the intracellular localization was detected by their characteristic motion such as 
transport by motor proteins.21,22 The signal of AFD is displayed in Figure 8.3.6a, Atto633 
fluorescence is shown in Figure 8.3.6b. For the characterization of the light-induced 
endosomal disruption, areas with colocalized signal of the two channels were investigated 
(see overlay, Figure 8.3.6c).  
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Figure 8.3.6 Photoinduced release of AFD from endosomes filled with CMS-Atto633-PS 
nanoparticles. The cell was exposed to the nanoparticles and AFD overnight.  (a) shows an 
Image overlay of the AFD (green, b) and particle-bound Atto633 (red, c) signal superimposed 
on the transmitted light image of the cell directly after activation of the  photosensitizer. A 
white circle indicates the cell nucleus; the white line represents the cell border. Scale bar: 10 
µm. (d) shows  fluorescence intensity plots of the AFD from 5 different endosomes; black 
lines correspond to the endosomes in boxes (a-c, filled with particles), the purple curve 
corresponds to the endosome in the circle (a-b, empty).  The data were recorded and analyzed 
by Anna M. Sauer from the group of Prof. Bräuchle, LMU Munich. 
 
The squares in Figures 8.3.6 a-c highlight the exemplary tracked endosomes. The time-related 
fluorescence intensity plots are displayed in Figure 8.3.6d. The cells were irradiated with 405 
nm light (0.2 W/cm2) for 1 minute for singlet oxygen production induced by the attached 
porphyrin-derivative. As can be seen from the intensity plots (Figure 8.3.6d), the AFD 
fluorescence suddenly drops, indicating the endosomal release of AFD. It should be noted that 
only particle-loaded endosomes collapse after light-irradiation. Endosomes that are not loaded 
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with CMS stay intact (Figure 8.3.6d, purple curve). We take this observation as a proof for the 
functionality of the synthesized nanostructures.  
 
8.4 Conclusion 
In summary, a novel synthetic route for the generation of photoactive nanocarriers as potential 
drug delivery devices is presented. In the synthesis, protoporphyrin IX was functionalized 
with p-phenylene diamine to give an amino-terminated structure. This derivative was 
subsequently attached to PEGylated CMS nanoparticles featuring a terminal carboxylic acid 
group. In contrast to earlier publications in this field, a different functionalization route was 
chosen and every step of the synthesis was characterized in detail. Another advantage 
compared to earlier work is the use of a poly(ethylene glycol) shell around the particles. As 
indicated in the literature, PEGylation of nanomaterials leads to stealth properties in the blood 
stream and results in enhanced colloidal and structural stability in biological fluids. Co-
incubation of the CMS with AFD confirms the endocytotic pathway of the cellular particle 
uptake. The obtained nanoparticles can directly induce endosomal escape upon light 
irradiation at 405 nm. This is of major importance for the application of such particles in drug 
delivery, where endosomal trapping is one of the key issues to be overcome. 
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 9. Light-Induced Delivery of Chromobodies from Lipid-Bilayer Coated 
Colloidal Mesoporous Silica 
 
9.1 Introduction 
In the previous Chapter 8 we have discussed the design of integrated multifunctional 
mesoporous nanoparticles that carry a covalently bound photosensitizer for light-induced 
endosomal escape. In the present Chapter, we want to show a first step towards an application 
of the photosensitizer-carrying nanoparticles as carrier-materials for intracellular release of 
biologically active compounds. In the literature, functional molecules like drugs or model 
compounds were incorporated into the pores of mesoporous silica nanoparticles and were 
released in cancer cells upon activating several types of triggers. For example, fluorescent 
dyes were delivered into cells by mesoporous silica nanoparticles additionally loaded with a 
photosensitizer.1 Nel et al. have shown the intracellular delivery of doxorubicin in 
combination with P-glycoprotein siRNA to drug-resistant KB-V1MDR cancer cells.2 They 
were able to increase the intracellular doxorubicin concentration compared to the incubation 
with free doxorubicin together with a downregulation of the P-glycoprotein (Pgp) expression. 
Another group used G-insulin-capped mesoporous silica nanoparticles loaded with 
membrane-impermeable cyclic adenosine monophosphate (cAMP).3 They showed a release of 
the cAMP that is selectively responsive to the presence of fructose in vitro and in cells. The 
same group showed a release of disulfide-bound cysteine upon cell uptake.4 They explain the 
release by the reductive milieu present in the cytosol. In contrast, we have recently 
demonstrated by live cell imaging methods on a single cell level, that endosomal escape is the 
essential step in the process of redox-driven controlled release from mesoporous silica (see 
Chapter 7).5 In order to demonstrate this mechanism, photosensitizers (porphyrine 
derivatives) that induce an endosomal collapse upon light irradiation were applied. The 
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applied photosensitizers were able to oxidize the membranes from the endosomes. As a result, 
uptaken particles were released into the cytosol.  
Supported lipid bilayers on mesoporous silica nanoparticles (MSN) were investigated. 
Brinker et al. demonstrated the release of calcein into Chinese hamster ovary cells from lipid-
bilayer coated MSN.6 Our group in cooperation with others has investigated the delivery of 
the plant toxin colchicine with such a system, followed by the effective depolymerization of 
the microtubules of cancer cells.7  
A combination of the two approaches (incorporation of photosensitizers and supported lipid 
bilayers as diffusion barrier for guest molecules) can lead to the contruction of a powerful, 
light-driven drug delivery system.   
In the present Chapter, the successful delivery of dye-labeled, tubulin-GFP-binding heavy-
chain antibodies from Camelidae sp. (so-called chromobodies)8 is demonstrated by confocal 
fluorescence microscopy on a single cell level. Chromobodies are up to ten times smaller than 
conventional antibodies and labeled with either fluorescent proteins or a fluorescent dye.  
Heavy-chain antibodies are devoid of light chains and recognize antigens via their variable 
domain (referred to as VHH, see Figure 9.1.1). 
 
 
Figure 9.1.1 Schematic outline of a conventional antibody in comparison with a Camelidae-
derived heavy-chain antibody and a generic chromobody. Picture taken from Ref. 8. 
 
For target cells, a tubulin-GFP expressing HeLa liver cancer cell line was chosen., A 
multifunctional mesoporous silica nanoparticle was developed as nanosized carrier, based on 
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our earlier work. Rothbauer et al. have initially studied the chromobodies, as they were 
isolated from GFP-immunized alpacas.8 They have co-transfected HeLa cells with GFP-β-
actin and GFP-chromobody expression vectors and analyzed them by live cell microscopy. It 
was shown that the GFP chromobodies co-localize with the GFP-β-actin on cytoskeletal actin 
filaments. For the present work, the group of Prof. H. Leonhardt (LMU) provided Atto594-
labeled chromobodies.  
Here we demonstrate the carrier-mediated delivery of these membrane-impermeable 
chromobodies from outside the cell by using highly functionalized mesoporous silica 
nanoparticles. 
Additionally, the enrichment of fluorescent structures along the microtubuli serves to show 
the functionality of our release mechanism. 
 For this purpose, the chromobodies are loaded into photosensitizer-functionalized colloidal 
mesoporous silica spheres, which are subsequently surrounded by a supported lipid bilayer. 
After endocytotic uptake in GFP-tubulin expressing HeLa cells, the cells are irradiated with a 
405 nm laser in order to induce the creation of singlet oxygen, as demonstrated in Chapter 8. 
The singlet oxygen will lead to the collapse of both the supported lipid bilayer and the 
endosomal membrane, followed by the release of the chromobodies (experimental scheme, 
see Figure 9.1.1). 
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Figure 9.1.1 Photosensitizer functionalized (stars), chromobody-loaded colloidal mesoporous 
silica nanoparticles release the chromobodies in HeLa cells upon irradiation with a 405 nm 
laser. The process can be monitored by the fluorescence of the chromobodies attaching to 
GFP-labeled tubulin, which is directly expressed in the HeLa cells. 
 
 A successful release of chromobodies is indicated by the coordination of GFP-tubulin, as 
characterized by confocal fluorescence microscopy in cooperation with the group of Prof. 
Bräuchle, LMU Munich. The work is a joint project within the Center for NanoScience 
(CeNS Munich). The collaborators are members of the groups of Prof. Leonhardt (Biology, 
LMU Munich), Prof. Bein and Prof. Bräuchle (Chemistry, LMU Munich), and Prof. Rädler 
(Physics, LMU Munich). The obtained results imply that this method can serve as an 
alternative approach to a technically demanding genetic transfection. 
The synthesis and characterization of the multifunctional nanoparticles was carried out in our 
laboratory and is my contribution to this interdisciplinary work.  
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9.2 Experimental Section 
9.2.1 Applied chemicals 
Tetraethylorthosilicate (TEOS, Fluka, >99%), (3-mercaptopropyl)-triethoxysilane (MPTES, 
Gelest, 95%), (3-aminopropyl)-triethoxysilane (APTES, Sigma, 98 %) 
cetyltrimethylammonium bromide (CTAC, Fluka, 25% in H2O), Phenyltriethoxysilane 
(PhTES, Sigma, 98%)  triethanolamine (TEA, Aldrich, 98%), Atto488-NHS ester and 
Atto633-NHS ester (both Atto-Tec), tetrahydrofuran (THF, Acros, 99.8%), protoporphyrin IX 
(Sigma, >95%), p-phenylenediamine (Sigma, 95%), triethylamine (Sigma, 99%), ethyl 
chloroformate (Fluka, >98%), ammonium nitrate (Sigma, 99%), 1-maleinimido-3-oxo-
7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oic acid (mal-dPEG(8)-COOH, Iris 
Biotech), N-hydroxysuccinimide (NHS, Aldrich, 98%), N-(3-dimethylaminopropyl)-N′-
ethylcarbodiimide (EDC, Sigma, 97%), toluene (Aldrich, 99.8 %) (1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC, Avanti Polar Lipids), Alexa Fluor 488 Dextran (AFD, MW 10 kDa, 
Invitrogen), cell culture media and fetal calf serum (Invitrogen). The group of Prof. Heinrich 
Leonhardt provided Atto594-chromobodies. All chemicals were used as received without 
further purification. Doubly distilled water from a Millipore system (Milli-Q Academic A10) 
was used for all synthesis and purification steps. 
 
9.2.2 Synthesis of bi-functionalized colloidal mesoporous silica (CMS-NH2core-SHshell) 
The colloidal mesoporous silica particles were synthesized according to our previously 
published procedure, see also Chapter 3.9 A mixture of TEOS (1.63 g, 9.22 mmol), PhTES 
(57 mg, 0.24 mmol), APTES (53.1 mg, 0.24 mmol), and TEA (14.3 g, 95.6 mmol) was heated 
for 20 at 90°C without stirring in a 100 mL polypropylene reactor. A solution of CTAC (25 % 
in water, 2.41 mL, 1.83 mmol) in water (21.7 g, 1.21 mol) preheated to 60 °C was added 
quickly. The resulting reaction mixture with a molar composition of 1 TEOS: 0.20 CTAC: 
10.37 TEA: 130.15 H2O was stirred at room temperature for 30 minutes. Then, a mixture of 
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TEOS (19.3 mg, 92.5 µmol) and MPTES (22 mg, 92.5 µmol) was added to the reaction. The 
resulting mixture was stirred at room temperature for another 12 hours. After the addition of 
100 mL ethanol, the mesoporous silica nanoparticles were collected by centrifugation, 
redispersed in 100 mL of ethanol and extracted according to the procedure described below.  
9.2.3 Extraction of the CMS samples 
Extraction of the organic template from the CMS materials was performed by heating the 
colloidal suspensions containing 250 mg of CMS for 45 minutes under reflux at 90 °C in a 
solution containing 2 g ammonium nitrate in 100 mL ethanol, followed by 45 minutes under 
reflux in a solution of 4 g concentrated hydrochloric acid in 100 mL ethanol. The CMS 
materials were separated by centrifugation and washed with ethanol after each extraction step. 
CMS materials were obtained as clear ethanolic suspensions.  
 
9.2.4 Preparation of non-porous, aminofunctionalized silica nanoparticles (Stöber-NH2) 
Silica nanoparticles were prepared according to a previously published procedure.10 To a 
mixture of water (17.7 mL, 0.98 mol), methanol (100 mL, 2.47 mol) and ammonia (8.86 mL, 
25 %wt. in H2O, 0.13 mol), TEOS was added under stirring (0.368 mL, 1.65 mmol) divided 
in two aliquots (0.184 mL each). The second aliquot was added 10 minutes after the first. The 
resulting mixture was stirred at room temperature for 120 minutes. The resulting particles 
were centrifuged and washed with 100 mL of ethanol followed by centrifugation. Finally, the 
washed silica nanoparticles were dispersed in 100 mL of ethanol. For the subsequent 
functionalization with (3-aminopropyl)triethoxysilane (APTES), a suspension containing 2 
mg of silica nanoparticles was transferred in toluene (5 mL, 47.2 mmol) by centrifugation. To 
the resulting suspension, APTES (281 µL, 1.2 mmol) was added. The resulting mixture was 
stirred under reflux conditions for 4 hours. The functionalized nanoparticles were washed in 
10 mL of ethanol by centrifugation and finally dispersed in 5 mL of ethanol.   
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9.2.5 PEGylation of CMS-NH2core-SHshell with maleinimido-3-oxo-7,10,13,16,19,22,25,28-
octaoxa-4-azahentriacontan-31-oic acid (Mal-dPEG(8)-COOH, sample CMS-NH2core-
PEGshell) 
The following synthesis was carried out as described in chapter 8. An ethanolic suspension 
containing 1 mg of CMS-NH2core-SHshell was centrifuged and redispersed in 500 µL of water. 
Subsequently, a 100 µL of solution of Mal-dPEG(8)-COOH (10 mg/mL) was added. The 
reaction mixture was stirred for 14 hours at room temperature. In order to remove the excess 
of Mal-dPEG(8)-COOH, the particles were washed three times with 1 mL of water followed 
by centrifugation. Finally, the sample was redispersed in 500 µL of absolute ethanol, yielding 
the sample CMS-NH2core-PEGshell. 
 
9.2.6 Synthesis of protoporphyrin-IX-bis(phenyleneaminoamide) (PP-NH2)  
Protoporphyrin-IX-bis(phenyleneaminoamide) was prepared according to a modified 
literature procedure, see also Chapter 8.11 In a dry and darkened 100 mL three-neck flask, 
protoporphyrin-IX (100 mg, 0.178 mmol, 1 eq.) was dissolved in 20 mL of water-free 
tetrahydrofurane and cooled to 0 °C under nitrogen atmosphere. Then, triethylamine (2.45 
mL, 17.7 mmol, 100 eq.) was added to the solution. Ethyl chloroformate (1.7 mL, 17.9 mmol, 
100 eq.) was added slowly (30 minutes) under stirring to the solution by using a dropping 
funnel. The resulting mixture 1 was stirred for 2 hours at 0 °C. 
In a second dried and darkened 100 mL three-neck flask, finely powdered p-phenylene 
diamine (1.95 g, 17.9 mmol, 100 eq.) was dissolved in 10 mL THF under nitrogen 
atmosphere. To this solution, mixture 1 was added slowly with a syringe. The resulting 
mixture was stirred for 24 hours at room temperature in the dark. The solvent was removed in 
vacuo. The resulting precipitate was suspended in 15 mL of ice-cold water. The resulting 
suspension was filtered and washed three times with each 15 mL of ice-cold water. PP-NH2 
was obtained as a brown precipitate (85 mg, 0.114 mmol, 64%). 
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Analytics: MS (ESI, acetonitrile/water): m/z = 743.38 [m+H]+, 765.36 [m+Na]+; exact 
formula mass: 742.37 g/mol; IR (emerging amide vibrations 1550 cm-1, 1634 cm-1)  
 
9.2.7 Attachment of PP-NH2 to CMS-NH2core-PEGshell (sample CMS-NH2core-PSshell, see 
also chapter 8) 
The as-synthesized sample CMS-NH2core-PEGshell (based on 1 mg silica particles, 
approximately 0.17 µmol –COOH) was mixed with PP-NH2 (2 mg, 2.7 µmol). Subsequently, 
N-hydroxysuccinimide (2.3 mg, 20 µmol) and EDC (3.5 µl, 20 µmol) were added. The 
resulting mixture was stirred at room temperature in the dark for 14 hours. Subsequently, the 
sample was washed 3 times with 1 mL THF and 1 mL water each.  
 
9.2.8 Loading of silica nanoparticles with Atto594-labeled chromobodies 
To a suspension containing 1 mg of the respective silica sample (CMS or Stöber) in 500 µL of 
sterile water, 50 µL of a solution containing chromobodies was added. The resulting mixture 
was shaken for 16 hours at room temperature in a darkened 1.5 mL polypropylene vial.  
 
9.2.9 Supported lipid bilayer preparation (samples CMS-NH2core-PSshell-DOPC)  
The amount of 2.5 mg DOPC was dissolved in a mixture of 40 %vol ethanol / 60 %vol  water. 
The chromobody-loaded CMS from 9.2.7 were centrifuged (14.000 rpm, 5 minutes) and 100 
µL of the lipid solution was added to the centrifuged pellet. Upon the addition of 700 µL of 
sterile water followed by a 3 minute treatment in an ultrasonic bath, the supported lipid 
bilayer was formed on the CMS samples. The samples were centrifuged and redispersed again 
in order to remove freely diffusing lipids and the ethanol. Before incubation with cells, the 
samples were filtered through a 250 nm filter to remove aggregates. The obtained samples 
were subsequently incubated with HeLa cells expressing tubulin-GFP.  
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9.2.10 Spinning disc confocal microscope 
As explained in chapter 7.2.9, confocal microscopy for live-cell imaging was performed on a 
setup based on the Nikon TE2000E and a spinning disk confocal microscope (Andor) 
utilizing a Yokogawa spinning disk unit CSU10. The system was equipped with a 1.49 NA 
100x Plan Apo oil immersion objective from Nikon. For two color detection of ATTO488 and 
ATTO633, dichroic mirrors and band-pass filters HQ 525/50 and 730/140 were used (AHF 
Analysentechnik AG). Image sequences were captured with an electron multiplier charge 
coupled device (EMCCD) camera (iXon DV884; Andor). 
 
9.3 Results and Discussion 
The synthesis of the core-shell functionalized colloidal mesoporous silica was carried out by 
applying a previously published procedure, see also Chapter 3.12,13 For this purpose, tetraethyl 
orthosilicate (TEOS) was hydrolyzed together with (3-aminopropyl)-triethoxysilane and 
phenyltriethoxysilane in a mixture containing cetyltrimethylammounium chloride as a 
template and triethanolamine (TEA) as base. A shell of TEOS was grown on the initial seeds 
after 30 minutes of stiring at room temperature in order to gain a spatial separation between 
the core and the shell functionality. Thiol-functionality exclusively placed on the outer 
surface of the porous nanoparticles was achieved by subsequently adding a 1:1 mixture of 
TEOS and (3-mercaptopropyl)triethoxysilane equivalent to 2 % of the total silane content. 
After twelve hours of condensation, the template was extracted. The obtained nanoparticles 
showed pore sizes around 3.9 nm and a BET surface area around 1000 m2g-1, as derived from 
nitrogen sorption. The corresponding isotherm and NLDFT pore size distribution can be 
found in Figure 9.3.1. 
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Figure 9.3.1 Nitrogen sorption isotherm (upper panel, adsorption plotted in black, desorption 
plotted in blue) and NLDFT pore size distribution (lower panel) of the sample  
CMS-NH2core-SHshell. 
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Next, the particles were reacted with maleinimido-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-
azahentriacontan-31-oic acid (Mal-dPEG(8)-COOH), yielding a carboxylic acid-terminated 
polyethylene glycol shell around the particles, as reported earlier in Chapter 8. The material 
was further functionalized with the previously synthesized protoporphyrin-IX-
bis(phenyleneaminoamide) (PP-NH2, refer to Chapter 8) in order to covalently attach the 
photosensitizer as additional function to the particle.  A detailed analysis of these reaction 
steps can be found in Chapter 8.  
Another important aspect of this work was to evaluate the beneficial role of using mesoporous 
particles compared to non-porous silica nanoparticles. As the chromobodies have a molecular 
mass of around 13 kDa14 it is unclear if they can fit completely into the 4 nm pores of our 
mesoporous particles. A chromobody uptake experiment was made to demonstrate that the 
porous structure of our nanoparticle allows a higher loading with the chromobodies compared 
to surface-adsorbed chromobodies on the surface of non-porous amino-functionalized silica 
nanoparticles.  
For the experiments, non-porous silica nanoparticles featuring an aminopropyl-grafted surface 
with a diameter of 80 nm were synthesized according to the literature (Stöber-NH2).10 A 
dynamic light scattering characterization of the sample Stöber-NH2 can be found in the 
Appendix (A-13). The amount of 1 mg of the respective samples was each subsequently 
soaked in 150 µL of a solution with Atto594-labeled chromobodies (CB) with a CB-
concentration of 5 µg/mL (total amount of CB 0.75 µg). After 14 hours, the samples were 
centrifuged and the residual solution was investigated by fluorescence spectroscopy. In 
parallel, a fluorescence intensity calibration curve was recorded to correlate known 
concentrations with the maximum fluorescence emissions at 620 nm of the supernatants of the 
investigated samples. The obtained calibration curve can be found in Figure 9.3.2.  
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Figure 9.3.2 Chromobody fluorescence intensity calibration curve (excitation at 594 nm). The 
red curve represents the linear regression of the obtained data points. The linear equation of 
the regression curve is displayed as an inset.  
  
The obtained CB concentrations and absolute CB uptake values per mg silica were calculated 
by using the linear regression from the calibration curve are displayed in Table 9.3.1. 
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Table 9.3.1 Fluorescence intensities of the three samples subjected to chromobody adsorption  
 CMS-NH2core-SHshell Stöber-NH2 
Measurement 1 790.165 4128.509 
Measurement 2 666.117 4385.087 
Average 728.141 4256.798 
Conc. of CB in supernantant [µg/ml] 0.345 2.050 
Sample Volume [µL] 150  150 
Absolute uptake values [µg/mg silica] 0.70 0.44 
 
As can be seen, the porous structure of the particle allows the loading with higher amounts of 
chromobodies than using non-porous silica as carrier material. With these values, the amount 
of loaded CB per particle can be calculated as follows. 
 
 
Calculation of CB-loading level 
Particle diameter: 80 nm 
Particle Volume (sphere): 2.14 •10-15 cm3 
Density assumption: 1.1 g cm-3 
 particle weight: 2.35 •10-15 g 
Adsorbed amount of CB (Sample CMS-NH2core): 0.7 
µg/mg silica 
 1.65 •10-18 g CB/ particle 
Molecular weight of CB: 13 kDa 
 1.27 • 10-22 mol CB/ particle 
 76 CB per particle can be assumed 
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For live-cell investigations, the sample CMS-NH2core-PSshell was loaded with Atto594-labeled 
chromobodies before being encapsulated in a supported lipid bilayer consisting of 1,2-
dioleoyl-SN-glycero-3-phosphocholine (DOPC). The encapsulation was carried out according 
to our previously reported procedures, yielding the sample CMS-NH2core-PSshell-DOPC.11  
The encapsulated Atto594-chromobodies specifically bind to green fluorescent protein (GFP) 
and were provided by the group of Heinrich Leonhardt (LMU Munich). The live-cell 
investigations were carried out by fluorescence microscopy in the group of Prof. Bräuchle, in 
particular by Anna M. Sauer.   
The GFP-tubulin expressing HeLa cells were exposed to small aliquots (several µg) of the 
CB-loaded sample CMS-NH2core-PSshell-DOPC and studied by confocal z-stacks after 24 
hours of incubation time. The endosomes were labeled by using Alexa Fluor 488 Dextran 
(AFD) as fluid phase marker by adding it to the cells along with the particles. From earlier 
work it is known that the cells take up the lipid bilayer-coated particles within that time period 
and that they do not show significant cytotoxicity.7 24 hours after the addition of AFD and the 
particles to the cells, the well plate was irradiated with 405 nm laser light (0.2 W/cm2) for one 
minute in order to stimulate the formation of singlet oxygen by the attached porphyrine 
derivative and thus, induce the endosomal release and the disruption of the supported lipid 
bilayer. This irradiation step is essential for the CB-release. 
Subsequently, the cells were investigated by confocal z-stack fluorescence microscopy. 
Figure 9.3.3 shows two representative images of single cells, consisting of an overlay of two 
fluorescence channels. In the red channel, the Atto594-labeled chromobodies and the 
fluorescence of the protoporphyrin derivative is displayed. In the green channel, the 
microtubuli-GFP appears as a filamentous structure and the fluorescence of the intra-
endosomal fluid phase marker AFD can be seen in the form of spots.  
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Figure 9.3.3 Fluorescence microscopy images of two single cells (left and right) treated with 
the sample CMS-NH2core-PSshell-DOPC (spinning disc confocal microscopy). The red channel 
shows fluorescence of the Atto594-chromobodies and protoporphyrin IX. The green channel 
shows microtubuli-GFP (filamentous) and fluid phase marker Alexa 488 Fluor Dextran 
(spots). Scale bar 10 µm. The data were recorded and analyzed by Anna M. Sauer from the 
group of Prof. Bräuchle (LMU Munich). 
 
As can be seen in Figure 9.3.3, some of the filamentous GFP-microtubule structures are 
clearly covered by the nanoparticle-delivered chromobodies.  This can be explained by the 
photochemical action of the attached porphyrin-derivative followed by a release of the loaded 
CB. The irradiation of the samples with 405 nm laser light induces the formation of singlet 
oxygen. This effect leads to a rupture of the surrounding supported lipid bilayer and the 
destruction of the endosomal membrane.  
The moderate overall coverage of the microtubuli by the CB can be explained by the small 
loading capacity for these large molecules (Mw= 13 kDa). Compared to direct genetic 
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production of CBs in earlier work, a similar amount of intracellular CB cannot be reached by 
our method. However, carrier-mediated delivery of chromobodies has not yet been reported in 
the literature. This method allows the incorporation of chromobodies into cells without the 
biological know-how of gene transfection. Aditionally, the carrier-mediated approach seems 
to be less stressful to the living cells compared to microinjection.  
In order to underline these findings, a sample without photosensitizer activation at 405 nm 
was investigated.  Following our argumentation above, no CB should be released, as they are 
encapsulated by the supported lipid bilayer in the porous carriers. Secondly, the endosomal 
membrane should represent an additional barrier to the CB. As expected, no structures of the 
GFP-tubulin were covered by the chromobodies (Figure 9.3.4, showing a representative cell 
sample). This negative control underlines the key role of the photosensitizer, which is directly 
attached to the outer surface of our particles.  
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Figure 9.3.4 Fluorescence microscopy image of a single cell incubated with the sample CMS-
NH2core-PSshell-DOPC. No activation at 405 nm prior to investigation. Green channel shows 
tubulin-GFP, red channel shows Atto594-chromobodies and protoporphyrin IX fluorescence. 
Scale bar 10 µm. The image was recorded and analyzed by Anna M. Sauer from the group of 
Prof. Bräuchle (LMU Munich). 
 
9.4 Conclusion 
To summarize, we have shown the applicability of our recently developed photoactive 
colloidal mesoporous silica nanoparticles as carriers for antibodies for the light-induced 
delivery in living cells. It was shown by in vitro measurements that the porous structure is 
beneficial for the amount of chromobodies adsorbed in/on the carrier. To achieve this, our 
recently developed pathway for the attachment of a protoporpyhrin IX derivative to the outer 
surface of CMS was applied. Irradiation of the samples with 405 nm light is necessary for the 
singlet-oxygen generation, which leads as a consequence to the rupture of the surrounding 
lipid membranes (artificial DOPC and endosomal membranes). In a control experiment, it was 
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shown that the photoinduced endosomal escape plays a key role in the delivery of the 
Atto594-chromobodies to the microtubuli-GFP.  
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 10. pH-Responsive Release of Acetal-Linked Mellitin from SBA-15 
Mesoporous Silica 
 
The following work is based on the publication indicated below: 
Axel Schlossbauer, Christian Dohmen, David Schaffert, Ernst Wagner, and Thomas Bein; 
submitted 
10.1 Introduction 
In the previous chapters, controlled release concepts based on triggers like temperature, 
enzymatic action or redox chemistry were introduced. Other concepts for delivery-on-demand 
systems based on mesoporous silica are presented in the literature. In most cases, large 
molecules or nanoparticles were attached reversibly to the pore mouths in order to sterically 
hinder loaded guest molecules (drugs or model compounds) from leaving the pores. For 
example, one study uses acetal-gated mesopores as pH- responsive gatekeeper for 
mesoporous silica.1 Another approach demonstrates that coumarin-derivatives can act as 
photo-responsive gatekeeper molecules for MCM-41. UV-light irradiation (λ > 310 nm) of 
the coumarin-functionalized silica surface causes a [2+2] photocycloaddition between two 
coumarin molecules, leading to an efficient closing of the pores. Reopening is achieved by 
irradiation at higher energy (λ ≈ 250 nm).2 
Another approach to create delivery-on-demand systems based on mesoporous materials is to 
directly attach the therapeutic molecules to the silica pore walls using reversible chemistry. 
One recent approach uses disulfide-bridged linkers between the pore wall and cysteine in 
mesoporous silica nanoparticles in order to generate a redox-responsive delivery mechanism.3  
We have contributed to this field by studying the cell uptake and drug release mechanism of 
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this method in great detail (see Chapter 7).4 As an additional option for biomedical 
applications, it would be highly desirable to have pH-responsive linkers between the 
substance to be delivered and the porous host, since the pH drops from 7.4 to 5.5 upon 
endosomal uptake.5  
Here we describe the use of acetal-linkers for a pH-responsive release study of mellitin from 
SBA-15 type mesoporous silica. Mellitin, the active component of bee venom, is a small 
peptide containing 26 amino acids. Currently this compound is widely investigated in the field 
of nanomedicine due to its lytic or apoptosis-inducing properties.6,7 It acts as a membrane-
invading agent, leading to a local disruption of lipid membranes. It has been used earlier as 
endosomolytic peptide for siRNA-polymer-conjugates.8 Here we evaluate the release of the 
peptide by an erythrocyte lysis assay. A triggered release of the peptide leads to lysis of 
mouse erythrocyte cells (Figure 10.1.1). 
 
Figure 10.1.1 Released mellitin peptides from mesoporous structure intercalate the 
membranes of erythrocytes (schematic). 
 
10. pH-Responsive Release of Acetal-Linked Mellitin from SBA-15 Mesoporous Silica 
 
 190
The structure of certain acetals offers a reasonable stability under extracelullar conditions 
while undergoing fast hydrolysis in an acidic milieu. The applicability of acetals for 
controlled release systems has been recently demonstrated with oligoethyleneimine 
conjugates.9 It was shown that acetal-linked oligoethyleneimines can be used as efficient pH-
sensitive gene carriers. Another group has applied this chemistry to create pH-sensitive 
polyethyleneoxide conjugates of model drugs.10 For protein delivery from mesoporous 
structures, acetal-linked proteins have not yet been reported. This work is the result of a joint 
project with Christian Dohmen from the group of Prof. Ernst Wagner (LMU). 
 
 
10.2 Experimental Section 
10.2.1 Applied Chemicals 
Tetraethyl orthosilicate (TEOS, Sigma-Aldrich, >98%), cetyltrimethylammonium bromide 
(CTAB, Aldrich, 95%), (3-mercaptopropyl)trimethoxysilane (MPTS, ABCR, 95%), 
mesitylene (Aldrich, 98%), 1,8-bis-maleimidodiethyleneglycol (BM-Linker, Pierce 
Biotechnology, Inc.), 2,2-Bis(N-maleimidoethyloxy)propane (MK-Linker, Organix, Inc.); 
Pluronic 123 block copolymer was received as a gift from BASF Company. Cystein-
terminated mellitin was synthesized and purchased from Biosynthan.  Doubly distilled water 
from a Millipore system (Milli-Q Academic A10) was used for buffer preparation and 
synthesis steps. All solvents and buffer contents were purchased from Sigma-Aldrich. All 
chemicals were used as received without further purification.  
 
10.2.2 Preparation of large-pore SBA-15 spherical particles  
For the synthesis of the applied SBA-15 material, a procedure from the literature was used.11 
To a solution of Pluronic 123 (3.0g) in hydrochloric acid (HCl, 60 mL, 1.5 M), another 
solution of cetyltrimethylammonium bromide (CTAB, 0.6 g) and mesitylene (1.5 g) in 25 mL 
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water was added. Subsequently, the amount of 20 mL ethanol (absolute) was added. Then, 10 
mL of tetraethyl orthosilicate (TEOS) were added dropwise and the resulting mixture was 
vigorously stirred at 35 °C for 45 minutes. The solution was subsequently transferred into a 
Parr autoclave for hydrothermal treatment at 75°C for 12 hours under static conditions. For 
aging, the reaction mixture was heated up to 125 °C for another 12 hours. The resulting 
powder was filtered and washed with both 100 mL of water and ethanol. The resulting 
powder was dried at 60 °C overnight. Removal of the template was performed by calcination 
at 550 °C for 5 hours (heating rate 1°C / min).  
 
10.2.3 Preparation of mercaptopropyl-functionalized SBA-15 (SBA-SH)  
The amount of 200 mg of freshly calcined SBA-15 was dried at 110 °C under vacuum 
conditions for 90 minutes. Afterwards, dry toluene was added under nitrogen atmosphere. 
Subsequently, 3-mercaptopropyltrimethoxysilane (MPTS, 1.5 mmol,) was added. The 
resulting mixture was stirred for 4 hours under nitrogen atmosphere while being heated to 
reflux temperature (oil bath temperature 120°C). The functionalized SBA-15 (SBA-SH) was 
filtered and subsequently washed with each 50 mL of toluene, methanol and water before 
being dried at 60 °C for 12 hours.  
 
 
10.2.4 Maleimide-linker attachment (samples SBA-MK, SBA-BM)  
The amount of 5 mg of the sample SBA-SH was dried at 110 °C under nitrogen atmosphere 
for 2 hours. After cooling to room temperature, the amount of 5 mL water-free 
dimethylsulfoxide (DMSO) was added. 33.5 µmol of the respective linker (MK-linker or BM-
linker, 10-fold excess) was then added to the resulting suspension. The mixture was stirred at 
room temperature under nitrogen atmosphere for 14 hours. The samples were filtered off and 
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washed with DMSO and PBS buffer (pH 7.4). Drying was performed under high vacuum 
conditions. The resulting white powder gave the sample SBA-MK or SBA-BM, respectively.  
 
10.2.5 Attachment of mellitin to SBA-15 (samples SBA-MK-Mel and SBA-BM-Mel)  
To a solution of mellitin (2893.6 g mol-1, 3 mg, 1.58 µmol) in 1.5 mL DMSO, 1 mg of linker 
functionalized SBA-15 was added. The reaction mixture was stirred for 60 minutes at room 
temperature. The samples were washed with PBS buffer solution (pH 7.4) by centrifugation. 
The resulting samples were named SBA-MK-Mel or SBA-BM-Mel, respectively.  
 
10.2.6 Erythrocyte leaching assay  
Mouse erythrocytes were isolated from fresh, citrate-treated blood and washed in phosphate 
buffered saline (PBS) by four centrifugation cycles, each at 800 g for 10 min at 4 °C. The 
erythrocyte pellet was diluted in PBS buffer to get a final cell concentration of 
5,0·107 cells/mL. The samples SBA-BM-Mel and SBA-MK-Mel were serially diluted in 
phosphate-buffered saline (PBS), resulting in theoretical mellitin concentrations of 5, 1, and 
0.1 µM, respectively. As a control, pure mellitin solutions having the same concentrations 
were prepared, 75 µL of a mouse erythrocyte solution (3.75·106 cells) was mixed with 75 µL 
of the sample suspensions and mellitin solution as reference. To define 100% lysis, 
erythrocytes were incubated with 1% Triton-X100 in PBS. For samples that were pre-
incubated at acidic conditions (MK-acidic, BM-acidic), the pH was adjusted to 5.0. The 
resulting acidic samples were incubated for 30 min before dilution. 75 µL erythrocyte 
suspension (3.75·106 cells) was added per well of a V-bottomed 96-well plate and mixed with 
75µL of the different melittin dilutions. For 100% lysis, cells were treated with 75 µL of 
buffer containing 1% Triton X-100. After incubation for 60 min at 37 °C under constant 
shaking, cells were centrifuged at 800 g for 10 min. The volume of 80 µl supernatant was 
analyzed for hemoglobin release at 405 nm using a microplate reader.  
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10.3 Results and Discussion 
As host material for the reversible encapsulation of mellitin, we used large-pore SBA-15-type 
mesoporous silica. The material was produced following previously published procedures.10 
A mixture of Pluronic 123, cetyl-trimethylammonium bromide (CTAB), mesitylene, 
potassium chloride and hydrochloric acid was prepared to hydrolyze tetraethylorthosilicate 
(TEOS) and assemble the mesoporous structure. After calcination, the nitrogen sorption 
isotherm gave pore diameters of about 11.1 nm (according to non-local density functional 
theory) and a Brunauer-Emmett-Teller (BET) surface area of about 700 m2/g-1. The 
corresponding isotherm and NLDFT pore size distribution graph can be found in Figure 
10.3.1. 
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Figure 10.3.1 Nitrogen sorption isotherm (upper graph) and NLDFT pore size distribution 
(lower graph) of the sample SBA-15. 
 
 The resulting material was subsequently functionalized with 3-mercapto-
propyltrimethoxysilane (MPTS) by post-synthetic grafting in toluene under nitrogen 
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atmosphere and reflux conditions, yielding sample SBA-SH. Thermogravimetric analysis 
(TGA) was performed in order to determine the amount of functionalization grafted to the 
mesoporous host. The obtained curve can be found in Figure 10.3.2. 
 
Figure 10.3.2 Thermogravimetric analysis for the samples SBA-15 (black) and SBA-SH 
(blue). 
 
A mass loss of 5 % during heating to 900°C was evaluated to correspond to a thiol content of 
0.67 mmol of mercaptopropyl moieties per gram material. It should be noted, that the 
resulting mass loss from dehydroxylation processes (>700°C) was not taken into account. The 
presence of thiols was also confirmed by the cleavage of 2,2´-dithiopyridine, releasing the 
yellow colored 2-thiopyridon (Ellman´s assay), as described in the literature.11 In the 
following, SBA-SH was dried under vacuum and was then suspended in water-free 
dimethylsulfoxide (DMSO) under nitrogen atmosphere. The sample was divided in two 
aliquots of 5 mg each. The samples were incubated with a 10-fold excess of MK- or BM-
linker relative to the thiol-content as evaluated by TGA, respectively (samples SBA-MK, 
SBA-BM, Figure 10.3.3). 
 
 
10. pH-Responsive Release of Acetal-Linked Mellitin from SBA-15 Mesoporous Silica 
 
 196
 
Figure 10.3.3 Attached linkers in the sample (a) SBA-MK, (b) SBA-BM; (c) shows a 3D 
scheme of the pH-sensitive attachment of mellitin in the pores of SBA-15 
 
The reactions were carried out for 14 hours under nitrogen at room temperature, followed by 
washing with DMSO. The increasing functionality of the material can be monitored by IR-
spectroscopy (see Figure 10.3.4). The presence of the maleimide-linked MK-moiety can be 
observed by the emerging C=O stretch signal at 1707 cm-1 (Figure 10.3.4b). In contrast, the 
sample SBA-BM shows also aliphatic ether vibrations around 1450 cm-1 (Figure 10.3.4c). 
Additionally, the C=C stretch of the maleimide is visible in the sample SBA-MK. The signals 
below 1250 cm-1 can be attributed to silica framework vibrations. IR-spectra from the pure 
linkers can be found in the Appendix (A-14) as a reference.  
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Figure 10.3.4 IR spectra (offset, normalized to the Si-O stretch) of the samples (a) SBA-SH, 
(b) SBA-MK and (c) SBA-BM; Bands discussed in the text are marked with asterisks. 
 
A negative Ellman´s assay also implies the reaction of the free thiol-groups with the 
maleimide-groups of the respective linkers.  Subsequently, 1.0 mg of each sample was 
incubated with a 1.5-fold excess (relative to the incorporated amount of thiols) of 
synthetically produced, cysteine-terminated mellitin at room temperature for 4 hours 
(Samples SBA-MK-Mel, and SBA-BM-Mel).   
The conjugation reaction was carried out under water-free conditions in DMSO in order to 
avoid unwanted cleavage of the acetal linker. After intense washing and centrifugation, the 
samples were exposed to an erythrocyte leakage assay.  
For this purpose, pure mellitin and the suspensions of the samples SBA-BM-Mel and SBA-
MK-Mel were serially diluted in phosphate-buffered saline (PBS), resulting in theoretical 
mellitin concentrations of 5, 1, and 0.1 µM, respectively. 75 µL of a mouse erythrocyte 
solution (3.75 x 106 cells) were mixed with 75  µL of the respective sample suspension and 
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mellitin solution as reference. To define 100% lysis, erythrocytes were incubated with 1% 
Triton-X100 in Phosphate-buffered saline. The acidic samples were pre-incubated at pH 5 for 
30 minutes before dilution. In Figure 10.3.5, the results of the leakage assay are shown. 
 
Figure 10.3.5 Results of the erythrocyte leakage assay. The five experiments listed in the 
figure are plotted in the same sequence from left to right at each different global 
concentration. 
 
It can be seen that the MK linker shows the desired behavior and remains stable at pH 7. 
However, when the pH is lowered, the MK-linker is cleaved, resulting in a release of the 
encapsulated mellitin. In contrast, the applied BM-linker remains stable upon pH decrease, 
keeping mellitin covalently bound to the pore walls.  
In order to quantify the amount of incorporated or released mellitin, a photometric approach 
was used.12 This approach is based on the prediction of the molar extinction coefficient ε of a 
peptide by taking into account the number of tryptophanes and tyrosines in the primary 
structure of the peptide and the disulfide bridges present. According to reference 18, every 
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tryptophane contributes 5500 M-1cm-1 to ε. Since the primary structure of mellitin contains 
only one tryptophane and none of the other relevant groups, we can set ε to 5500 M-1cm-1. For 
the experiment, 1 mg of SBA-MK was incubated with 3 mg of mellitin in 1.5 mL water-free 
DMSO for 4 hours. The silica was separated from the suspension by centrifugation. 
Absorption measurements of the supernatant at 280 nm gave an amount of 1.85 mg peptide in 
solution, or 1.15 mg (0.4 µmol) mellitin of the uptaken mellitin, respectively. Relative to the 
initial amount of 3-mercaptopropyl-moieties, the occupation of the potential binding sites for 
the mellitin peptide can be calculated to 60 %. The centrifugate was re-suspended in 1.5 mL 
of PBS buffer (pH 7.4). Subsequently, the resulting suspension was separated into two equal 
aliquots. One of the two resulting samples was centrifuged down, the other one was filled up 
with 750 µL of PBS-buffer (pH 7.4). The resulting pellet was resuspended in 1.5 mL PBS 
buffer (pH 5.5). The two resulting samples are defined as Quant-MK-7.4 and Quant-MK-5.5. 
After 60 minutes of incubation, the samples were centrifuged off and the absorption at 280 
nm of the supernatant was determined. It was found that the sample Quant-MK-5.5 has 
released the amount of 0.615 mg of mellitin, while the sample Quant-MK-7.4 only released 
0.015 mg. The observed value of released peptide corresponds well to the determined amount 
of incorporated mellitin. A detailed calculation of the UV-absorption using Lambert-Beer´s 
law can be found in the Appendix (A-15).  
 
10.4 Conclusion 
To summarize, we have shown that acetals can be applied as pH-sensitive linkers for the 
delivery of a biomedically relevant peptide from mesoporous silica. The obtained results 
represent an interesting alternative for the release of bioactive compounds from mesoporous 
hybrid materials. The investigated acetal linkers attached between the pore walls and the 
peptides clearly show an on/off mechanism in the observed time intervals for the release. The 
investigated pH-values represent the pH values in the human blood stream (7.4) and late 
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endosomes in cells (5.5), respectively. This implies that the obtained results are of significant 
importance in the field of targeted drug delivery.  
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  11. General Conclusions and Outlook 
In the present work, new pathways for the construction of nanosized drug delivery devices 
based on mesoporous silica were developed.  
First, a sequential co-condensation approach was developed in order to obtain multiple 
functionality within single colloidal mesoporous silica particles. It was shown that a spatial 
separation of two different molecular functions can be achieved by adding the functionalized 
precursors at different time-points of the particle growth.  
Click-chemistry was evaluated as a mild synthetic tool for the covalent attachment of 
sensitive biomolecules in the pores of mesoporous silica. It was demonstrated that the activity 
of enzymes can be conserved in the protected environment of a mesoporous silica host and 
that the enzyme can be exposed to many recovery cycles. The careful investigation of this 
strategy was necessary as it was further applied as a synthesis step in the construction of a 
DNA-based molecular valve.  
Controlled release of model compounds or bioactive molecules was also investigated. 
Molecular valves that open upon enzymatic digestion were developed. By placing avidin 
proteins that act as molecular caps on the pore mouths of mesoporous silica nanoparticles, 
fluorescein was encapsulated inside the pores. The addition of trypsin caused opening of the 
caps and the dye was able to leach out of the particle.  
Attaching DNA-linkers between the silica surface and the protein caps successfully extended 
this capping concept. This approach allowed us to impart a programmable release temperature 
to the colloidal mesoporous silica.  It was shown that the length of the DNA-linker and thus 
its melting temperature defines the temperature for the guest release.  
Other approaches do not use external caps on the outer surface of the pores, but directly link 
the guest (or cargo) molecules to the inner pore walls. Mesoporous silica nanoparticles with 
disulfide-linked cysteine inside the pores were synthesized and investigated during the course 
of this work. It was shown that the amino acid is released upon creation of a reductive milieu 
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in vitro. However, studies in living cancer cells have demonstrated that the reductive potential 
in an endosome is not sufficient to release the guest. This issue was investigated in 
cooperation with the group of Prof. Bräuchle, and we could show that photosensitizers 
producing singlet oxygen induce the endosomal escape of the drug carriers and therefore lead 
to a successful drug delivery.  
Taking into account these results, we designed particles that carry a modified derivative of 
protoporphyrin IX covalently attached to the outer surface of the mesoporous nanoparticles. 
The biological activity of these sytems was again demonstrated by live-cell imaging at a 
single cell level in cooperation with the group of Prof. Bräuchle.  
Encouraged by these results, we applied this approach to the light-induced delivery of small 
antibodies (chromobodies) from lipid-bilayer coated mesoporous silica nanoparticles. GFP-
labeled microtubuli in HuH7 cells were successfully labeled with the chromobodies. This 
demonstrates the applicability of our mesoporous silica nanoparticles as carriers for these 
biomolecules.   
Finally, another way to use reversible chemistry in drug delivery is to utilize the dramatic pH 
drop from cell medium (around 7.4) to late endosomes (around 5.4). In this context, acetal 
linkers were integrated into the mesopores to trigger the release of the apoptotic peptide 
mellitin from SBA-15 mesoporous silica. In a joint project with the group of Prof. Wagner we 
could show that the membrane intercalating peptide destroys mouse erythrocytes only at low 
pH values around 5, while it stays encapsulated in the host at a neutral pH.  
 
 Further experiments based on the findings from this work will provide multifunctional 
mesoporous silica nanoparticles with larger pores than 4 nm. A larger pore diameter enables 
the encapsulation of therapeutic biomolecules like siRNA, peptide nucleic acids (PNA) or 
peptides into nanosized carriers. Another next step will be the use of the introduced DNA-
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based cap system (Chapter 6) in living cells. A possible release trigger in cells can be a 
concurrent hybridization with intracellular single stranded oligonucleotides.  
The attachment of targeting ligands in order to provide a specialized affinity to a cancer cell 
should also be one of the next steps. Interesting molecules to be bound to the particle´s 
surface are the RGD peptide, the epidermal growth factor (EGF), folic acid, or even a 
combination of the three.  
Another interesting aspect to investigate is the in vivo behavior of the synthesized silica 
nanoparticles, for example, in a mouse model. The blood circulation time is an important 
factor for the efficiency of nanosized drug delivery and imaging devices. Different surface 
functionalities can have a dramatic influence on the behavior of the particles in a biological 
system. 
The findings of this work are the product of a successful cooperation of different fields of 
science, such as chemistry, physics, pharmaceutics and medicine. It can be seen that the 
interdisciplinary cooperation of different fields of science opens the gate to new materials 
with striking properties. Thus, the integration of functional biomolecules in inorganic 
structures can lead to novel macroscopic functions of the synthesized material. 
 12. Appendix 
A-1 Isotherms and NLDFT pore size distribution of the samples synthesized in 
Approach A and B 
The nitrogen sorption values shown in Table 3.3.1 and Table 3.3.2 were derived from the data 
shown in Figures A-1.1, A-1.2, and A-1.3  
 
Figure A-1.1 Nitrogen sorption isotherms (left) and NLDFT pore size distributions (right, 
offset) of the samples Un-CMS (), CMS(A)-ClOUT (), and CMS(A)-ClOUT-NHIN () 
 
 
Figure A-1.2 Nitrogen sorption isotherms (left) and NLDFT pore size distributions (right, 
offset) of the samples Un-CMS (), CMS(A)-NHOUT () and CMS(A)-NHOUT-ClIN () 
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Figure A-1.3 Nitrogen sorption isotherms (left) and NLDFT pore size distributions (right, 
offset) of the samples Un-CMS (), CMS(B)-PhIN-NHOUT () and CMS(B)-(Ph/NH)IN () 
 
A-2 Detailed calculations for thermogravimetric analysis (TGA) of the samples SBA-Cl 
and SBA-trypsin 
 
(a) TGA-Calculations for SBA-Cl 
1 g sample contains 50 mg of choroproyl-residues (C3H6Cl, 77.53 gmol-1). 
€ 
0.05g
77.53gmol−1 = 6.45⋅ 10
−4mol  pro g SBA-Cl 
 1 g silica has bound 
€ 
6.45⋅ 10−4mol
0.95g = 6.79⋅ 10
−4 mol  chloropropyl-residues 
(b) TGA calculation for SBA-trypsin 
1 g sample contains 150 mg of organic compouds. Thus, 1 g SBA-15 has bound 
€ 
0.15g
0.85g = 0.176g organic compounds. 
The amount of chloropropyl residues is substracted in order to get the amount fo enzyme 
attached to the surface.  
0.176g – 0.053g =  0.12 g of trypsin attached to 1 g of SBA-15 
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A-3. Detailed calculations for the protein quantification from BCA-assay for the samples 
SBA-trypsin and Cab-o-Sil-trypsin  
The supernatants of the reactions 3.2.6 (preparation of SBA-trypsin) and 3.2.9 (preparation of 
Cab-o-Sil-trypsin) were analyzed in order to determine the amount of enzyme that reacted 
with SBA-N3. In both reactions 3.2.6 and 3.2.9, the amount of 7.0 mg protein was used. The 
presence of 1.0 mg protein in the supernatant in reaction 3.2.6 implies that 6.0 mg protein 
have bound to 50 mg of SBA-N3. This value confirms the results from TGA of the sample 
SBA-trypsin (12%). In reaction 3.2.9, no protein could be detected by the BCA method. The 
applied amount of enzyme was completely attached to the surface. 
 
A-4. NLDFT pore size distributions of the samples prepared in chapter 5 
The pore size distribution curves are shown in Figure A-4.1 
 
Figure A-4.1 NLDFT pore size distribution of the samples (a) CMS, (b) CMS-SH, (c) CMS-
BIO and (d) CMS-AVI 
 
12. Appendix 
 207 
A-5. Reference experiment from unfucntionalized CMS (Chapter 5)  
 
 
Figure A-5.1 Release of non-encapsulated fluorescein through a dialysis membrane 
 
A-6. Fluorescein release quantification of the samples prepared in Chapter 5 and 6.  
For quantification, a calibration curve for fluorescein was recorded (Figure A-6.1) in the UV-
vis spectrometer and the released fluorescein was quantified. 
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Figure A-6.1 Calibration curve for fluorescein concentration determination 
 
The fluorescein solutions from the release experiment were diluted by the factor of 10. The 
absorption at 495 nm was recorded and the amount of released dye was quantified (Table A-
6.1).  
Table A-6.1 Quantification of release of fluorescein from CMS samples 
Sample CMS CMS-AVI 
Thermoresponsive 
CMS-AVI 
Protease-responsive 
Abs. at 495 nm 0.760 0.689 0.702 
Concentration 
(mg ml-1) 
0.0023 0.0021 0.0022 
Released fluorescein 
[mg/mg sample] 
0.035 0.031 0.033 
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Example for the calculation (CMS): 
An absorbance of 0.760 leads to a sample concentration of 0.0023 mg/ml using the calibration 
curve.  
The sample was diluted by the factor of 10.  Original sample concentration: 0.023 mg/ml.  
Sample volume is 3 ml  Total amount of released fluorescein: is 0.069 mg.  
The fluorescein was released from 2 mg of CMS: Released fluorescein is 0.035 mg/mg CMS 
 
 
 
A-7. FRET-experiment with pure as-received 15mer DNA-strands 
 
 
Figure A-7.1 FRET measurement of the pure as-received 15mer DNA double strand at 25°C 
(black), at 45 °C (red), and after rehybridization at 25°C (blue) 
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A-8. Raw data for the programmed thermoresponsive release experiments  
The raw data for the investigated fluorescein release are displayed in the Figures A-8.1, A-
8.2. A-8.3, and A-8-4. 
 
 
Figure A-8.1 Series of emission spectra of sample CMS-DNA15-AVI at 25°C. Data was 
collected for 1 hour in 5 minutes intervals. 
 
 
12. Appendix 
 211 
 
Figure A-8.2 Series of emission spectra of sample CMS-DNA15-AVI at 45°C. 
Acquisition every 2 minutes 
 
 
Figure A-8.3 Series of emission spectra of sample CMS-DNA25-AVI, ten minutes between 
the acquisitions. (Black lines: 25°C; Red lines: 45°C) 
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Figure A-8.4 Series of emission spectra of sample CMS-DNA25-AVI, ten minutes between 
the acquisitions. Temperature 65 °C (open state) 
 
A-9. UV-vis calculation for the released amounts of fluorescein from the CMS-DNA-AVI 
samples 
Fluorescein solutions showing the corresponding maximum fluorescent counts released from 
the samples CMS-DNA15-AVI and CMS-DNA25-AVI were prepared and then diluted by the 
factor of ten. The absorption at 495 nm of the prepared samples can be used to determine the 
exact fluorescein content of the solution (A calibration curve is shown in Figure A-6.1). 
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Table A-9.1 Quantification of release of fluorescein from CMS samples  
Sample CMS-DNA15-AVI CMS-DNA25-AVI 
Abs. at 495 nm 0.344 0.348 
Concentration 
(mg ml-1) 
0.0011 0.0013 
Released fluorescein 
[mg/mg sample] 
0.033 0.040 
 
 
Example for the calculation (CMS): 
An absorbance of 0.344 leads to a sample concentration of 0.0011 mg/ml by using the 
calibration curve´s linear regression.  
The sample was diluted by the factor of 10.  Original sample concentration: 0.011 mg/ml.  
Sample volume is 3 ml  Total amount of released fluorescein: is 0.033 mg.  
The fluorescein was released from 1 mg of CMS: Released fluorescein is 0.033 mg/mg CMS 
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A-10. Nitrogen Sorption Isotherm of the sample CMS-SHcore-NH2shell (Chapter 7) 
The nitrogen sorption isotherm of the sample CMS-SHcore-NH2shell can be found in Figure A-
10.1. 
 
 
Figure A-10.1 Nitrogen sorption isotherm of the sample CMS-SHcore-NH2shell 
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A-11. Reference microscopy measurements of Chapter 7 
 
 
Figure A-11.1. Influence of a TPPS2a solution on redox-cleavable CMS-CysATTO633core-
NH2shell measured at a single particle level 
 
Redox-cleavable CMS-CysATTO633core-NH2shell nanoparticles were incubated in a TPPS2a 
solution on glass coverslips on the microscope. TPPS2a was activated with a 405 nm laser. A 
movie was recorded at 642 nm illumination with an exposure time of 200 ms and a frame rate of 
3.4 s-1. The CysATTO633 intensity of single particles (black curves) on glass and background 
(red curve) was extracted from the movie, normalized and plotted versus time. The control 
measurement shows that activated TPPS2a in solution has no influence on the fluorescence 
intensity of CMS-CysATTO633core-NH2shell particles. 
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A-12. Nitrogen sorption isotherm of the sample CMS-NH2core-SHshell 
 
The isotherm of the sample CMS-NH2core-SHshell  can be found in Figure A-12.1, the 
corresponding NLDFT pore size distribution can be found in Figure A12-2. 
 
 
Figure A-12.1 Nitrogen sorption isotherm of the sample CMS-NH2core-SHshell. Adsorption is 
plotted in black, desorption is plotted in blue.  
 
 
12. Appendix 
 217 
 
Figure A-12.2 NLDFT pore size distribution of the sample CMS-NH2core-SHshell 
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A-13. ESI-MS of the sample PP-NH2 
A scan of the obtained sheet from ESI-MS can be seen in Figure A-13.1. The [m+H]+ peak at 
743.38 and the [m+Na]+ peak at 765.36 clearly show the succesful synthesis of PP-NH2. 
(exact formula mass: 742.37g/mol) 
 
 
 
 
Figure A.13-1 Scan of the obtained spectra from ESI-MS 
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A-14. DLS of the sample Stöber-NH2 (Chapter 9) 
A number-weighted statistics graph of the sample Stöber-NH2 can be found in Figure A-14.1. 
 
 
Figure A-14.1 DLS-measurement of the sample Stöber-NH2 
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A-15. IR-spectra of the applied bismaleimide linkers (Chapter 10) 
The reference spectra of the applied linkers and the mellitin peptide are displayed in Figure A-
15.1. 
 
 
Figure A-15.1 IR-spectra of (a) MK-linker, (b) BM-linker, and (c) mellitin 
 
A-16 Mellitin quantification with UV-vis spectroscopy (Chapter 10) 
For quantification of the uptaken and released amount of mellitin, the samples Quant-MK-7.4 
and Quant-MK-5.5 were prepared. For the synthesis, the procedure described in 10.2.6 was 
followed, using the MK-linker. After mellitin attachment, the sample was centrifuged down 
and the pellet was washed and resuspended in PBS buffer at pH 7.4. Then, the sample was 
divided in two equal aliquots. For the sample Quant-MK-7.4, the amount of 750 µL of PBS-
buffer (7.4) was added, to give a resulting sample volume of 1.5 mL. For the preparation of 
the sample Quant-MK-5.5, the respective aliquot was centrifuged and redispersed in PBS 
buffer (5.5).  Incubation time for the release was one hour.  
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The theoretical calculated extinction coefficient of the mellitin can be calculated according to 
reference 13 (Formula A-16.1).  
 
€ 
ε(280)(M−1cm−1) = (#Trp)(5500) + (#Tyr)(1490) + (#cystines)(125) 
Formula A-16.1. Calculation of the molar extinction coefficient ε according to ref. 13. 
 
The primary structure of our cysteine-terminated mellitin is: 
CIGA VLKV LTTG LPAL ISWI KRKR QQ-OH; all D-amino acid, Mw: 2893.6 Da 
 
For the quantification of the uptake, 10 µL of the supernatant was diluted with 100 µl PBS 
buffer. The absorption was A280 = 0.213 
According to Lambert-Beer´s law, the concentration can be calculated as follows. 
 
 Under consideration of the dilution factor of 11, the Mellitin concentration in the observed 
sample can be calculated to 0.4257 µmol/mL or 1.85 mg of mellitin in 1.5 mL supernatant.  
This results in an uptaken amount of mellitin of 1.15 mg per mg SBA-MK or a linker 
occupancy of about 60 %.  
The loaded SBA-MK-Mel was separated in two equal aliquots. 
The amount of released Mellitin in the sample Quant-MK-5.5 was quantified as follows. 
A280=0.779 (no dilution!) 
c = 0.615 mg in 1.5 mL solution 
This value is multiplied by 2, since only one of the aliquots was transferred to pH 5.5. 
According to our measurements, we have released 1.23 mg Mellitin from 1 mg SBA-MK at a 
pH of 5.5 within 60 Minutes.  
The other aliquot was incubated at pH of 7.4 for 60 minutes. Again, absorption at 280 nm was 
measured. 
A280 = 0.020 
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This value can further be calculated to a mellitin release of 0.030 mg per 1 mg of SBA-MK 
within on hour at a pH of 7.4.  
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